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Medically Unexplained Symptoms: modern equivalent of an ancient problem
 Aelius Aristides, born on November 26th in the year 117 after Christ, is mostly known as a 
Greek orator and author. In one of his most famous works, the ‘Sacred Tales’, Aristides comes 
forward as a wealthy man, with religious interests and many health issues. Aristides suffers 
from many physical complaints, for which doctors cannot find a decent explanation: 
 “The doctors were wholly at a loss not only as to how to help, but even to recognize what 
the whole thing was. But the hardest and most difficult thing of all was that my breathing 
was constricted. With much effort and disbelief, scarcely would I breathe forcibly and 
rarely, and a constant constriction in my throat followed and I had fits of shivering, and 
there was need for more covering than I could bear. Besides, other unspeakable things 
troubled me.” (Behr, 1968)
Aristides is one out of many persons or characters known in the world literature suffering 
from physical symptoms in the absence of detectable disease. For instance, Emma Bovary, 
main character in the novel ‘Madame Bovary’ (Flaubert, 1857), suffers from many of these 
physical complaints: 
 “She was seized with giddiness, and from that evening her illness recommenced, with a 
more uncertain character, it is true, and more complex symptoms. Now she suffered in her 
heart, then in the chest, the head, the limbs.” (Flaubert,1857)
In ‘Burmese Days’, the first novel written by George Orwell (1934), medically unexplained 
symptoms (MUS) are described as ‘devilish’, as persons suffering from these complaints do 
not receive any sympathy from (significant) others: 
 “It is devilish to suffer from a pain that is all but nameless. Blessed are they who are 
stricken only with classifiable diseases! Blessed are the poor, the sick, the crossed in love, 
for at least other people know what is the matter with them and will listen to their belly-
achings with sympathy.”  (Orwell, 1934)
Although it is thinkable that in modern times doctors could have cured the physical 
complaints of Aristides and Emma Bovary with our current knowledge of medicine, the 
burden of having MUS is well illustrated by the quotes above.
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Consequences of medically unexplained 
symptoms 
 In line with current scientific research, the quotes 
above show that MUS can be a burden for patients 
themselves, for doctors, and for society. On a personal 
level, patients suffering from MUS typically report 
multiple symptoms, such as fatigue, joint pains or 
stomachaches, simultaneously (Wessely et al., 1999; 
Olde Hartman et al., 2004), that most likely decrease the 
experienced quality of life (Dirkzwager & Verhaak, 2007; 
Koch et al., 2007). Interestingly, ancient texts show that 
doctors have struggled with psychosomatic pain and 
other unexplained physical complaints since the start of 
modern medicine (Ackerknecht, 1982). Current studies 
show that doctors report difficulties in the communication 
with this patient group since they are not able to explain 
the origin of the patients’ symptoms and feel pressurized 
to offer medical interventions (Olde Hartman et al., 2009), 
which can put patients at risk for false positive results 
and iatrogenic damage (Ring et al., 2005). In line with this, 
patients with MUS have approximately twice as much 
health care costs compared to non-somatizing patients 
(Barskey et al., 2005), making them an expensive patient 
group to society. 
Defining medically unexplained symptoms
 Over the years, many definitions have been 
proposed for physical complaints that cannot be 
explained by somatic disease. In earlier days, terms like 
psychosomatic medicine and somatization (Lipowski, 
1988) were used to describe respectively the complex 
interaction between body and mind and the tendency to 
experience bodily discomfort without underlying physical 
disease. Nowadays the term ‘Medically Unexplained 
Symptoms’ (MUS) is most frequently used to describe 
physical complaints in the absence of disease; however, 
until now, no consensus has been reached about the 
definition of MUS. In this dissertation, the definition 
provided by the Dutch College of General Practitioners 
Brief history of 
psychosomatic medicine
Greek and Roman medicine: 
Strong focus on somatic medicine. 
Psychosomatic medicine is first 
described by Galen, under the 
label of ‘passions’. 
Middle ages:
The idea of ‘passions’ is enriched 
by the influence of the Arabs. 
Maimonides stated that emotions 
can produce bodily changes. 
Philosophy, story telling and 
music are important treatment 
strategies, as well as ‘ora et labora’. 
Renaissance:
The disengagement from religion 
encourages the introduction of 
the concept of ‘imagination’: the 
idea of being capable of producing 
and curing disease, including 
psychosomatic disease.  
19th century:
Scientific discoveries regarding 
bodily functioning and causation 
of disease stimulate not only the 
interest in physical diagnosis, but 
also in psychosomatic problems.
As an example, Trousseau 
identified psychological factors in 
common chronic illnesses. 
20th century:
Freud’s concept of psychogenic 
neuroses stimulated the 
unification of many psychosomatic 
observations into one system. 
Various disciplines, such as 
internists, became interested in 
psychosomatic problems. 
Contemporary medicine:
Ongoing research regarding 
the genesis of psychosomatic 
problems and the use of 
psychotherapeutic treatment 
for psychosomatic problems. 
Recognition of the need for 
dialogue between the patient with 
psychosomatic problems and his/
her doctor.  
Based on: Ackerknecht, 1982
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is used: ‘physical symptoms that have existed for more than several weeks and for which 
adequate medical examination has not revealed any condition that sufficiently explains the 
symptoms’ (Olde Hartman et al., 2013). 
 This definition is only partly in line with recent changes in the Diagnostic and 
Statistical Manual of Mental Disorders (DSM), the standard psychiatric classification system 
of mental disorders. Compared with the classification in the fourth edition of this manual 
(APA, 2000), the fifth edition (APA, 2013) abandoned the distinction between medically 
unexplained and medically explained symptoms (MES) and changed the name of the 
classification from somatoform disorders into somatic symptom disorder. Instead, the 
DSM-5 focuses on the presence of positive criteria, such as disproportionate thoughts 
about health that are associated with the physical complaint (Dimsdale et al., 2013). This 
seems especially important for older patients, as in later life MUS are seldom presented as 
exclusively unexplained physical symptoms (Benraad et al., 2013); also, comorbidity and 
the use of multiple drugs hamper the interpretation of symptoms as medically unexplained 
in older adults. Patients with a so-called functional syndrome (Barsky & Borus, 1999) -e.g. 
fibromyalgia, irritable bowel syndrome, chronic fatigue syndrome- can also be considered 
MUS patients. Indeed, several studies (Olde Hartman et al., 2004; Wessely et al., 1999) have 
shown that these functional syndromes are actually referring to a wide range of unexplained 
physical symptoms. 
 Taking this together, we choose to use the definition of MUS from the Dutch College 
of General Practitioners as this definition embeds the previously mentioned considerations 
regarding psychiatric classifications and functional syndromes.   
Prevalence of medically unexplained symptoms
 Not surprisingly given the broad range of MUS definitions, prevalence estimates of MUS 
vary widely between studies. Studies conducted in primary care show that between 25% 
and 50% of all consultations (Verhaak et al., 2006) to even two thirds of all consultations 
(Steinbrecher et al., 2011) remain medically unexplained. Studies conducted in secondary 
care show prevalence estimates of 21% (Reid et al., 2001) in frequently attending patients to 
51% across a variety of medical specialities (Nimmuan et al., 2001). Mostly, these complaints 
are not a burden for patients and their physicians as they have a favourable course due 
spontaneous cure and/or management by the general practitioner. The prevalence of 
problematic, chronic MUS is much lower (2,5%) (Verhaak et al., 2006), but the burden is high 
for both the patient and the general practitioner. 
 Hilderink et al. (2013) compared prevalence estimates of MUS between age groups 
in a systematic review. Prevalence estimates were lowest in older persons over 65 years 
(between 4.6% and 18%), compared to prevalence estimates in younger adults under 50 
years (between 1.6% and 70%) and in middle-aged adults between 50 and 65 years old 
(between 2.4% and 87%). Although this study (Hilderink et al., 2013) shows that MUS are 
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less frequent in later life, the authors point out that prevalence rates in older adults might 
actually be underestimations due to increasing prevalence rates of chronic somatic diseases 
with aging. Patients with co-morbid somatic disorders are often excluded in research studies 
and if not, physical symptoms in later life may falsely be ascribed to these chronic somatic 
diseases. Furthermore, one could suggest that even if MUS are less prevalent in later life, the 
consequences of MUS can have great impact on medical and mental health institutions due 
to ageing of the population in most (Western) countries. 
Determinants of medically unexplained symptoms 
 Following the biopsychosocial model of disease by Engel (1977), empirical studies 
in younger MUS patients have identified demographic, physical, psychological, and social 
determinants that are involved in the onset and maintenance of MUS. 
 First of all, a lower age and female gender have frequently been identified as 
determinants of MUS (Koch et al., 2007; Verhaak et al., 2006; Steinbrecher & Hiller, 2011). 
Results with regard to educational level are equivocal as both lower and higher educational 
levels have been identified as determinants of MUS (Koch et al., 2007; Verhaak et al., 2006). 
 Second, psychological and psychiatric factors are associated with MUS. Psychological 
constructs that have been related to MUS include an insecure attachment style (Taylor et 
al., 2012), the presence of alexithymia (Deary et al., 1997), a high number of negative life 
events or traumatic experiences in childhood or adulthood (Van den Berg et al., 2005; Katon 
et al., 2001; Afari et al., 2014), personality traits such as neuroticism (Katon et al., 2001), a 
negative illness perception and the presence of catastrophizing cognitions (Steinbrecher & 
Hiller, 2011). Furthermore, psychiatric comorbidity is frequently found in patients with MUS, 
as up to 60% of patients have clinically relevant levels of comorbid anxiety and/or depressed 
mood (Barskey et al., 2005; Van Boven et al., 2011). Moreover, comorbid anxiety or depressive 
disorder is associated with higher functional impairment levels in MUS patients (De Waal 
et al., 2004). With respect to cognitive functioning, it is generally assumed that nonspecific 
cognitive abnormalities are present in MUS patients in the absence of a neurological disease 
(Binder & Campbell, 2004). For example, a pilot study on cognitive functioning in patients 
with a somatization disorder or undifferentiated somatoform disorder found impaired 
verbal memory capacity, impaired visuo-spatial skills and attention deficits in somatizing 
patients compared to non-somatizing patients (Niemi et al., 2002). Intelligence is negatively 
associated with the number of MUS (Kingma et al., 2009). 
 Third, several social factors are possibly involved in the maintenance of MUS. For 
instance, patients with MUS more often had a widowed or divorced marital status (Verhaak 
et al., 2006) and a higher degree of social isolation (Dirkzwager & Verhaak, 2007) compared to 
a frequent attending primary care group with medically explained physical symptoms. 
Physical determinants have received relatively little attention in research conducted in 
younger adults, which is understandable given the low prevalence rates of somatic disease in 
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younger age groups. A large-scale study found no association between childhood disease and 
MUS in adulthood (Hotopf et al., 1999). Other physical characteristics of adult MUS patients 
have, as far as we know, only been studied in the context of evaluating the risk of overlooking 
underlying somatic disease. A recent systematic review and meta-analysis (Eikelboom et al., 
2016) showed that, after diagnostic evaluation, in 8.8% of assumed MUS patients a somatic 
disease was found that could explain the physical symptoms; the percentage of missed 
somatic diagnoses during follow-up was estimated 0.5%, indicating somatic disease is 
seldom overlooked by doctors. 
 Interestingly, pain experience in depression, which is often considered medically 
unexplained pain (Katona et al., 2005), has been studied quite well. These studies show that 
pain and depression occur more often together than can be expected by chance (Bair et 
al., 2003), with slightly more evidence for the hypothesis of depression as a consequence 
of pain (Fishbain et al., 1997; Goesling et al., 2013). Also, it seems that pain severity, among 
other pain characteristics, is associated with more depressive symptoms, while at the same 
time more severe depressive symptoms are associated with e.g. greater pain intensity (Bair 
et al., 2003). From a neurobiological view, evidence has been found for a pain-depression 
association because of similarities in brain regions involved in processing physical and 
psychological pain, and shared neurotransmitters for the expression of depression and pain 
(Goesling et al., 2013). In addition, evidence has been found that psychosocial factors -such 
as catastrophizing, affective factors, disturbed sleeping patterns and fear-related avoidance- 
are mediating the association between pain and depression (Goesling et al., 2013). 
 In sum, MUS and pain in depression seem to be the result of a complex interplay 
between physical, psychiatric, psychological, cognitive, and social determinants that may 
have great impact on the patient’s wellbeing and health-related quality of life (Anderson & 
Ferrans, 1997; Dirkzwager & Verhaak, 2007; Creed et al., 2001; Fagring et al., 2008; Gralnek et 
al., 2000; Duddu et al., 2008; Elliot et al., 2003). 
Medically unexplained symptoms in later life: unresolved issues in clinical 
practice
 As many of the studies above focus on relatively younger patients or even exclude 
older patients, it remains unknown whether or not the previously described determinants 
are also associated with MUS in later life. Empirical studies on the determinants and patient 
characteristics of MUS in later life are scarce and limited to smaller pilot studies. The assumed 
lower prevalence rate of MUS in older persons as well as an increased prevalence of MES with 
aging argue for age-specific studies to confirm or refute the above described associations in 
older samples.
 Thus far, only one study, conducted in a specialized outpatient clinic for late-life 
MUS, has described the characteristics of older MUS patients. This pilot study showed that 
older MUS patients often present themselves with a mixture of explained and unexplained 
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physical complaints (Benraad et al., 2013). Furthermore, this study shows that older MUS 
patients have high psychiatric comorbidity rates as 69% of the patients also suffered from 
a depressive disorder, anxiety, and/or substance abuse disorder (Hilderink et al., 2009). 
Finally, these patients experience substantial limitations in social interaction, mobility, and 
household activities (Hilderink et al., 2009). 
 Although this pilot study (Benraad et al., 2013; Hilderink et al., 2009) emphasizes the 
complexity of late-life MUS, the sample size of this study was small (n=37), the patient group 
was highly selected and no comparison group was used. In studies concerning younger MUS 
patients, most frequently healthy control groups are used. Studies using a control group of 
persons with MES show that MUS patients and MES patients have more patient characteristics 
in common than formerly was believed. For instance, Kisely and Simon (2006) showed that 
somatic symptoms, irrespective of etiology, were associated with increased psychosocial 
morbidity and physical functioning. As MES get more common with increasing age, it would 
be interesting to compare patient characteristics of MUS patients with those of patients with 
MES. In what ways do these patient groups resemble each other? In what ways are these 
patient groups different? Also, previous research in younger adults might not have considered 
age-specific determinants, such as a decreased sense of meaning in life (Pinquart, 2002) or 
physical determinants due to a higher prevalence of chronic somatic diseases (Benraad et 
al., 2013) in older MUS patients. In this dissertation, we try to address these previous study 
limitations by exploring general and age-specific determinants and patient characteristics in 
older (60 years and over) MUS patients and older patients with chronic MES.  
 Knowledge about determinants and patient characteristics of late-life MUS can 
contribute to the development of appropriate interventions for older patients with chronic 
MUS. Should we focus on treating physical symptoms? Should we refer to psychological 
treatment? Should we focus on strengthening the social network? Or should we combine 
treatment programs? Moreover, knowledge about late-life MUS can possibly give practical 
guidance to doctors and other formal caregivers, as many doctors find it difficult to explain 
MUS to patients (Olde Hartman et al., 2009). 
Aims of this dissertation 
The aim of this dissertation is twofold (see Figure 1 for a schematic overview of the 
associations that are studied in this dissertation):
1. The first aim of this thesis is to describe the association between general functioning and 
late-life MUS.  
In Part I of this thesis we first examine the relationship between late-life MUS and health-
related quality of life (HRQoL) (Chapter 2). Also, we study the association between late-life 
MUS and HRQoL over time (Chapter 3). Furthermore, we examine the relationship between 
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late-life MUS and meaning in life (Chapter 4), as it is known that people are better capable 
of adapting to illness when they find a sense of meaning in life (Thompson, 1991; Park et al., 
2008). 
2. The second aim of this thesis is to explore biopsychosocial determinants and patient 
characteristics of older persons with MUS. 
In Part II of this thesis we examine chronic pain characteristics of late-life MUS, MES, and 
depression (Chapter 5), and biopsychosocial determinants of pain in older persons with 
depression (Chapter 6). In Part III we study psychological characteristics of late-life MUS, 
specifically personality traits (Chapter 7) and illness cognitions (Chapter 8). In Part IV, we 
examine social characteristics of late-life MUS (Chapter 10), for which we first validated a 
social support scale in a Dutch psychiatric population (Chapter 9). In Chapter 10, we also 
identify care needs of older MUS patients, as this gives us the opportunity to explore possible 
treatment goals for this patient group and, in the long term, explore future intervention 
programmes for late-life MUS.  
Figure 1: Schematic overview of the associations that are studied in this dissertation.
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Data sources in this dissertation 
 In the current dissertation, we use data from the Older Persons with medically 
Unexplained Symptoms (OPUS) Study, the Netherlands Study of Depression in Older Persons 
(NESDO) and the Netherlands Study of Depression and Anxiety (NESDA). Our research team 
gathered the OPUS data; the data from the other two studies were made available by the 
research teams of NESDO and NESDA.
Older Persons with medically Unexplained Symptoms (OPUS) Study 
 In the first part of the OPUS study, we aim to explore possible biopsychosocial 
determinants and the course of late-life MUS, using both quantitative and qualitative research 
designs. The quantitative part of our research consists of a case-control study and a follow-
up measurement in which we compare patient characteristics of 118 older MUS patients (>60 
years) with chronic MUS (>3 months) to 154 older patients with chronic (>3 months) MES, such 
as rheumatoid arthritis or COPD. To compose a varied study group regarding the severity of 
MUS, participants with MUS and MES were recruited in the community by advertisements in 
local newspapers, in primary care, and in secondary health care; the latter including both an 
outpatient mental health clinic for old age psychiatry and the department of geriatrics of a 
University Medical Center. Exclusion criteria for both cases and controls were the presence of 
a primary psychotic disorder, cognitive impairment, terminal illness, severe auditory and/or 
visual limitations, and insufficient command of the Dutch language. 
 The qualitative part of our research consists of individual in-depth interviews with 16 
older MUS patients in which we explored the concept of ‘meaning in life’. Participants for 
the qualitative in-depth interviews were selected from the OPUS study case-control sample 
using purposive sampling techniques.
 In the second part of the OPUS study interventions were developed for the different 
echelons in our health care system, i.e. for welfare workers outside the medical system, for 
primary care and for secondary mental health care. Only the results of the first part of the 
study are presented in this dissertation.  
Netherlands Study of Depression in Older Persons (NESDO)
 NESDO aims to study neurobiological, physical, and psychosocial determinants and 
the course of late-life depression in a multisite, naturalistic, prospective cohort study (Comijs 
et al., 2011). The NESDO study sample consists of 378 older (> 60 years) participants with a 
6-months diagnosis of major or minor depression or dysthymia, and a comparison group 
of 132 non-depressed participants (> 60 years) without a history of depression. Depressed 
participants were recruited from mental health care institutes and general practices. 
Nondepressed controls were recruited from general practices only. Exclusion criteria 
were (suspicion of) a primary diagnosis of dementia (operationalized as a Mini Mental 
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State Examination-score < 19; Folstein et al., 1975) and insufficient command of the Dutch 
language. A more detailed description of the NESDO study can be found elsewhere (Comijs 
et al., 2011).
Netherlands Study of Depression and Anxiety (NESDA)
 NESDA aims to study the clinical, biological, and psychosocial determinants and 
consequences of depressive and anxiety disorders in adults (18-65 years) (Penninx et al., 
2008). In this multisite, longitudinal, naturalistic cohort study, 1701 participants with an 
anxiety and/or depressive disorder in the past six months, 907 participants with a lifetime 
diagnosis of depressive and/or anxiety disorders, and 373 healthy controls with no history 
of anxiety or depressive disorder, were included. Patients were recruited from community, 
primary care, and mental health organizations. Exclusion criteria were the presence of other 
primary, clinically overt diseases such as psychotic disorder, obsessive-compulsive disorder, 
bipolar disorder, or severe addiction disorder, and language problems that could disturb 
reliable data collection. A more detailed description of the study sample and procedures can 
be found in Penninx et al. (2008). 

 
Part I.
General functioning & medically unexplained symptoms 
in later life.
 

2.
Health-related quality of life in older persons with 
medically unexplained symptoms.
Hanssen, D.J.C., Lucassen, P.L.B.J., Hilderink, P.H., Naarding, P., & Oude Voshaar, R.C. (2016). 
Health-related quality of life in older persons with medically unexplained symptoms. 
American Journal of Geriatric Psychiatry, 24(11), 1117-1127. 
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Abstract
Research on Health-Related Quality of Life (HRQoL) in older persons with Medically 
Unexplained Symptoms (MUS) is scarce, whereas in contrast to younger patients, 
interactions with chronic somatic diseases are more complex. In the current study we 
compare HRQoL between older persons with MUS and older persons with Medically 
Explained Symptoms (MES). Our study sample consists of 118 older MUS patients and 
154 older MES patients. The diagnosis of MUS was ascertained by the GP and confirmed 
by a geriatrician within a multidisciplinary diagnostic assessment. Additional 
characteristics, including HRQoL (Short-Form-36), were assessed during a home-visit. 
MES patients received two home-visits to assess all measures. Multiple linear regression 
analyses, adjusted for age, sex, education, cognitive functioning and psychiatric 
diagnoses, were performed to assess the relationship between group (MUS/MES) and 
HRQoL. Analyses were repeated with additional adjustments for somatization and 
hypochondriacal cognitions. Older patients with MUS had a significantly lower level 
of HRQoL compared to older patients with MES. Even after adjustments, the presence 
of MUS was still associated with both a lower physical and mental HRQoL. These 
associations disappeared, however, after additional adjustments for somatization 
and hypochondriacal cognitions. Within the subgroup of MUS patients, a higher level 
of hypochondriac anxiety and of somatization were significantly associated with both 
lower physical and mental HRQoL. Associations between HRQoL and late-life MUS 
disappear when corrected for somatization and hypochondriacal cognitions, which 
is in line with the DSM-5 classification of somatic symptom disorder. Appropriate 
psychological treatment seems needed to improve HRQoL in older MUS patients.  
HEALTH-RELATED QUALITY OF LIFE IN OLDER PERSONS WITH MEDICALLY UNEXPLAINED SYMPTOMS. 
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Introduction
 The World Health Organization defines Quality of Life (QoL) as the ‘individuals’ 
perception of their position in life in the context of the culture and value systems in which 
they live and in relation to their goals, expectations, standards and concerns’.  Following this 
definition, QoL is a subjective, multidimensional concept in which physical, material, social, 
and emotional wellbeing, activity and development should be taken into account (Felce 
& Perry, 1995). Over the years, much research in medicine has been performed on Health-
Related Quality of Life (HRQoL) on the assumption that medical treatment should not only 
improve disease outcomes but also HRQoL (Wilson & Cleary, 1995; Ferrans et al., 2005). 
 Knowledge on HRQoL in older adults with Medically Unexplained Symptoms (MUS) 
is limited. MUS are physical symptoms that are present for more than several weeks and 
for which, even after adequate medical examination, no sufficient medical explanation has 
been found (Olde Hartman et al., 2013). In the DSM-IV TR (APA, 2000), MUS are classified 
under the section of somatoform disorders. This section has been replaced by the section 
on somatic symptom disorders in DSM-5 (APA, 2013) in which the distinction between MUS 
and Medically Explained Symptoms (MES) is abandoned and replaced by positive criteria like 
disproportionate thoughts (e.g. health anxiety) or behavior (e.g. somatization) associated 
with a physical symptom. MUS patients are highly expensive for society due to frequent use of 
health services (Konnopka et al., 2012), whereas their needs are not adequately addressed by 
the medical system. Moreover, older MUS patients have high levels of psychiatric comorbidity, 
especially depression and anxiety (Hilderink et al., 2009), as well as multiple somatic diseases 
(Benraad et al., 2013). In addition to the severity of the MUS, HRQoL may thus be affected by 
these high psychiatric and somatic comorbidity rates (Sheehan & Banerjee, 1999).
 In younger age groups, the presence of MUS has consistently been associated with 
lower HRQoL scores (Anderson & Ferrans, 1997; Dirkzwager & Verhaak, 2007; Creed et al., 
2001; Fagring et al., 2008; Gralnek et al., 2000; Duddu et al., 2008), which are persistent over 
time (Ternesten-Hasséus et al., 2007). Depending on the severity of MUS, the strength of this 
association may somewhat differ for mental and physical HRQoL. For example, in a general 
primary care sample, early stage MUS was most strongly related to the physical component 
of HRQoL (Koch et al., 2007), whereas in patients with severe, persistent chronic fatigue 
mental and physical components were equally affected (Anderson & Ferrans, 1997).
 To our knowledge, only three studies have been conducted on HRQoL in older MUS 
patients. The first study showed that the severity of fibromyalgia was lower and HRQoL 
better in patients aged 60 years and older compared to their younger counterparts. However, 
HRQoL in older participants was still significantly lower than the norm scores across all age 
groups (Jiao et al., 2014). The second study (Joustra et al., 2015) investigated HRQoL in a 
general population sample consisting of persons with functional syndromes, persons with 
MES and healthy controls, including participants over 60 years. This study shows that patients 
with functional syndromes report lower HRQoL scores when compared to healthy controls, 
but equal HRQoL scores when compared to MES patients. Unfortunately, the authors did 
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not differentiate between age groups. The third study did differentiate between age groups 
and found that the association between MUS and HRQoL declines with age. Furthermore, 
the association between late-life MUS and HRQoL had a similar strength as the association 
between late-life MES and HRQoL, when corrected for the presence of depressive and anxiety 
disorders (Hilderink et al., 2015). Though these studies show that late-life MUS possibly affect 
HRQoL, the results of two of the described studies are based on highly selective patient 
groups (patients with functional syndromes) and all studies lack a physical examination 
to classify patients into study groups. Also, even though these studies did correct for the 
presence of psychiatric disorder, the role of somatization and hypochondriacal cognitions 
in the association between HRQoL and late-life MUS remains unknown. Consequently, 
extensive research is needed to clarify the link between HRQoL and late-life MUS. If there 
is a link between HRQoL and MUS in older patients, this should have consequences for the 
treatment of older MUS patients in the light of the limited availability of evidence-based 
treatments for MUS.
 Therefore, the aim of the present study is to compare the level of both physical and 
mental HRQoL between a well-characterized and representative cohort of older patients with 
MUS and older patients with MES. Subsequently, we will explore whether indicators of the 
severity of MUS are associated with HRQoL in the subgroup of older MUS patients. 
Methods
Study design 
 The Older Persons with medically Unexplained Symptoms (OPUS) project is a large 
observational study aiming to explore physical, psychological and social determinants of 
late-life MUS in order to develop suitable interventions for this patient group. 
 As part of this research project, we performed a case-control study in which we compare 
118 older (>60 years) patients with chronic MUS (cases) to 154 older persons suffering from 
MES (comparison group). To compose a diverse research group regarding the severity of MUS, 
possible participants with MUS and MES were recruited in the community by advertisements 
in local news papers (self-referral), in primary care, specifically by General Practitioners 
(GPs), and in secondary health care, including both an outpatient mental health clinic for 
old age psychiatry and the department of geriatrics of the Radboud University Medical 
Center (Nijmegen, the Netherlands). To assist GPs with selecting possible participants, the 
top 20% of older frequent attending patients in their own practice were extracted from the 
GP Information System. Subsequently, the GP manually selected possible participants using 
the definition of MUS and MES and the following exclusion criteria: 1) presence of a primary 
psychotic disorder; 2) presence of cognitive impairment, defined as a Mini Mental State 
Examination (MMSE; Folstein et al., 1975) total score below 19 or an established diagnosis of 
dementia; 3) suffering from terminal illness; 4) not sufficiently mastering the Dutch language; 
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and 5) severe auditory and/or visual limitations hindering reliable data collection. This 
selection method was chosen based on previous research projects on MUS and other high 
utilizing patient groups in primary care (e.g. Katon et al., 2001; Smits et al., 2009). A detailed 
illustration of our patient recruitment can be found in Figure 1. 
Specialized Mental 
Health care (n=96) 
 
 
Frequent attenders  
primary care (n=512) 
 
 
Cases 
Patients with MUS (n=118): 
•  Geriatric assessment (n=118): 
•  Full (n=70) 
•  Limited (n=48) 
•  Psychiatric assessment (n=118) 
•  Research interview (n=109) 
 
Suspected  
MES (n=370) 
 
 
Referred by GP (n=46)   Suspected          
Self-referrals (n=50)    MUS (n=142) 
 
Comparison group 
Patients with MES (n=154): 
•  Geriatric assessment (n=154): 
•  Full (n=0) 
•  Limited (n=154) 
•  Psychiatric assessment (n=154) 
•  Research interview (n=150) 
Excluded (n=17): 
•  No physical complaints (N=17) 
 
Refused consent (N=199): 
•  No interest or time (N=97) 
•  Too ill physically (N=33) 
•  Other or unknown (N=69) 
Excluded (n=30): 
•  No MUS confirmed by GP/geriatrician (N=23)* 
•  No physical complaints anymore (N=7) 
 
Refused consent (N=90):  
•  No interest or time (N=19) 
•  Refused psychiatric assessment (N=10) 
•  Too ill physically (N=5) 
•  Other or unknown (N=56) 
Figure 1: Recruitment of participants.
 If MUS patients decided to participate in our study, they visited a multidisciplinary 
clinic specialized in late-life MUS for an extensive diagnostic process. First, a geriatrician 
performed a comprehensive physical examination in which the severity and location(s) of 
the complaints, somatic comorbidity, and medication use were assessed, amongst others 
(‘full geriatric assessment’). An old-age psychiatrist assessed the presence of a somatoform 
disorder according to DSM-IV criteria and checked for possible psychiatric comorbidity. Also, 
a psychologist explored illness cognitions, consequences of the physical complaints and 
quality of life of the older MUS patients. Last, a researcher visited the older MUS patients to 
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assess additional measures, such as social and cognitive functioning. In case MUS patients 
refused to participate or were physically unable to visit the clinic (n=45), but nevertheless 
agreed to participate in the OPUS study, a well-trained researcher visited the participants twice. 
During the additional home-visit all instruments used by the multidisciplinary team, with the 
exception of some geriatric measures (CIRS-G), for which training was deemed insufficient 
to ensure reliable data-collection, were assessed. In that case, the geriatric assessment was 
limited to the severity and location(s) of the complaints, somatic comorbidity, gait speed, 
handgrip strength, weight loss, and medication use (‘limited geriatric assessment’). This 
procedure was similar to the procedure of participants in the comparison group that also did 
not receive the multidisciplinary screening, and also were visited twice by the researcher. All 
measurements have been performed between September 2011 and March 2014. 
 All participants gave written informed consent after receiving oral and written 
information. The local Medical Ethical Committee approved the study protocol. 
Cases and comparison group
 MUS patients were included if they met the definition of MUS of the Dutch General 
Practitioners Guideline (Olde Hartman et al., 2013), meaning they had physical symptoms 
for which, after extensive physical examination, no sufficient medical explanation had been 
found. Also, patients were included if a so-called functional syndrome was present, i.e. 
fibromyalgia or chronic fatigue syndrome (Wessely et al., 1999). The unexplained symptoms 
needed to be present for at least three months. Furthermore, the older person’s GP and/or the 
multidisciplinary team needed to confirm the presence of MUS. Patients were included even 
when explained physical symptoms were present as well, as it is known late-life MUS is often 
presented as a combination of unexplained and explained physical symptoms (Benraad et 
al., 2013).
 MES patients were selected if they were frequently attending visitors of their GPs with 
one or more evident physical complaints that were present for three months or longer, 
that could be fully explained by the presence of at least one chronic somatic disease, e.g. 
rheumatoid arthritis or asthma. The patient’s GP needed to reconfirm the explained nature 
of the complaints.
 Exclusion criteria for both MUS patients and MES patients are described above. 
Measures
Health-Related Quality of Life
 HRQoL was assessed with a Dutch version of the Medical Outcome Study Short Form 
Health Survey (SF-36; Brook et al., 1979; Van der Zee & Sanderman, 2012). The SF-36 consists 
of eight subscales: ‘physical functioning’ (10 items), ‘role limitations due to physical problem’ (4 
items), ‘bodily pain’ (2 items), ‘general health’ (5 items), that were combined into the physical 
HRQoL component score, and ‘vitality’ (4 items), ‘social functioning’ (2 items), ‘role limitations 
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due to emotional problem’ (3 items) and ‘mental health’ (5 items), that were combined into 
the mental HRQoL component score. 
 We scored the questionnaire in accordance with the official Dutch guidelines (Van 
der Zee & Sanderman, 2012). Subscale scores ranged from 0 to 100, zero meaning very low 
HRQoL. A higher component score indicates higher levels of physical or mental HRQoL. The 
SF-36 subscale scores and component scores were our primary variables of interest. 
Characteristics of Medically Unexplained Symptoms
 Several measures were included to characterize MUS in more detail. These additional 
measures are in fact severity measures of specific aspects of MUS:
 The severity of the primary physical complaint was assessed with a Visual Analogue 
Scale (VAS-scale), ranging from 0 (not severe at all) to 100 (very severe). Higher scores on this 
scale indicate a more severe perceived intensity of the physical complaint.
 We used the Brief Symptom Inventory (BSI-53; Derogatis, 1975) somatization subscale 
to assess the level of somatization. This 7-item subscale with answering categories from 
1 (not present at all) through 5 (present all the time) assesses the presence of physical 
complaints typical for functional disorders. A higher subscale score indicates increased levels 
of somatization. 
 We used the Whitely Index (WI; Pilowsky, 1967) to assess the presence of hypochondriac 
cognitions. This questionnaire consists of 14 statements that have to be answered with yes or 
no; higher scores indicate more hypochondriac cognitions. 
 The presence of psychiatric disorders according to DSM-IV-TR criteria was assessed with 
the Mini International Neuropsychiatric Interview (MINI, version 5.0; Sheehan et al., 1998), a 
semi-structured psychiatric interview. Psychiatric disorders were subsequently classified in 
the following categories due to low numbers for some individual disorders: the presence of a 
somatoform disorder (somatization disorder/hypochondria/pain disorder/undifferentiated 
somatoform disorder/somatoform disorder NOS), a mood disorder (major depressive 
disorder/dysthymia), an anxiety disorder (panic disorder/agoraphobia/social phobia/
obsessive-compulsive disorder/posttraumatic stress disorder/general anxiety disorder), and 
finally a substance use disorder (alcohol- and substance dependence and abuse).
Covariates
 We assessed age (in years) at the moment of inclusion, gender and education (low, 
average, high) as socio-demographic variables. Global cognitive functioning was assessed 
with the MMSE (Folstein et al., 1975). 
Statistical analyses
 First, we compared differences between older MUS patients and older MES patients 
regarding patient characteristics and HRQoL by t-tests for independent samples in case of 
continuous, normally distributed variables, Mann Whitney U-tests for continuous variables 
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that are not normally distributed and Chi Square tests for categorical variables. Subsequently, 
we performed multiple linear regression analyses with the SF-36 subscales and component 
scores as outcomes, adjusted for socio-demographic variables (age, gender, education), the 
presence of mood disorder (yes/no), anxiety disorder (yes/no), and substance use disorder 
(yes/no), and a global score of cognitive functioning (MMSE total score; Folstein et al., 1975), 
to explore the associations with the presence of late-life MUS (versus MES). 
 Finally, we explored to what extent characteristics of late-life MUS (somatization, 
hypochondriac cognitions, somatoform disorder according to DSM-IV, any other psychiatric 
diagnosis according to DSM-IV, and severity of primary physical complaint) were associated 
with HRQoL scores in older MUS patients. Multiple linear regression analyses were performed 
for the mental and physical HRQoL component scores, adjusted for socio-demographic 
variables and a global score of cognitive functioning. We detected no multicollinearity 
problems after inspecting the correlation matrix and the Variance Inflation Factors (VIFs) 
(range 1.044 – 1.874). All characteristics significant at the p<.05 level were entered into 
the final models; final models were adjusted for socio-demographic variables and global 
cognitive functioning score.  
 For all linear regression analyses B-scores (B), Standard Errors (SE), standardized 
B-values (Beta values), t-values, df-values, and p-values are reported. Furthermore, R2 values 
are reported to express how much of the variability of HRQoL is explained by the tested 
model. Differences are considered statistically significant if p<.05. All statistical analyses were 
performed using IBM SPSS version 20. 
Results
Sample characteristics
 Table 1 shows the patient characteristics and levels of HRQoL for older adults with MUS 
and MES separately. MUS patients were significantly younger and more often female than 
MES patients. Furthermore, older MUS patients scored approximately 10 points lower on 
all SF-36 subscales compared to older MES patients, except for the General Health subscale 
and Social Functioning subscale. In line with this, MUS patients reported lower mental and 
physical HRQoL component scores than MES patients (table 1).  
 
Associations between group (late-life MUS/MES) and HRQoL
 Linear regression analysis (table 2) showed that MUS was negatively associated with 
both mental and physical HRQoL component scores. Specifically, late-life MUS (versus MES 
as independent variable) were significantly and negatively associated with all but two SF-36 
subscales (as dependent variables), namely general health and social functioning (table 2). 
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Associations between HRQoL and severity measures of late-life MUS
 Because of the significant association between late-life MUS and HRQoL scores, more 
detailed analyses on HRQoL in older MUS patients were performed. Table 3 shows the results 
of our multiple linear regression analyses, adjusted for socio-demographic variables and 
cognitive functioning. 
 
Table 1: Patient characteristics of the study sample (N=272), specified for older persons with chronic 
Medically Unexplained Symptoms (MUS) and older persons with Medically Explained Symptoms (MES). 
Characteristics Values 
Cases 
 
Older  
persons with 
MUSa
(n=118)
Values 
Comparison 
group
 
Older persons 
with MESb
(n=154)
t / U / chi2  
(df )
p value 
Patient 
characteristics
 
Age
 
Mean (SD)
 
70.54 (6.72)
 
73.42 (7.74)
 
-3.23 (270)
 
.001 c
Female % (n) 64.4 (76) 43.5 (67) 11.70 (1) .001 e
Education 
-lower 
-average 
-higher
 
% (n) 
% (n) 
% (n)
 
26.9 (29) 
45.4 (49) 
27.8 (30)
 
17.8 (27) 
52.6 (80) 
29.6 (45)
 
 
 
3.17 (2)
 
 
 
.205 e
Differential 
characteristics 
MUS/MES
 
Somatization 
(BSI-53)
Mean (SD) .81 (.65) .52 (.50) 3.97 (241) <.001 c
Hypochondriacal 
cognitions (WI)
Mean (SD) 4.31 (2.95) 2.18 (2.43) 4490 <.001 d
Somatoform 
Disorder 
according to 
DSM-IV criteria 
% (n) 58.5 (69) 0 (0) 120.03 (1) <.001 e
Mood Disorder 
according to 
DSM-IV criteria
% (n) 26.3 (31) 20.9 (32) 1.07 (1) .301 e
Anxiety Disorder 
according to 
DSM-IV criteria
% (n) 18.6 (22) 8.5 (13) 6.10 (1) .014 e
Substance 
Use Disorder 
according to 
DSM-IV criteria
% (n)  5.1 (6) 2.0 (3) 2.02 (1) .156 e
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Severity of 
primary physical 
complaint (VAS-
scale)
Mean (SD) 48.79 (18.09) 46.24 (25.70) .86 (238) .393 c 
Health-Related 
Quality of Life
SF-36 subscales: 
- Physical 
functioning 
- Role limitations 
physical problem 
- Bodily pain 
- General health 
- Vitality 
- Social 
functioning 
- Role limitations 
emotional 
problem 
- Mental health
 
Mean (SD) 
Mean (SD) 
Mean (SD) 
Mean (SD) 
Mean (SD) 
Mean (SD) 
Mean (SD) 
Mean (SD)
 
63.05 (28.83) 
45.71 (39.45) 
55.87 (27.19) 
53.94 (15.59) 
54.29 (23.33) 
45.79 (10.25) 
75.16 (36.82) 
70.44 (22.30)
 
72.29 (24.93) 
66.50 (37.95) 
70.81 (23.81) 
57.75 (16.64) 
67.29 (20.14) 
47.55 (11.83) 
90.63 (25.21) 
83.50 (16.60)
 
-2.74 (256) 
-4.25 (256) 
-4.68 (257) 
-1.84 (255) 
-4.77 (256) 
-1.23 (255) 
-4.02 (257) 
-5.39 (256)
 
.007 c 
<.001 c 
<.001 c 
.066 c 
<.001 c 
.219 c 
<.001 c 
<.001 c
Mental Health-
Related Quality 
of Life 
Component 
Score (SF-36)
Mean (SD) 61.56 (18.64) 72.24 (13.52) -5.33 (255) <.001 c
Physical 
Health-Related 
Quality of Life 
Component 
Score (SF-36)
Mean (SD) 55.46 (21.80) 66.84 (19.87) -4.31 (253) <.001 c
a Medically Unexplained Symptoms
b Medically Explained Symptoms
c Significance values derived from independent samples t-tests
d Significance values derived from Mann-Whitney U-tests 
e Significance values derived from Chi-square tests
HEALTH-RELATED QUALITY OF LIFE IN OLDER PERSONS WITH MEDICALLY UNEXPLAINED SYMPTOMS. 
31
Ch
ap
te
r 2
Table 2: Associations between group (Medically Unexplained Symptoms- MUS/Medically Explained 
Symptoms- MES) and Health-Related Quality of Life scores, derived from the Short Form-36 (SF-
36) scores.
Outcomes B (SE) Beta t (df ) p-value R2
Component score: 
Physical Health-Related Quality of 
Life (SF-36)
Group (MUS/MES) b -11.10 (2.72) -.258 -4.09 (230) <.001 .186
Corresponding SF-36 subscales:
- Physical functioning
Group (MUS/MES)b -10.88 (3.40) -.201 -3.20 (231) .002 .196
- Role limitations physical problem
 Group (MUS/MES) 
b
-20.12 (5.18) -.251 -3.89 (232) <.001 .142
- Bodily pain
Group (MUS/MES) b -12.49 (3.35) -.236 -3.73 (232) <.001 .174
- General health
Group (MUS/MES) b -3.84 (2.22) -.117 -1.73 (231) .085 .064
Component score: 
Mental Health-Related Quality of 
Life (SF-36)
.
Group (MUS/MES) b -9.03 (1.97) -.270 -4.59 (232) <.001 .286
Corresponding SF-36 subscales:
- Vitality 
Group (MUS/MES) b -11.74 (2.84) -.254 -4.04 (232) <.001 .181
- Social functioning
Group (MUS/MES) b -2.11 (1.55) -.093 -1.36 (232) .174 .036
- Role limitations emotional problem
Group (MUS/MES) b -13.02 (3.91) -.206 -3.33 (232) .001 .211
- Mental health
Group (MUS/MES) b -10.16 (2.34) -.250 -4.34 (232) <.001 .315
a Associations examined using linear regression analyses
b Adjusted for socio-demographic variables (age, gender, education), the presence of mood disorder (yes/no), of 
anxiety disorder (yes/no), and of substance use disorder (yes/no), and global score cognitive functioning (MMSE 
total score). 
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Table 4: Associations between group (Medically Unexplained Symptoms- MUS/Medically Explained 
Symptoms-MES) and Health-Related Quality of Life scores, additionally adjusted for levels of 
somatization and hypochondriacal cognitions.
Outcomes B (SE) Beta t (df ) p-value R2
Component score: 
Physical Health-Related Quality of Life  
(SF-36)
Group (MUS/MES) a -2.66 (2.45) -.062 -1.08 (219) .280 .447
- Physical functioning
Group (MUS/MES) a -4.65 (3.47) -.086 -1.34 (219) .182 .303
- Role limitations physical problem
Group (MUS/MES) a -7.12 (5.09) -.089 -1.40 (219) .163 .315
- Bodily pain
Group (MUS/MES) a -4.01 (3.25) -.075 -1.23 (219) .220 .358
- General health
Group (MUS/MES) a 1.82 (2.18) .055 .83 (219) .406 .249
Component score 
Mental Health-Related Quality of Life  
(SF-36)
Group (MUS/MES) a -3.10 (1.84) -.093 -1.68 (219) .094 .483
- Vitality 
Group (MUS/MES) a -3.60 (2.72) -.080 -1.32 (219) .187 .382
- Social functioning
Group (MUS/MES) a -1.51 (1.69) -.067 -.89 (219) .375 .045
- Role limitations emotional problem
Group (MUS/MES) a -4.33 (3.97) -.068 -1.09 (219) .277 .330
- Mental health
Group (MUS/MES) a -3.92 (2.27) -.097 -1.73 (219) .085 .469
a Adjusted for socio-demographic variables (age, gender, education), the presence of mood disorder (yes/no), of 
anxiety disorder (yes/no), and of substance use disorder (yes/no), global score cognitive functioning (MMSE total 
score), levels of somatization (BSI-53) and hypochondriacal cognitions (WI). 
 
 The final model (R2 = .512) showed significant, negative associations between mental 
HRQoL and hypochondriac cognitions (Beta=-.299;t(73)=-3.17;p=.002), somatisation 
(Beta=-.301; t(73)=-2.99;p=.004) and the presence of a somatoform disorder (Beta=-.263; 
t(73)=-3.07;p=.003) in older adults with MUS. The final model for physical HRQoL (R2=.486) 
showed negative associations with hypochondriac cognitions (Beta=-.236;t(74)=-2.45;p=.017) 
and somatization (Beta=-.327;t(74)=-3.32;p=.001).
 Following these results, the linear regression analyses presented in table 2 were 
additionally adjusted for levels of somatization and hypochondriacal cognitions. These 
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analyses show that the group (MUS/MES) and HRQoL association was not statistically 
significant any more for both the SF-36 component scores and all SF-36 subscales (table 4). 
Discussion 
Main findings
 Older persons with Medically Unexplained Symptoms (MUS) reported decreased 
levels of mental and physical Health-Related Quality of Life (HRQoL), when compared to 
older persons with Medically Explained Symptoms (MES). Interestingly, these associations 
disappeared when additionally corrected for somatization and hypochondriac cognitions. 
 Within the subgroup of older persons with MUS, levels of somatization, hypochondriac 
cognitions, and the presence of a primary somatoform disorder according to DSM-IV criteria, 
explained most variance of mental HRQoL. Levels of somatization and hypochondriac 
cognitions explained most variance of physical HRQoL in older MUS patients. The perceived 
severity of the physical complaint was not associated with HRQoL. 
Comparison with literature
 Although previous research found that late-life MUS are associated with higher HRQoL 
scores compared to older MES patients (Hilderink et al., 2015), the current study indicates 
that MUS patients report lower HRQoL compared to persons that received a clear diagnosis 
for their physical complaints. How can these contrasting findings be explained? Contrary to 
the study by Hilderink et al. (2015), in the current study all patients were classified as either 
MUS or MES by their own GPs, in most cases with confirmation by a geriatrician after a 
comprehensive geriatric assessment. This extensive physical examination and chart review 
possibly contributed to a more accurate diagnosis of late-life MUS and MES (Benraad et al., 
2013) compared to assessment of physical symptoms and classification as either MUS or MES 
with the CIDI. This being said, when statistical analyses were additionally adjusted for levels 
of somatization and hypochondriac cognitions, group status (MUS/MES) and HRQoL were 
not statistically significant associated any more, which is in line with the DSM-5 criteria for 
somatic symptom disorder (APA, 2013; Klaus et al., 2013). 
 The current findings indicate that older MUS patients score approximately 10 points 
lower on both physical and mental HRQoL scores than older MES patients, which indicates 
a statistical significant difference. It is questionable whether or not these differences are 
clinically meaningful as well. It is assumed that whether or not differences in HRQoL scores are 
clinically meaningful is eventually in the hands of doctors and the patients themselves (Hays 
& Woolley, 2000). As previous studies have shown the meaningfulness of decreased HRQoL 
scores in older persons with MES (e.g. Dominick et al., 2004), and as we know doctors report 
severe troubles with managing MUS (Ring et al., 2005), we assume that the demonstrated 
differences between older MUS- and MES patients are clinically relevant. 
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 Our current findings are in line with previous studies that showed that HRQoL is 
associated with psychological factors, such as the level of somatization, in younger patients 
with a functional syndrome (Luscombe, 2000) and in older persons (Sheehan et al., 2005). 
The current study shows somatization –measured by counting the number of physical 
symptoms using the BSI-53 (Derogatis, 1975)- was associated with HRQoL, which is in line 
with the idea that the number of physical complaints is associated with health status in MUS 
patients (Tomenson et al., 2013). Furthermore, the severity of the physical complaints was not 
significantly associated with HRQoL. Given these findings and the additional finding that in 
our final models the presence of a somatoform disorder according to DSM-IV criteria was not 
or only weakly associated with HRQoL component scores in older MUS patients, the DSM-5 
diagnoses of somatic symptom and related disorders (APA, 2013) seem to be more appropriate 
for older MUS patients. These DSM-5 diagnoses are independent of a physical origin as well 
as the severity of the MUS, but rather rely on positive psychiatric criteria accompanying a 
physical symptom, such as the presence of hypochondriac cognitions or somatization. 
Strengths and limitations of the current study
 The current study has several methodological strengths. First of all, by comparing late-
life MUS to late-life MES, we are able to investigate how unexplained physical symptoms are 
different from explained physical symptoms in older adults. The extensive multidisciplinary 
screening and the clinical judgment of the participant’s GP have contributed to a valid 
classification of MUS and MES. Furthermore, our comparison group consists of MES patients 
that were selected using the frequent attenders method, meaning only patients with severe 
MES were included in our study sample. Taking this into account, even larger effects are 
expected in studies using a population-based comparison group. Another strength refers to 
the use of the SF-36 for measuring HRQoL, as the SF-36 is a well-validated (Walters et al., 
2001) scale that shows good reliability rates (Hayes et al., 1995) for older adults. 
 Nevertheless, the current study has methodological limitations as well. By recruiting 
patients across different settings (population/primary care/specialized health care), we 
succeeded in composing a sample of MUS patients in various developmental and severity 
stages. Nonetheless, within these settings we still recruited convenience samples and our 
study was not designed to be epidemiologically representative of an underlying population. 
Second, a geriatrician examined some participants extensively, but other MUS patients 
refused this examination (40.7% of the total MUS-sample), because of mobility problems or 
resistance against visiting the multidisciplinary clinic. The latter group of MUS patients is only 
screened by their GP, herewith increasing the risk of unjust classification of MUS. However, 
excluding this latter group could be harmful, as this group of patients may vary with respect 
to the severity of physical complaints or the quality of the patient-doctor relationship when 
compared to those patients accepting the screening. Another limitation of the current study 
concerns the use of the BSI-53 (Derogatis, 1975) for assessing somatization. Since the BSI 
somatization subscale actually assesses the presence of physical complaints that often 
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remain medically unexplained (e.g. upset stomach), this might lead to an overestimation of 
somatization levels in an older study sample. Consequently, our finding that somatization 
and physical HRQoL are associated should be interpreted cautiously. Lastly, longitudinal 
studies are needed to determine temporal relationships between medically unexplained 
symptoms and characteristics that are associated with HRQoL. 
Implications for research and clinical practice
 Even though the concept of MUS is released in the DSM-5 criteria for somatic symptom 
disorder (APA, 2013), in clinical practice, MUS patients are often considered difficult (Luscombe 
et al., 2000) and challenging patients (Sheehan et al., 2005). GPs and medical specialists should 
keep in mind that, in the absence of disease, physical symptoms reduce HRQoL more than 
when disease is present, according to our findings. That being said, our study findings are in 
line with DSM-5 criteria, that allow MES to be influenced by somatization and hypochondriac 
cognitions. Also, previous research in younger MUS patients has shown that other factors, 
such as levels of anxiety, depression and social factors (Anderson & Ferrans, 1997; Luo et al., 
2014) might be affecting HRQoL as well. During consultation it is important for doctors to 
explore the level of e.g. somatization and hypochondriac cognitions in older patients with 
physical complaints, as these factors contribute negatively to the perceived HRQoL. When, 
for instance, the MUS are accompanied by hypochondriac cognitions, general practitioners 
could refer these older patients to psychological treatment, in addition to possible somatic 
treatment. Since Cognitive Behavioral Therapy (Kroenke & Swindle, 2000) has proven to be 
an evidence-based treatment for MUS and somatization in general in younger patients, this 
treatment will most likely be effective in older adults too. However, specific studies on the 
effectiveness of psychological or multidisciplinary treatment programs for late-life MUS are 
currently lacking. 
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Abstract
The objective of the current study is to explore predictors of the course of health-related 
quality of life (HRQoL) in older patients suffering from either medically unexplained 
symptoms (MUS) or medically explained symptoms (MES). 69 MUS- and 105 MES patients 
(≥ 60 years) were reassessed after a mean duration of follow-up of 98 weeks with respect 
to HRQoL (SF-36). 
Repeated measures ANOVA showed significantly lower HRQoL in MUS- compared to 
MES patients. Mental HRQoL declined significantly less in MUS- than in MES patients. 
Somatic comorbidity, health anxiety and loneliness predicted lower mental HRQoL 
in MUS patients. With respect to physical HRQoL, the decline over time did not differ 
between MUS- and MES patients. In the combined sample, level of education, primary 
symptom severity and depressive symptoms predicted lower physical HRQoL. The 
identified predictors for HRQoL are modifiable and could, if replicated, provide future 
directions for treatment. 
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Introduction
 Medically Unexplained Symptoms (MUS) are physical symptoms that cannot (fully) 
be explained by a somatic disease after adequate medical examination. Prevalence rates 
among older persons range from 4.6% to 18% (Hilderink et al., 2013). Older patients with 
MUS report a lower level of health-related quality of life (HRQoL), even when compared to 
older patients with similar severity of a medically explained symptom (MES) (Hanssen et al., 
2016). The lower HRQoL possibly contributes to the high level of health care consumption 
associated with MUS (Barskey et al., 2005).
 In relatively younger MUS patients the severity of the physical complaints at baseline 
predicts an unfavourable prognosis (Olde Hartman et al., 2009), with HRQoL decreasing 
significantly over time (Ternesten-Hasséus et al., 2007). To our knowledge, no longitudinal 
data on HRQoL in older MUS patients have been reported yet. Since explanatory models for 
MUS often emphasize the complex and multifactorial origin of these symptoms (Henningsen 
et al., 2007), we explored the impact of biomedical, psychological and social factors on the 
course of HRQoL among older MUS patients. 
Methods
 We performed a follow-up study by sending self-report questionnaires to all 
participants of the Older Persons with medically Unexplained Symptoms (OPUS) study 
(Hanssen et al., 2016). In brief, the OPUS study has included 272 older patients suffering from 
actual physical symptoms, i.e. 118 cases suffering from MUS and a comparison group of 154 
patients suffering from MES. Inclusion criteria for cases were 1) ≥60 years; and 2) MUS for 
at least three months according to the general practitioner and, if possible, confirmed by a 
multidisciplinary examination including a geriatric assessment. Cases were recruited from 
the community, primary care (among frequent attenders), and specialized health care, in 
order to recruit a diverse group regarding the severity of MUS. Patients suffering from MES 
were recruited among frequent attenders in primary care to guarantee comparability with 
respect to the severity of the physical symptoms (Hanssen et al., 2016). Cases and MES 
patients were excluded in case of 1) psychotic disorder; 2) dementia; 3) terminal illness; 4) 
insufficient mastery of the Dutch language; or 5) severe auditory or visual restraints.
 All participants of the OPUS study underwent an extensive baseline assessment, 
including a geriatric examination, semi-structured psychiatric interview and numerous 
observer-rated and self-report questionnaires between September 2011 and March 2014. A 
follow-up study was performed between October and December 2014. The Medical Ethical 
Committee of the Radboud University Nijmegen Medical Center has approved this follow-up 
study. Additional informed consent was asked for all participants of the OPUS study. 
 The primary outcomes of this follow-up are the mental health and the physical health 
component scores of the Medical Outcome Study Short Form Health Survey (SF-36), a widely 
used and well-validated, reliable measure of HRQoL (Van der Zee & Sanderman, 2012). 
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 As potential predictors, we examined demographic characteristics (age, sex, level 
of education), as well as biomedical, psychological and social characteristics with 
questionnaires well validated for older persons.
 We examined the following biomedical characteristics: 1) group status (MUS or MES); 2) 
highest severity of the primary complaint in the past month (10 cm visual analogue scale); 
3) duration of the primary complaint; 4) whether or not the primary symptom was pain; 
5) burden of chronic somatic diseases (Charlson Index); and 6) cognitive functioning (Mini 
Mental State Examination, MMSE).
 We examined the following psychological characteristics: 1) psychiatric disorders 
according to DSM-IV-TR criteria (Mini-International Neuropsychiatric Interview, MINI); 2) 
depressive symptom severity (30-item Inventory of Depressive Symptomatology, IDS); 3) 
anxiety (Hospital Anxiety and Depression Scale- Anxiety subscale, HADS-A); and 4) health 
anxiety (Whitely Index, WI).
 Finally, we examined the following social characteristics: 1) partner (yes/no); 2) social 
network size (number of family members and friends with whom the patient has frequent and 
important contacts in 6 categories); and 3) loneliness (De Jong-Gierveld loneliness scale). 
 Baseline characteristics of completers and non-completers of the follow-up measures 
were compared by chi-square, Student’s t-test or Mann-Whitney U tests. Course of HRQoL 
over time was examined with repeated measures ANOVA, including an interaction term with 
group (MUS/MES). Subsequently, linear regression analyses with HRQoL at follow-up as the 
dependent variable, adjusted for baseline HRQoL, were conducted to explore the impact of 
all potential predictors separately. Characteristics contributing to HRQoL (p<.15) at follow-up 
were entered in a final multivariate regression analysis using a stepwise procedure. P-values 
<.05 were then considered significant. All analyses were conducted with SPSS, version 23. 
Results
 Of the 272, 182 patients consented for the follow-up study. As eight patients had died 
(one MUS patient, seven MES patients), the overall response rate was 182/264 (68.9%). 
Reasons for dropout included being not motivated (47, 57.3%), remitted symptoms (6, 7.3%), 
too ill (18, 22.0%), and lost to follow-up (11, 13.4%), and did not differ between MUS- and 
MES patients (Chi2=2.1, df=3, p=.552). Another 11 patients had to be excluded due to missing 
values on the SF-36. 
 Completers of the present study (n=171, 62.9% of the original sample) had a higher 
level of education (Chi2=18.5, df=2, p<.001) and cognitive functioning (t=2.4, df=247, p=.017) 
compared to non-completers (n=101). Other characteristics did not differ, especially not 
baseline mental (t=.1, df=255, p=.901) and physical (t=.4, df=253, p=.673) HRQoL.
BIO-, PSYCHO-, AND SOCIAL PREDICTORS OF 
HEALTH-RELATED QUALITY OF LIFE IN OLDER PERSONS WITH MEDICALLY UNEXPLAINED SYMPTOMS. 
43
Ch
ap
te
r 3
 Of the 171 participants, 69 were MUS patients (58.0% female sex; 69.9 (standard 
deviation (SD)=6.4) years old) and 102 were MES patients (42.2% females; 73.0 (SD=7.9) years 
old). The mean (SD) duration of follow-up was 98 (27) weeks (range 57 – 163 weeks). Duration 
of follow-up was neither associated with mental HRQoL (Pearsons’ r=-0.02, p=.771) nor with 
physical HRQoL (Pearson’s r=-0.01, p=.891), and therefore not included as a covariate in the 
regression models. 
 Repeated measures ANOVA showed that mental HRQoL was significantly lower among 
MUS- compared to MES patients (F=19,2, df=1, p<.001). Mental HRQoL significantly decreased 
during follow-up (F=20.1, df=1,164, p<.001), with a significantly smaller effect among MUS 
patients (Cohen’s d=0.14) compared to MES patients (Cohen’s d=0.61) (interaction time x 
group: F=5.1, df=1,164, p=.026). 
 Physical HRQoL was also lower in MUS- compared to MES patients (F=4.3, df=1, p=.041), 
and decreased significantly over time (F=21.7, df=1,162, p<.001) with a Cohen’s d effect size 
of 0.35, with no difference between MUS- and MES patients (interaction time x group: F=2.2, 
df=1.162, p=.144).
 Table 1 presents the predictive value for HRQoL at follow-up for all biopsychosocial 
characteristics separately, adjusted for baseline value of HRQoL only. Since cognitive 
functioning (MMSE) and somatic comorbidity (Charlson Index) significantly interacted with 
group in predicting mental HRQoL (p-values < .05), results with respect to mental HRQoL are 
presented separately for MUS- and MES patients. As for physical HRQoL none of the predictors 
interacted significantly with group, these results are presented for the combined sample.
 When entering only those variables associated with the outcome under study at the 15% 
level (see table 1), the multivariate linear regression model (R2=0.57; F=33.3, df=2,52, p<.001) 
showed that mental HRQoL at follow-up was predicted by baseline mental HRQoL (ß=0.51, 
p=<.001) and loneliness (ß=-0.32, p=.009) in MUS patients. Depressive symptom severity (ß=-
0.38, p=.002) and cognitive functioning (ß=0.21, p=.016), adjusted for baseline mental HRQoL 
(ß=0.19, p=.114), predicted mental HRQoL at follow-up in MES patients (R2=0.34; F=162, 
df=3.95, p<.001). Physical HRQoL was predicted by baseline physical HRQoL (ß=0.52, p<.001), 
level of education (medium level: ß=0.17, p=.114; higher level: ß=0.32, p=.004), and severity 
of depressive symptoms (ß=-0.22, p=.002) (R2=0.45; F=23.8, df=4,117, p<.001) in the combined 
sample. 
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Table 1: Predictors of mental and physical HRQoL at follow-up in older patients with MUS or MES.
Mental HRQoL Physical HRQoL
MUS patients MES patients All patients*
Predictors: ß p ß p ß p
Baseline (mental/physical) HRQoL 0.72 <.001 0.48 <.001 0.67 <.001
Demographics:
- Age (years) -0.01 .953 -0.04 .669 -0.02 .743
- Gender (female sex) -0.12 .188 -0.01 .904 0.04 .499
- Level of education (lower = reference):
o Medium 0.20 .094 0.09 .539 0.10 .255
o Higher 0.08 .686 0.30 .047 0.18 .045
Biomedical characteristics:
- Severity of primary complaint (VAS) -0.03 .807 -0.10 .304 -0.19 .005
- Duration of primary complaint (years) 0.12 .276 -0.02 .810 -0.12 .076
- Pain as the primary symptom -0.04 .687 -0.11 .224 -0.02 .734
- Cognitive functioning (MMSE) <-0.01 .973 0.22 .010 0.11 .055
- Somatic comorbidity (Charlson Index) 0.18 .050 -0.12 .189 -0.10 .098
Psychiatric & psychological characteristics:
- Somatoform disorder (DSM-IV) 0.02 .862 n.a. 0.01 .854
- Psychiatric disorder (DSM-IV), other 
than somatoform disorder
-0.05 .620 -0.08 .403 -0.02 .719
- Health anxiety (Whitely index) -0.24 .022 -0.02 .831 -0.09 .156
- Depressive symptom severity (IDS) -0.22 .128 -0.36 .003 -0.17 .020
- Anxiety (HADS-Anxiety subscale) -0.08 .573 -0.20 .094 -0.08 .222
Social characteristics:
- Partner present -0.03 .783 -0.04 .664 -0.04 .541
- Social network size 0.19 .063 0.14 .113 0.06 .291
- Loneliness (De Jong-Gierveld scale) -0.24 .022 -0.04 .685 -0.09 .137
* Since none of the predictors significantly interacted with group (MUS/MES), the analyses were not stratified 
by group.
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Discussion
 Mental HRQoL in MUS patients at follow-up is predicted by bio- (somatic comorbidity), 
psycho- (health anxiety), social (loneliness) characteristics, of which loneliness remained 
statistically significant in the multivariate model. Interestingly, all of these characteristics 
may be modifiable and thus offering treatment opportunities for MUS in later life. 
 In contrast, only cognitive functioning (educational background; actual cognitive 
functioning) and depressive symptom severity affected mental HRQoL over time in MES 
patients. This fits with consistently reported associations between lower educational level 
and multimorbidity, as well as the reciprocal relationship between depression and chronic 
somatic disorders (Katon et al., 2007; Penninx et al., 2013). Improving mental HRQoL over 
time in MES patients might thus best be focused on preventing or targeting depression. In 
line with the findings of mental HRQoL in MES patients, physical HRQoL in the whole sample 
was affected by level of education, depressive symptom severity and, not unexpectedly, the 
severity of the primary physical complaint. Interestingly, the decline in physical HRQoL of 
MUS patients did not differ from that of patients with MES. 
 Main limitations of the current study are the relatively small sample and substantial 
number of dropouts. This being said, our attrition rate does not seem extraordinary, 
as dropout levels between 20 and 30% are normal in older populations and we selected 
patients with current physical symptoms (Provencher et al., 2014). Nonetheless, as this is the 
first study on the course of HRQoL in older MUS patients, replication of results is warranted.
 Acknowledging the fact that MUS patients suffer from a low HRQoL, even lower compared 
to MES patients, we hope our results will motivate replication as well as intervention studies, 
since our findings point to biopsychosocial treatment targets for improving HRQoL in older 
patients with MUS. 

4.
Exploring meaning in life in older persons with chronic 
medically unexplained symptoms.
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Lucassen, P.L.B.J. Exploring meaning in life in older persons with chronic medically 
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Abstract
Having a sense of meaning in life contributes to successful aging and subjective 
wellbeing. Although several studies have been conducted on meaning in later life with 
disease, no studies have investigated meaning in later life with Medically Unexplained 
Symptoms (MUS). 
The objective of the current study is, therefore, to explore meaning in life in older 
persons with MUS. As part of the Older Persons with medically Unexplained Symptoms 
(OPUS) study, qualitative in-depth interviews (1.5 hour) with 16 older persons (>60 
years) with chronic MUS (>3 months) were performed. A topic list was constructed by 
using the symbolic interactionism perspective. After five interviews, two researchers 
coded transcriptions of the interviews independently and the topic list was adjusted in 
consequence of these first results. Thereafter, a cyclic procedure of interviewing, coding 
and adjusting the topic list was performed until saturation was reached. Older MUS 
patients report that negative reactions from significant others and changes in daily 
life activities lead to a need to plan life, which is paradoxically not possible, because 
of the unpredictability of the MUS. Consequently, a decreased sense of control over 
life is noticed, making it harder to cope with MUS when new stressors arise. By seeking 
an explanation for their MUS, older MUS patients try to regain control over their lives, 
thereby providing a sense of meaning in life. Older adults with MUS need to understand 
the integrated view of physical, psychological, social, and age-related aspects in their 
lives in order to find meaning in life. 
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Introduction 
 Old age has its infirmities. With increasing age, the chance of suffering from physical 
complaints gets more common. Interestingly, patients with physical disabilities can better 
adapt to living with illness when they are able to find meaning in life (Thompson, 1991; Park 
et al., 2008). According to Ryff (1989), the concept of meaning in life refers to having goals, 
intentions, and a sense of direction in life. Therefore, finding meaning in life contributes to 
successful aging (Wong, 1989) and contributes to our subjective well-being (Ryff, 1989). 
 In 1963, Frankl introduced the concept of meaning in life in the field of medicine. He 
stated that the definition of meaning in life ‘differs from man to man and from moment to 
moment’. Consequently, the conceptualization of meaning in life should take into account 
individual differences and changes over time. Fife (1994) summarized the many definitions 
of meaning in life with illness as ‘an individual’s perception of the potential significance of 
an event, such as the occurrence of serious illness, for the self and one’s plan of action’. With 
this definition, meaning is presented as a continuum that goes from positive to negative, in 
which both self-meaning –the effect of the illness on one’s identity- and contextual meaning 
–the characteristics of the illness itself and the social circumstances around it- are important. 
Although research on meaning in life in older patients with chronic diseases has been 
conducted frequently (e.g. Park et al., 2008; Arvig, 2006; Fegg et al., 2010), as far as we know, 
no research has been performed on meaning in life in older persons with chronic Medically 
Unexplained Symptoms (MUS). 
 MUS are defined as ‘physical symptoms that have existed for more than several weeks 
and for which adequate medical examination has not revealed any condition that sufficiently 
explains the symptoms’ (Olde Hartman et al., 2013). Although a Dutch primary care study 
indicates that chronic MUS is more prevalent in older persons (Lisdonk et al., 2008), a 
recent systematic review shows MUS might be less prevalent in older age groups compared 
to younger age groups (Hilderink et al., 2013). Persons with chronic MUS often experience 
negative consequences as a result of their symptoms and report a decreased quality of life 
(Koch et al., 2007). 
 Previous research showed difficulties with finding meaning in life in younger persons 
with chronic MUS. A study in younger men with unexplained joint pains, for example, showed 
that difficulties in working situations led to a reduced feeling of meaning in life.  As these men 
would only get meaningless tasks because of their chronic pain, they felt like outsiders. Also, 
the inability to play with their children made life less meaningful (Paulson et al., 2002). Similar 
to these findings, younger female patients with unexplained chronic fatigue and unexplained 
joint pains reported social and job-related changes. For instance, as the patients were not 
longer able to carry out their work and/or had financial problems because of unemployment, 
patients felt isolated and they felt like they were on the fringe of society (Asbring, 2001), which 
is in line with the notion that in Western society it is not accepted to feel ill in the absence of 
disease (Nettleton, 2006). 
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 As sources of meaning in later life change with aging (Missinne & Willeke-Kay, 1985; 
Thompson, 1992; Krause, 2004) and as it remains unclear whether older adults show a different 
fulfillment of their meaning in life than younger adults (Pinquart, 2002), results obtained in 
younger age samples cannot be extrapolated to older persons with MUS. Consequently, this 
paper aims to explore how older persons with chronic MUS find meaning in life.  
Methods
Study design & sampling strategy
 The Older Persons with medically Unexplained Symptoms (OPUS) Study aims to explore 
possible biopsychosocial determinants of late-life MUS. As part of this study, we performed 
a qualitative study consisting of in-depth interviews with 16 older patients (>60 years) with 
chronic MUS (>3 months) in which we explored the concept of meaning in life. All interviews 
were conducted between March 2012 and December 2013. This study has been approved by 
the local Medical Ethics Committee.
 Participants were selected from the OPUS study survey sample using purposive 
sampling techniques. This sampling method is frequently used in qualitative research in order 
to compose a diverse study sample. In this case, participants were selected by gender, age 
at the moment of inclusion (≤ 75 years/ >75 years), perceived health status (good/average/
poor), partner status (single/in a relationship) and household income (< Dutch average 
income [< €1800,-/month], average income [€1800-2000/month]; >average income [€2000/
month]) as an indication of socio-economic status. Patient characteristics are presented in 
table 1. 
 
Construction and adjustment of the topic list
 All interviews focused on the meaning of later-life with chronic MUS. The definition of 
meaning in life with illness in this paper (Fife, 1994) is in line with symbolic interactionism, 
originally a sociological perspective introduced by Mead (Mead, 1934). In this perspective, 
‘meaning’ is the result of the interaction of a person and his (social) environment, specifically 
interaction of a person within his current situation (e.g. with social contacts), interaction with 
the self (‘thinking’), interaction with past experiences and the experienced sense of control 
over life. 
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Table 1: Patient characteristics of the interviewed older persons with MUS (N=16).
Participant Most 
prominent 
MUS
Duration 
of 
symptoms
Age Gender Perceived 
health 
status
Partner Income Recruitment 
via
1 Pain 10 months 70 Female Good Yes Average 
income
Self-referral
2 Pain (arms) 10 years 77 Male Poor Yes > Average 
income
Self-referral
3 Diffuse MUS Unknown 75 Male Poor Yes < Average 
income
Outpatient 
clinic
4 Pain (arms) 2 years 70 Male Good Yes < Average 
income
Self-referral
5 Pain (chest) 5 years 64 Female Average Yes > Average 
income
Self-referral
6 Pain (arms) 6 years 69 Male Average Yes > Average 
income
Outpatient 
clinic
7 Pain (arms) 65 years 80 Female Good No Unknown Outpatient 
clinic
8 Pain (arms) 5 years 71 Female Average No Unknown GP
9 Fatigue 4 years 67 Female Good No < Average 
income
Self-referral
10 Pain (back) 2 years 64 Female Good Yes < Average 
income
GP
11 Nausea 1 year 64 Female Average No < Average 
income
Outpatient 
clinic
12 Pain (arms) 10 years 82 Male Average Yes > Average 
income
GP
13 Dizziness 29 years 82 Female Average No Unknown GP
14 Pain (back) 15 years 61 Male Average No < Average 
income
GP
15 Pain (arms) 1 year 79 Male Good Yes Unknown GP
16 Diffuse MUS 10 years 65 Male Poor No < Average 
income
GP
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Table 2: Initial topic list for the in-depth interviews focusing on meaning in later life with MUS, 
constructed with use of the symbolic interactionism perspective.
In-depth interview Characteristic of 
Symbolic Interactionism
Interview topics
Opening question What is it like to live with Medically 
Unexplained Symptoms?
Topics Social interaction 1. Relationships with friends and family
2. Relationships with colleagues and 
employers
3. Relationships with general 
practitioners and other doctors
Human thinking 4. Self-perception
5. Future
Definition of current situation 6. Experience of current situation
Current situation and the past 7. Past experiences and events
Active role in live 8. Control
9. Independency
 As these features of the symbolic interactionistic perspective all contribute to the sense 
of meaning in life with illness (Charon & Cahill, 2004), these aspects were the starting point 
for constructing our topic list. Within our multidisciplinary research team, we translated 
the principle of definition of and interaction within the current situation into the topics 
‘experience of current situation’, ‘relationships with friends and family’, ‘relationships with 
colleagues and employers’ and ‘relationships with general practitioners and other doctors’. 
The principle of interaction with the self was translated into two topics: ‘self-perception’ and 
‘future’. In addition, we asked for past experiences and events; the principle of control was 
operationalized in the topics ‘control’ and ‘independency’, resulting in nine interview topics 
(table 2).
 After each round of interviewing (see ‘Data analysis’) the topic list was adjusted, 
meaning that irrelevant topics were left out in the next interviews and topics that newly 
appeared during the interviews were added.   
Interview procedure
 Before the contacted persons needed to decide whether they would participate in this 
part of the OPUS study, a researcher sent written information on the purpose of the interview, 
the time investment and the patient’s anonymity. Approximately one week after receiving 
this information, the researcher (DH or NJ) called the patient to answer any questions. 
Subsequently, patients were asked to participate in the interview. If the patient decided to 
participate, we scheduled a home visit. All persons that were selected to take part of this 
study consented to participate. 
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 Prior to the interview, the interviewer (DH or NJ) and the participant signed an 
Informed Consent Form to give permission for using the data for scientific purposes. If the 
participant explicitly asked for this, his or her partner was allowed to attend the interview. 
All interviews started with the same opening question: ‘What is it like to live with Medically 
Unexplained Symptoms?’. During the interviews, the topics were issued in interrogative form 
to facilitate the interview process (e.g. ‘To what extent do you have control over your life 
with (unexplained) physical symptoms?’). In addition, several questions were formulated 
as statements, such as ‘I changed as a person because of my physical complaints’, in order 
to excite stronger reactions from our older participants. Subsequently, the interview topics 
(table 2) were explored in a one-hour audio taped interview. 
 During and immediately after the interview, the interviewer made notes about the 
context of the interview and observations concerning the participant’s behavior and, if 
present, the participants’ partner. 
Data analysis
 The analysis followed a cyclic process of interviewing and analysis; this process was 
repeated until saturation was reached, meaning that no new information came forward for 
answering the research question of the current study. 
 When the first five interviews were conducted, the interviews were transcribed 
verbatim. Two researchers (DH & NJ) started coding all of the participants’ statements 
independently using Atlas.ti7, a software program for processing qualitative data. In this 
first stage of our study, we applied an open coding strategy to detect general themes of our 
interviews. Subsequently, both researchers came together to discuss and reach consensus 
about this first coding scheme. Following the results of this preliminary analysis, the topic list 
was adjusted. Subsequently, six more older persons with MUS were invited to participate in 
the in-depth interview, using the adjusted topic list. Next, these interviews were thoroughly 
analyzed by both researchers and the topic list was adjusted once again. This cycle was 
repeated with five more participants, after which saturation was reached. 
 After the analysis of the last interviews, the final codes were linked together and findings 
were summarized in order to answer our research question. These findings were applied to 
all previous interviews in order to make sure the findings were grounded in the data; also, 
these findings were discussed in our multidisciplinary research team in order to make sure 
these findings were consistent with clinical and daily practice. 
Results
 Older persons with MUS reported they feel like living in a vicious circle, resulting in a 
decreased sense of control and meaning in life, which is explained in detail below.
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Loss of control
 All older persons with MUS reported changes in their lives because of their MUS. 
Negative changes concerning social relationships, such as the relationships with their 
partners, children and/or other family members, were mentioned most frequently. Older 
persons with MUS seemed to be disappointed in their significant others, because of a lack of 
understanding for their physical complaints:  
 
Sometimes the older persons with MUS even felt distanced from society, because of a 
reduced self-esteem and the lack of social contacts in their lives: 
 Apart from social changes, changes in daily activities were mentioned. For instance, 
older persons with MUS could not go out any more or could not perform hobbies anymore, 
because of their physical complaints. Even though these daily activities were missed, the 
need to plan all daily activities was experienced as most burdensome: 
“My children, they joined me during my doctor’s appointments. But after these visits, 
they did not contact me anymore. I mean, I was crying during these appointments. 
They can see how difficult this is for me, but they never ask ‘How are you doing now, 
mom?’. (…). I miss sympathy. (…). I miss understanding.”
[Female, 64 years]
“I go out less, and have, for instance, less contact with my grandchildren. I cannot 
babysit any more, which bothers me a lot. Well, it’s just too much for me. Mostly, it gives 
me a feeling of not participating in society and in life anymore.” 
[Female, 64 years]
“You get the feeling you are irrelevant for society.”
[Female, 82 years]
“I cannot just go out any more, just go away, just jump on my bike, do some groceries; 
my complaints are holding me back from everything.” 
[Female, 70 years]
“ ‘When shall we leave?’ my wife would say. ‘Tomorrow!’, I would say. She would say 
‘ok’, and then we would go off for fourteen days or so. But we cannot do that anymore. 
Everything has to be planned now.” 
[Male, 69 years]
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Unfortunately, even with decent planning, older persons with MUS couldn’t live their lives like 
they used to do anymore, mainly because of the unpredictability of their MUS: 
This paradox of feeling the urge to plan life and at the same time being incapable to do so, 
led to a lack of control over one’s life: 
As a result, most older persons with chronic MUS did not make plans for the future. They were 
inclined to live life in the here and now:
 
 The lack of control over one’s life and living life day by day seemed to make older 
persons with MUS fragile. As soon as a new problem arose, such as a new physical complaint 
or worries about significant others, older persons with MUS reported more difficulties in 
coping with MUS, leading to even less control over their lives:
“When my symptoms arise quickly, I have to let go of my planning.”
[Male, 77 years] 
“I have very little control about my life with unexplained symptoms. The things I would 
like to do, I cannot do them. It’s because of this unpredictability. I go to lectures quite 
often. It has happened for several times now that I fell asleep during these lectures. 
That’s so clumsy and embarrassing. And I cannot feel it coming.”
[Male, 65 years]
“My worries and the pains I have, I cannot control them anymore. I would love to have this 
control, but now I live my life in quite a forced way. I always pay attention to my pain. My 
careless life is gone, and the easy part of life goes away. Everything gets more difficult”. 
[Female, 64 years] 
“I live my life day by day.” 
[Male, 77 years]
“Last year, I felt better, more secure. But then in February, I suddenly got dizzy: I got 
thrown back again. Now, it controls me and I can’t manage it any more. I was already 
struggling, having a hard time, but with some help from my husband I could manage 
it. And now this comes along, and I can’t get out anymore. It goes on and on. It seems 
like I’m living in a circle now.” 
[Female, 70 years] 
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 Summarized, because of social changes and changes in daily life activities, older 
persons with MUS felt the urge to plan life. However, they were incapable in doing so, leading 
to a lack of control over one’s life. When new problems appeared, coping problems arose, 
resulting in less control. In addition, the negative reactions of significant others to the physical 
complaints led to a lower self-esteem, making it even harder to control life. Therefore, a 
negative vicious circle of control was present in older persons with MUS (figure 1).
Reduced	sense	of	
control	over	life	
New	problem	arises	
-	Physical	complaint	
-	Worries	about	e.g.	
signiﬁcant	others	
Coping	problems	
Chronic	Medically	Unexplained	
Symptoms		(MUS)		in	later	life	
Changes	in	daily	life	
-	Social	life	
-	Daily	ac;vi;es	
Paradox	of	planning	
Unpredictability	of	
MUS	
Searching	for	
explanaBons	for	the	
MUS	
Figure 1: Negative vicious circle of control in later life with chronic Medically Unexplained 
Symptoms.
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Escaping the vicious circle
 While some older persons with MUS reported they were stuck in the vicious circle 
resulting in feelings of anger or sadness, several others tried to escape from this vicious circle 
repeatedly by looking for an explanation for the MUS. Sometimes this explanation was given 
by a doctor or therapist, but most times this explanation was provided by the patient itself, 
with a frequent use of metaphors: 
By finding a satisfying explanation, these older persons with MUS were capable to incorporate 
MUS in their definitions of their life situations and in defining their selves; this provided for a 
sense of control and meaning in later life with MUS. 
Empowering the sense of meaning in later life with medically unexplained symptoms
 The older persons that searched for an explanation for their MUS suggested professional 
caregivers could improve their sense of meaning in life by taking their life with MUS seriously. 
Patients want to be seen as a whole person, not just a body. Therefore, doctors should 
not only take all physical complaints into account, but also relevant psychological factors, 
social factors and changes due to the process of getting older. However, from the patient’s 
perspective, this integrated view was almost never accomplished:   
One of the older persons with MUS looked back at previous doctor’s experiences to illustrate 
the relevance of thinking out of the box by doctors –beyond physical complaints-: 
“I see myself as kind of a computer. They sometimes say that that your brains perceive 
everything. Some of the things that happened to me [traumatic experiences], they should 
have been deleted. And that makes a person tired, I guess. Because the memories, they 
are in the background and they sometimes come up again.” 
[Male, 69 years]
“I went to this medical specialist with a lot of complaints, my whole story: my ears, my 
throat, my nose, my head, my neck. That was too much for this guy, because he only 
wanted to take a look at my mouth. He could not find anything wrong, so I could go home 
with nothing again. I could not talk about the whole picture, because he did not show any 
interest in it anyway.” 
[Female, 70 years]
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 Concluding, in order to take the physical complaints of older persons with MUS seriously 
and to acknowledge the patients’ complaints, a comprehensive view is suggested for doctors 
and other professional caregivers. By exploring not only physical, but psychological, social 
and age-related changes as well, the older persons with MUS can possibly better integrate 
their physical complaints into their lives, hereby empowering a sense of control and meaning 
in life. 
Discussion
Main findings
 Control might be the key concept for finding meaning in later life with MUS. Older MUS 
patients are aware they can easily fall into the vicious circle of losing control over their lives: 
when negative changes in their lives come across, it gets more difficult to cope with MUS, 
resulting in a decreased feeling of control. When new problems appear, the sense of control 
over life further diminishes. 
 If the older person with MUS has the feeling of controlling life with MUS, e.g. by accepting 
a satisfying explanation for the MUS, this helps to get grip on life with MUS. By adopting a 
comprehensive, integrated view, in which physical complaints, psychological, social and 
age-related changes are integrated, formal caregivers can promote a sense of control and 
meaning in older patients with chronic MUS by helping them to create their own personal 
explanation or story about the MUS. 
Links to existing models and theory 
 The common-sense model of illness representations (CSM; Diefenbach & Leventhal, 
1996; Hagger & Orbell, 2003) describes how emotions and personal ideas about physical 
complaints, so called ‘illness representations’, are involved in giving meaning to health and 
illness, even when disease is absent. In this model, illness is defined as ‘the social definition of 
disease’, and therefore ‘illness emerges when practitioner and family agree that an individual 
is sick’ (Diefenbach & Leventhal, 1996; p.13). Strikingly, the present study emphasizes that 
social contacts, e.g. doctors or family members, often do not recognize the patient’s physical 
complaints, indicating older MUS patients may feel ill, but they are not perceived as ill 
through the eyes of significant others; thus, having late-life MUS might not only influence the 
 “When I visited my gynecologist, back in the eighties, after eight failed IVF trajectories for 
a final consultation, he told me ‘It’s not finished yet’. I told him: ‘For me, it is finished now’. 
‘No’, he said, ‘It is not finished, because you are getting older and you’re having friends 
that will have children and become grandmothers. And you will never be a grandmother.’ 
He just said it like that! Face to face! That really helped me.” 
[Female, 64 years] 
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perception of health, but also the perception of life in general, hereby affecting the patients’ 
goals and sense of direction in life. 
 The current findings are partially in line with findings regarding meaning in later life with 
explained physical symptoms. For instance, Delmar et al. (2005) underline the importance 
of significant others in finding meaning in life with illness, whereas Krause (2004) showed 
the importance of emotional support in finding meaning in life. Social relationships seem 
important in later life with MUS as well; however, maintaining or regaining control seems to 
be the most relevant concept in later life with chronic MUS. According to the CSM, coping is 
guided through hypothesizing about causes, consequences and ways to control the physical 
symptoms. In line with this, the current study shows that older persons with MUS – like other 
patients - hypothesize about their own health by formulating possible explanations for their 
MUS, to manage and cope with their unexplained physical complaints; coping becomes 
troublesome when a satisfying explanation for MUS is absent. Although the explanations 
might be rather illogical from a medical perspective, for the patients themselves they give a 
feeling of control over their lives. Therefore, these explanations should at all times be taken 
seriously by professional caregivers; in fact, professional caregivers should actively explore 
these explanations during consultations to investigate to what extent patients experience 
control over their later life with MUS. 
 Although caregivers often presume that patients with MUS are not willing to talk about 
psychosocial problems (Salmon et al., 2004), the current study indicates differently. However, 
it is important to integrate the ‘story’ of the present psychosocial problems within the ‘story’ 
of life with unexplained symptoms; in this way, the older persons with MUS can experience 
a sense of coherence in life (Antonovsky, 1996). If a person experiences a sense of coherence 
in life, this person will experience life as comprehensible, manageable and meaningful. Also, 
this sense of coherence provides for the ability to cope with new problems, as the person 
can use this sense of coherence in dealing with new stressors. Moreover, by finding balance 
between body, mind and spirit and having significant relationships with others, quality of life 
can increase (Albrecht & Devlieger, 1999). Previous research has shown positive effects of life-
reviewing and life-review therapy on meaning in life in depressed older persons (Korte et al., 
2012) and in a general population with mental health issues (Westerhof et al., 2010). It would 
be interesting to investigate the effect of life reviewing on meaning in later life with MUS. 
Methodological considerations
 Our study has multiple methodological strengths. First, the qualitative research design 
aligns with the explorative character of our research question. Especially in case of a difficult 
quantifiable concept as meaning in life, in-depth interviews or other qualitative research 
methods are preferable. Another strength refers to our operationalization of the concept 
‘meaning in life’. By using the symbolic interactionism view for operationalizing the concept 
of ‘meaning in life’, the concept becomes better understandable, resulting in increased 
construct validity. 
CHAPTER 4
60
 As in other research, several methodological limitations are present in the current 
study. First, patients who decided to participate in our study might be more open to e.g. talk 
about psychological and social problems than patients that did not participate in the OPUS 
study. With this, our results might be more pronounced than in a more general population of 
older persons with chronic MUS and, consequently, the external validity might be reduced. 
Also, these findings should be integrated with findings from quantitative study designs to 
provide for a complete biopsychosocial view on later life with MUS. 
Recommendations for clinical practice  & future research
 Both doctors and their patients could benefit from discussing psychosocial and life-
related changes during consultation, in addition to discussing the physical complaints. By 
adopting this integrated view - which can be challenging, as doctors often have a stereotyped 
image of MUS patients (e.g. Tait, 2013) - patients will truly feel they are being taken seriously. 
In a best case scenario, general practitioners and medical specialists help older MUS patients 
with integrating their physical complaints in their ‘life story’, in order to empower a sense of 
meaning in life. It would be interesting to explore whether providing structural and satisfying 
explanations and/or integrating MUS in the older patient’s life story could improve e.g. daily 
life functioning or quality of life. Furthermore, future research could aim at investigating 
possible positive effects of interventions aimed at patient empowerment, changing illness 
cognitions and/or life reviewing in older persons with chronic MUS.
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Part II.
Physical characteristics of medically unexplained symptoms 
in later life.
 

5.
Pain characteristics of older persons with medically 
unexplained symptoms, older persons with medically 
explained symptoms, and older persons with depression.
Hanssen, D.J.C., Lucassen, P.L.B.J., Naarding, P., De Waal, M.W.M., & Oude Voshaar, R.C. 
Pain characteristics of older persons with medically unexplained symptoms, older persons with 
medically explained symptoms, and older persons with depression
[Under review]
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Abstract
The objective of the current study is to explore the role of somatization and 
hypochondriacal cognitions in the experience of chronic pain in later life. We compared 
pain characteristics of older patients suffering from Medically Unexplained Symptoms 
(MUS) with both patients suffering from Medically Explained Symptoms (MES), and 
those suffering from Major Depressive Disorder (MDD). By combining data from the 
OPUS and the NESDO study, we compared pain characteristics of 102 older (>60 years) 
MUS patients to 145 older MES patients and 275 older MDD patients using a case-
control study design. Group differences were analyzed using ANCOVA, adjusted for 
demographic and physical characteristics. Linear regression was applied to examine 
the association between pain characteristics and somatization (BSI-53 somatization 
scale) and health anxiety (Whitely Index). Older persons with MUS have approximately 
2 times more chance of suffering from chronic pain when compared to older MES 
patients (OR=2.01; p=.013) but equal chances as opposed to MDD patients. Adjusted 
for demographic and physical variables, MUS patients report higher pain intensity and 
disability scores and more pain locations when compared to MES patients, but equal 
values as depressed persons. Health anxiety and somatization levels were positively 
associated with the number of pain sites in MUS patients, but not with pain severity or 
disability. Older MUS patients did not differ from MDD patients with respect to any of the 
chronic pain characteristics, but had more intense pain, more disabling pain and more 
pain locations when compared to older MES patients. 
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Introduction
 Chronic pain belongs to the most common, costly, and disabling conditions in later 
life (Institute of Medicine, 2011). Although a recent meta-analysis showed that anxiety, 
somatization and –to lesser extent- depressive symptoms are common in chronic pain 
patients (Burke et al., 2015), only a minority of patients in pain clinics seems to suffer from 
psychiatric disorders (Tyrer et al., 1989; Merskey et al., 1987). When a medical explanation for 
the pain is lacking, as is most likely the case in patients with comorbid pain and depression 
(Katona et al., 2005), it is often assumed that the pain has a psychological origin. 
 In older age groups, research on pain in somatoform and depressive disorders is 
complicated by high levels of somatic comorbidity that also result in pain symptoms (Blazer, 
2003; Wijeratne et al., 2003). Nonetheless, pain has been extensively examined in late-life 
depression. First, most studies show that pain precedes depression (Arola et al., 2010; 
Fishbain et al., 1997; Hilderink et al., 2012), although some studies also demonstrated a 
reciprocal association (Chou, 2007; Geerlings et al., 2002). Second, these studies point out 
the importance of psychological determinants like anxiety (Casten et al., 1995; Hanssen et al., 
2014), and self-efficacy (Turner et al., 2005) in experiencing and managing pain in depressed 
older adults. Although we assume that somatization and hypochondriacal cognitions might 
affect pain experience in older pain patients primarily suffering from psychiatric disorders, 
direct comparisons of pain characteristics of older patients suffering from medically 
unexplained symptoms (MUS), somatoform disorders or depression have never been 
compared to older patients suffering from pain due to an identified, somatic disorder. 
 Pain presentation and determinants of chronic pain could differ between these patient 
groups and such knowledge might be of help to refine treatment programs for chronic 
pain in later life. Therefore, we have combined data from the Older Persons with medically 
Unexplained Symptoms (OPUS) Study (Hanssen et al., 2016) and the Netherlands Study of 
Depression in Older Persons (NESDO) (Comijs et al., 2011). This offers the unique opportunity 
1) to compare the prevalence of chronic pain in older patients suffering from either MUS, 
Medically Explained Symptoms (MES), and Major Depressive Disorder (MDD), 2) to examine 
the characteristics of chronic pain in the context of either MUS, MES and MDD, and finally 3) to 
examine the association between severity indices of MUS and chronic pain in MUS patients. 
Methods
Study designs
Older persons with medically unexplained symptoms (OPUS) study
 The Older Persons with medically Unexplained Symptoms (OPUS) study aims to 
explore possible determinants of late-life MUS. Specifically, we performed a case-control 
study consisting of 118 older (> 60 years) persons with MUS and 154 older persons with MES. 
In the OPUS study, MUS were defined as ‘physical symptoms that have existed for more than 
several weeks and for which adequate medical examination has not revealed any condition 
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that sufficiently explains the symptoms’ (Olde Hartman et al., 2013). Initially, the older 
person’s own general practitioner decided whether or not this person met the definition 
of MUS. Subsequently, a multidisciplinary team (consisting of a geriatrician (Benraad et 
al., 2013), an old-age psychiatrist and a psychologist) thoroughly assessed the older MUS 
patient to confirm the unexplained origin of the physical complaints. MES were defined 
as physical symptoms that are present for more than several weeks for which adequate 
medical examination has revealed a somatic disease (e.g. asthma, rheumatoid arthritis) that 
sufficiently explains the symptoms. Exclusion criteria for both cases and controls were the 
presence of a primary psychotic disorder; presence of cognitive impairment, defined as a Mini 
Mental State Examination (MMSE; Folstein et al., 1975) total score below 19 or an established 
diagnosis of dementia; suffering from terminal illness; not sufficiently mastering the Dutch 
language; and severe auditory and/or visual limitations. Participants were recruited in the 
community by advertisements in local newspapers, via general practices, and in secondary 
health care, particularly via an outpatient mental health clinic and the geriatrics department 
of the Radboud University Medical Center (Nijmegen, the Netherlands). 
 After the multidisciplinary screening, MUS patients were visited at home for further 
assessment of social and cognitive determinants as well as care needs. In addition, 
all MUS patients filled out self-report questionnaires. Older MUS patients rejecting the 
multidisciplinary assessment (38.1%) (e.g. because they were not willing to visit a psychiatrist 
or psychologist), but agreed to participate in the study, received an additional home-visit by 
a researcher during which all standardized measurements of the multidisciplinary team were 
conducted (except for the full geriatric assessment). Older persons with MES were visited at 
home twice to complete all measures, similarly to the MUS patients. All data were gathered 
between 2011 and 2014. 
 102/118 (86.4%) Older participants with MUS and 145/154 (94.2%) older participants 
with MES completed the Graded Chronic Pain Scale (GCPS). The main reason for not 
completing this questionnaire was dropout between the first and second research interview 
due to no interest in a home-visit (anymore). 
Netherlands study of depression in older persons (NESDO)
 The Netherlands Study of Depression in Older persons (NESDO Study; Comijs et al., 
2011) is a prospective cohort study that aims to study late-life depression, its course and 
comorbidities.
 In the current study, the baseline data of 275 older participants that fulfilled the criteria 
of a DSM-IV diagnosis of Major Depressive Disorder (MDD) in the past month were used as a 
second comparison group. Exclusion criteria for the NESDO study were a MMSE (Folstein et al., 
1975) score below 19 and insufficient command of the Dutch language. In the NESDO study, 
depressed participants were recruited via general practices, and via out- and inpatient clinics 
in different regions of the Netherlands. Baseline data were acquired with questionnaires, 
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interviews and physical assessments between 2007 and 2010. All of the participants with a 
one month diagnosis of MDD (100%) completed the questionnaire on pain characteristics. 
 In both the OPUS and the NESDO study, all participants gave informed consent after 
receiving written and oral information about the study. Furthermore, local Medical Ethics 
Committees approved both the OPUS and the NESDO study. 
Measures
General characteristic
- Basic demographic variables: We assessed age (in years), gender and highest level of 
education achieved (categorized as low, middle, and higher education level). 
- Severity of depressive symptoms: We used the 30-item Inventory of Depressive 
Symptomatology (IDS-SR; Rush et al., 1986) to assess the severity of depressive symptoms 
over the past seven days (max. score: 84 points, with higher scores indicative of more severe 
depressive symptoms). 
Physical characteristics
- Somatic comorbidity: The presence of somatic comorbidity was assessed by asking the 
presence of nine common diseases in later life: cardiac failure, rheumatoid arthritis, vascular 
disease, diabetes mellitus, stroke, cancer, peptic ulcer, liver disease and lung diseases 
(asthma, COPD). The total number of somatic diseases was calculated, resulting in a 
maximum score of 9.  
- Medication: The patient’s medication was listed to determine the total number of different 
medicines, including psychiatric medications. To increase reliability, the researcher inspected 
drug containers and/or asked for a list of medication use from the person’s pharmacist. 
- Cognitive functioning: The MMSE (Folstein et al., 1975) was assessed in all participants 
to provide a global indication of cognitive functioning (max. score: 30, with higher scores 
indicative of better cognitive functioning). 
 
Pain characteristics
 The Graded Chronic Pain Scale (GCPS; Von Korff et al., 1992; von Korff & Miglioretti, 
2005) was used to assess pain characteristics in the three patient groups. This self-report 
questionnaire questions the presence of seven pain locations: ‘In the past six months, did 
you experience any -back pain, neck pain, headache/migraine, face-ache, abdominal pain, 
joint pain, chest pain-?’ (yes/no). In addition, the current use of pain medication was charted. 
 If pain was present in one or more pain locations in the past six months, first, the most 
prominent pain location was asked: ‘If you had any pain in the past six months, which pain 
did affect you most?’. Next, additional questions were asked to examine characteristics of 
the most prominent pain location, specifically pain intensity, the degree to which one feels 
disabled, and the number of days in pain. In line with the suggestions of the International 
Association for the Study of Pain (1986) and consistent with previous studies (e.g. Hanssen et 
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al., 2014; Gerrits et al., 2012), we defined chronic pain as pain that was present for 90 days or 
more in the past six months. 
 Three pain characteristics were derived from the GCPS: 
1) Pain intensity score – The pain intensity score was calculated by taking the average of three 
individual item scores on the pain intensity of the most prominent pain location, namely 
‘How would you describe your pain at this moment?’, ‘How intense was your worst pain over 
the past six months?’ and ‘How intense was your average pain over the past six months?’ 
Answers were given on a 0-10 scale. The average score on these three items was multiplied 
by ten, resulting in a pain intensity score ranging from 0 (no pain) to 100 (high pain intensity).
2) Pain disability score – Three questions regarding pain disability were asked: ‘To what extent 
have you been limited by your chronic pain in carrying out your daily activities over the past 
six months?’, ‘To what extent have you been limited in your spare time, your social life, and 
during family activities because of your chronic pain over the past six months?’ and ‘To what 
extent have you been limited in carrying out your work (housework included) because of 
your chronic pain over the past six months?’. Answers were given on a 0-10 scale. The average 
score on these three items was multiplied by ten, resulting in a scale from 0 (no pain disability) 
to 100 (high pain disability). 
3) Number of pain locations - The number of pain locations was assessed by counting the 
number of pain locations that were present in the past six months, resulting in a score 
ranging from 0 to 7. 
Severity indices of MUS
 Among patients with MUS, several measures were used as severity indicators of the MUS.
-  Severity of the primary physical complaint: This was assessed using a Visual Analogue Scale 
(VAS) from 0 (not severe at all) to 100 (very severe): ‘How severe was your primary physical 
complaint over the past six months, on average?’
- Presence of a Somatoform Disorder according to DSM-IV criteria: The Mini-International 
Neuropsychiatric Interview (MINI; Sheehan et al., 1998) was used to assess the presence of a 
Somatoform Disorder (APA, 2000). With this semi-structured interview, the DSM-IV criteria of 
Somatization Disorder, Pain Disorder, and Hypochondria were assessed. 
- Presence of a comorbid disorder according to DSM-IV criteria: This was assessed with the 
MINI as well, by asking the sections about depressive disorders, anxiety disorders, obsessive-
compulsive disorder, and alcohol and drugs dependence/abuse. 
- Hypochondriac cognitions: The Whitely Index (WI; Pilowsky, 1967), a questionnaire consisting 
of 14 statements with answering categories yes/no (range 0-14), was used to assess the levels 
of hypochondriac cognitions. 
- Somatization: Levels of somatization were assessed using the Brief Symptom Inventory’s 
(BSI) somatization subscale that consists of seven items with answering categories from 1 
(not present at all) to 5 (present all the time) in the past week. This scale reflects ‘psychological 
distress arising from perception of bodily dysfunction’ (Derogatis, 1975). 
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Statistical analyses
 Descriptive statistics, such as mean scores (M) and standard deviations (SD), are 
reported for all demographic and pain characteristics. Univariate Analyses of Variance 
(ANOVAs) (for continuous variables) and Chi-Square tests (for categorical variables) were 
performed to assess between-group (MUS/MDD/MES) differences regarding patient- and 
pain characteristics. In addition, Analyses of Covariance (ANCOVAs) were performed to assess 
between-group differences of the pain intensity score, the pain disability score, and the 
number of pain locations, adjusted for demographic (age, gender, education) and physical 
characteristics (somatic comorbidity, medication use, cognitive functioning). In case of 
statistically significant differences (p<.05), Bonferroni post-hoc analyses were performed 
to assess contrasts, using the older MUS-group as a reference category. For all ANCOVAs, 
degrees of freedom (df), F-values and p-values are reported, as well as the eta2 value as an 
estimation of the effect size.  
 In order to assess whether the presence of chronic pain was associated with the three 
patient groups, a binary logistic regression analysis was performed with chronic pain (yes/no) 
as dependent variable and dummies for group status as the independent variable (with MUS 
as the reference group), adjusted for age, gender, education, somatic comorbidity, number 
of medication use and cognitive functioning. This analysis was repeated with additional 
adjustments for the severity of depressive symptoms (IDS-score), since depressive symptoms 
in itself may also affect the experience of pain. Odds ratios (ORs), 95% confidence interval 
(CI) values, and significance values (p-values) of these binary logistic regression models are 
reported.
 To examine the association between severity measures of MUS and pain characteristics 
in older MUS patients with chronic pain, multiple linear regression analyses were performed 
with outcomes pain intensity, pain disability and the number of pain locations. These models 
were all adjusted for demographic (age, gender, education) and physical variables (somatic 
comorbidity, number of medication use, cognitive functioning). For all regression models 
B-values, Standard Errors (SE), Beta-values, p-values and R2’s are presented. 
 P-values under .05 were considered statistically meaningful. All statistical analyses 
were performed using IBM SPSS version 20. 
Results
Sample characteristics
 Table 1 presents patient characteristics per patient group. In sum, MUS patients were 
significantly younger than MES patients and MDD patients. Furthermore, whereas MUS 
patients and MDD patients were more often female, MES patients were more often male. MDD 
patients reported a significantly higher severity of depressive symptoms than MUS patients, 
which in turn reported a significantly higher severity of depressive symptoms than MES 
patients. The three groups did not differ regarding somatic comorbidity and the number of 
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medication use. Compared to older MES- and MDD patients, older MUS patients most often 
suffered from chronic pain. 
Table 1: Patient characteristics of the study sample.
Older persons 
with MUS  
(n=104)
Older persons 
with MES 
(n=145)
Older persons 
with MDD 
(n=275)
p-valuesa
Descriptive characteristics
•	 Age Mean (SD) 70.51 (6.75) 73.09 (7.65) 70.48 (7.22) .001b,d
•	 Female % (n) 62.5 (65) 44.8 (65) 64.7 (178) <.001
•	 Education
o Low % (n) 26.5 (27) 18.2 (26) 46.2 (127)
<.001o Medium % (n) 46.1 (47) 51.7 (74) 34.9 (96)
o High % (n) 27.5 (28) 30.1 (43) 18.9 (52)
•	 Somatic comorbidity Mean (SD) 0.90 (1.12) 1.13 (1.02) 1.11 (1.09) .160
•	 Number of medication use Mean (SD) 5.89 (4.23) 5.48 (3.53) 6.00 (3.36) .399
•	 Global cognitive functioning Mean (SD) 28.20 (2.12) 28.23 (1.88) 27.59 (2.11) .003c,d
•	 Depressive symptom severity Mean (SD) 21.01 (11.68) 15.02 (9.33) 32.99 (12.25) <.001b,c,d
Pain characteristics  
(past 6 months)
•	 Chronic pain % (n) 66.7 (68) 43.4 (62) 53.8 (148) .001
•	 Usage of pain medication % (n) 73.5 (75) 58.7 (84) 66.5 (183) .051
a Significance values derived from one-way ANOVAs and chi-square tests
b Post-hoc Bonferroni test shows p-value <.05 for comparison between older persons with MUS and older 
persons with MES
c Post-hoc Bonferroni test shows p-value <.05 for comparison between older persons with MUS and depressed 
older persons 
d Post-hoc Bonferroni test shows p-value <.05 for comparison between older persons with MES and depressed 
older persons
 Adjusted for demographic (age, gender, education) and physical variables (somatic 
comorbidity, number of medication use, and level of cognitive functioning), the odds ratio of 
having chronic pain was about two times greater for older MUS patients as opposed to older 
MES patients (OR=2.01; 95% CI: 1.16-3.49; p =.013), but similar for older MUS and MDD patients 
(OR=.83; 95% CI: .52-1.33; p = .438). When additionally adjusted for depressive symptom 
severity, again, the odds of having chronic pain were increased for older MUS patients as 
opposed to older MES patients (OR = 3.24; 95% CI: 1.66-6.32; p = .001), but not as opposed to 
depressed older adults (OR=1.48; 95% CI: .84-2.59; p = .175). 
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Characteristics of chronic pain in the context of either MUS, MES or MDD
 Table 2 presents the chronic pain characteristics per patient group. In sum, the frequency 
of the most prominent pain location did not differ significantly between the three groups, 
whereas the other characteristics did. Post-hoc tests showed that chronic pain had fewer 
locations and was less intense in MES patients compared with either MUS patients as well 
as MDD patients, whereas disability due to pain only differed significantly between MES- and 
MDD patients, with lower disability scores in MES patients. MUS- and MDD patients did not 
differ on any of the characteristics. 
Table 2: Chronic pain characteristics in the context of MUS, MES and MDD.
Older persons 
with MUS
(n=68)
Older persons 
with MES
(n=62)
Older persons 
with MDD
(n=148)
p-valuesa
Most prominent pain location .228
- Back pain % (n) 28.4 (19) 38.7 (24) 28.4 (42)
- Neck pain % (n) 9.0 (6) 12.9 (8) 11.5 (17)
- Headache/migraine % (n) 6.0 (4) 3.2 (2) 6.1 (9)
- Face-ache % (n) 6.0 (4) 0.0 (0) 2.0 (3)
- Abdominal pain % (n) 10.4 (7) 1.6 (1) 9.5 (14)
- Joint pain % (n) 37.3 (25) 43.5 (27) 37.8 (56)
- Chest pain % (n) 3.0 (2) 0.0 (0) 4.7 (7)
Days (no.) with pain in  
past 6 months Mean (SD) 170.51 (26.10)
173.32 
(21.87) 162.97 (31.66) .030
Pain intensity score Mean (SD) 63.63 (13.88) 53.66 (17.07) 61.73 (17.60) .001b,d
Pain disability score Mean (SD) 45.44 (25.11) 34.43 (28.33) 50.27 (25.85) <.001d
Number of pain locations Mean (SD) 4.04 (1.40) 2.92 (1.45) 3.72 (1.71) <.001b,d
a Significance values derived from one-way ANOVAs and chi-square tests
b Post-hoc Bonferroni test shows p-value <.05 for comparison between older persons with MUS and older 
persons with MES
c Post-hoc Bonferroni test shows p-value <.05 for comparison between older persons with MUS and depressed 
older persons 
d Post-hoc Bonferroni test shows p-value <.05 for comparison between older persons with MES and depressed 
older persons
 
 Figures 1-3 present these group differences, based on MANOVAs adjusted for demographic 
(age, gender, education), and physical variables (somatic comorbidity, number of medication use, 
and level of cognitive functioning). In comparison to the results shown in Table 2, the differences 
between MUS and MDD weakened after adjustments for demographic and physical variables. 
However, differences between MUS- and MES patients remained statistically significant. 
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Associations between MUS severity indices and chronic pain characteristics 
 Multiple linear regression analyses were performed with outcomes pain intensity, pain 
disability, and the number of pain locations, and severity measures of MUS, adjusted for 
demographic and physical variables (Table 3). In sum, in older MUS patients with chronic 
pain, the self-perceived severity of the primary physical complaint was associated with 
higher pain intensity scores, whereas the presence of a primary somatoform disorder and 
the presence of a comorbid diagnosis according to DSM-IV criteria were associated with pain 
disability scores. Furthermore, a higher number of pain locations was associated with both 
a higher level of hypochondriac cognitions, as well as higher levels of somatization in older 
MUS patients with chronic pain.
Table 3: Associations between severity measures of MUS and pain intensity, pain disability and the 
number of pain locations in older MUS patients with chronic pain (n=68).
Outcomes B (SE) Beta p-value R2
Pain intensity
Severity of primary physical complaint (VAS)a .289 (.100) .386 .006 .290
Presence of a primary Somatoform Disordera 5.847 (3.598) .212 .111 .209
Levels of hypochondriac cognitions (WI)a -.180 (.737) -.036 .808 .167
Levels of somatization (BSI-53 subscale)a 2.795 (3.673) .128 .451 .177
Comorbid DSM-IV diagnosisa 3.962 (4.223) .129 .353 .181
Pain disability
Severity of primary physical complaint (VAS)a .329 (.180) .243 .074 .289
Presence of a primary Somatoform Disordera 14.464 (6.033) .290 .020 .321
Levels of hypochondriac cognitions (WI)a .832 (1.269) .092 .515 .246
Levels of somatization (BSI-53 subscale)a 3.272 (6.369) .083 .610 .244
Comorbid DSM-IV diagnosisa 14.885 (7.041) .268 .040 .304
Number of pain locations
Severity of primary physical complaint (VAS)a .007 (.011) .086 .572 .076
Presence of a primary Somatoform Disordera .373 (.389) .134 .343 .087
Levels of hypochondriac cognitions (WI)a .161 (.075) .319 .037 .151
Levels of somatization (BSI-53 subscale)a 1.035 (.359) .471 .006 .227
Comorbid DSM-IV diagnosisa -.016 (.453) -.005 .972 .070
a Adjusted for demographic variables (age, gender, education) and physical variables (somatic comorbidity, 
number of medication use, MMSE total score)
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Figure 1: Adjusted means of pain intensity scores of older persons with chronic pain*.* F(2,245) = 4.99; p = .008; eta2=.04** p<.05
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Figure 2: Adjusted means of pain disability scores of older persons with chronic pain*.
* F(2,244) = 3.83; p = .023; eta2=.03** p<.05
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Figure 3: Adjusted means of the number of pain locations of older persons with chronic pain*.
* F(2,245) = 4.28; p = .015; eta2=.03
** p<.05
Discussion
Main findings
 In our study, two-thirds of older patients with MUS suffered from chronic pain and half 
of the depressed older patients. Older persons with MUS have approximately 2 times more 
chance of suffering from chronic pain when compared to older persons with MES and equal 
chances of having chronic pain as opposed to older persons with MDD. Older persons with 
MUS and older persons with MDD report equal chronic pain intensity levels and an equal 
number of pain locations, but more intense chronic pain and pain in more sites when 
compared to older MES patients. 
 Among MUS patients with chronic pain, severity measures of MUS were differentially 
related to the pain characteristics under study: 1) higher pain intensity scores were associated 
with higher self-perceived severity of the primary physical complaint; 2) higher pain disability 
scores were associated with the presence of a psychiatric disorder, namely both a primary 
somatoform disorder as well as comorbid (other) psychiatric disorders; and last; 3) more 
pain locations were associated with higher levels of somatization as well as hypochondria. 
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Integration with previous findings
 The present study clearly shows that pain characteristics in older MUS patients and MDD 
patients are comparable with respect to intensity, number of pain locations and disability. 
These similarities in the phenotypic expression of pain may point to shared underlying 
pathways for chronic pain in patients with either MUS or MDD, as was previously mentioned 
by Katona et al., 2005.  
 By studying the associations between pain characteristics and MUS severity indicators 
in older MUS patients, we found that pain intensity was associated with the severity of the 
primary unexplained symptom. This makes sense, acknowledging that pain was the primary 
physical complaint in most of our MUS patients. The absence of an association between pain 
intensity and all other indicators of MUS-severity, however, may be more interesting: we found 
that with increasing perceived severity of MUS, pain intensity is not the pain characteristic 
that amplifies. Rather, older MUS patients express the increased severity of MUS by a higher 
level of pain disability and by more pain locations. 
 More specific, pain disability in older MUS patients is associated with the presence 
of a (co-morbid) psychiatric disorder, irrespective whether this is a somatoform, anxiety or 
depressive disorder. At first sight, this might not be surprising as (severe) functional disability 
is a prerequisite for having a psychiatric disorder (APA, 2000). Nonetheless, we measured 
pain disability using a self-report questionnaire (GCPS); clinicians, on the other hand, set 
the psychiatric diagnoses. Although several studies have shown that patients and clinicians 
often disagree about the level of the patient’s disability (e.g. Rothwell et al., 1997), this cannot 
simply be generalized to older MUS patients according to our findings. Moreover, when older 
MUS patients experience high pain disability, this might be an indication for psychiatrists to 
consider the presence and treatment of psychiatric comorbidity.
 Last, a higher number of pain locations was associated with more hypochondriac 
cognitions and a higher level of somatization. The direction of this association, however, 
cannot be established within the present study. It seems most likely that a high level of 
somatization or health anxiety results in attentional bias for physical signals and subsequently 
in the emergence of more pain locations. If true, psychological treatment might reduce the 
burden of chronic pain, in this case by reducing the number of pain sites. On the other hand, 
we cannot exclude the possibility that more pain locations simply result in increased levels 
of health anxiety and somatization.
Strengths and limitations of the current study
 As far as we know, this is the first study to explore differences in chronic pain 
characteristics between older persons with MUS, MES and MDD. To interpret our findings 
correctly, several limitations should be taken into account. 
 First, we combined data of the OPUS and the NESDO study (Comijs et al., 2011). 
Participants were thus recruited using slightly different study protocols, increasing the 
chance of selection bias. Over- or underrepresentation of specific subgroups in the studies, 
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such as patients with very mild or very severe complaints, could distort our research findings, 
herewith possibly reducing external validity. 
 In line with this, the presence of psychiatric diagnoses was based on the MINI in the 
OPUS study (Sheehan et al., 1998) and on the CIDI in the NESDO study (Wittchen et al., 
1991). Furthermore, in the NESDO study only the CIDI sections about depressive and anxiety 
disorders were administered. Therefore, we do not know how many of the depressed older 
adults actually had a comorbid somatoform disorder. In the OPUS study, participants were 
allowed to have comorbid depression and anxiety next to the primary somatoform disorder. 
As we did not compare psychiatric diagnoses in the current study and a previous study has 
demonstrated a high level of agreement between psychiatric diagnoses based on both 
instruments (Lecrubier et al., 1997), consequences of the use of different measurements are 
probably limited. 
Implications for clinical practice
 Compared to chronic pain in MES patients, chronic pain in older patients with MUS or 
MDD has a higher intensity, presents in a higher number of locations and is more disabling. 
These findings might indicate the importance of an intensive dual-track pain-management 
program for older patients with MUS or depression. Good somatic health care is crucial for 
relieving pain, while it is known that psychiatric patients often receive suboptimal health care 
(Corrigan, 2004; Kohn et al., 2004). Pain management could be focused on learning adequate 
coping skills as offered in mental health care programs for chronic pain or somatoform 
disorders (Ashburn & Staats, 1999; Campbell et al., 2003), while taking into account the 
treatment preferences of the older age group (Lansbury, 2000). Our results point to several 
potential treatment targets in older adults, namely the level of hypochondria, somatization 
and comorbid psychiatric disorders, as for all of these aspects evidence based interventions 
are available (e.g. Speckens et al., 1995; Allen et al., 2006; McGuire et al., 2014; Olatunji et al., 
2014). Moreover, integrated programs combining optimal medical and mental management 
are in line with the DSM-5 classification of Somatic Symptom Disorder that emphasizes the 
interaction between medically (un)explained symptoms and psychological symptoms, such 
as depressive symptoms (APA, 2013). 
 The effects of multidisciplinary chronic pain management programs are promising, e.g. 
in achieving more effective coping strategies (Jensen et al., 2001). The positive effects of these 
chronic pain management programs are also endorsed for older adults (McGuire et al., 2014). 
Nonetheless, the high prevalence of chronic pain identified in our patient samples- two-thirds 
of all older MUS patients and half of all older persons with MDD- suggests underutilization of 
these programs for older adults. Our findings may not only stress the importance of such 
treatment programs for older patients, but may also help to refine treatment programs for 
this age group.
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Abstract
Late-life depression and pain more often co-occur than can be explained by chance. 
Determinants of pain in late-life depression are unknown, even though knowledge on 
possible determinants of pain in depression is important for clinical practice. Therefore, 
the objectives of the present study were 1) to describe pain characteristics of depressed 
older adults and a nondepressed comparison group and 2) to explore physical, lifestyle, 
psychological and social determinants of acute and chronic pain intensity, disability, and 
multisite pain in depressed older adults. Data of the Netherlands Study of Depression 
in Older persons cohort, consisting of 378 depressed persons, diagnosed according to 
Diagnostic and Statistical Manual of Mental Disorders, 4th edition criteria, and 132 
non-depressed persons of 60 years and older, were used in a cross-sectional design. 
Pain characteristics were measured by the Chronic Graded Pain Scale. Multiple linear 
regression analyses were performed to explore the contribution of physical, lifestyle, 
psychological, and social determinants to outcomes pain intensity, disability and the 
number of pain locations. Depressed older adults more often reported chronic pain and 
experienced their pain as more intense and disabling compared to nondepressed older 
adults. Adjusted for demographic, physical, and lifestyle characteristics, multinominal 
logistic regression analyses showed increased odds ratios (OR) for depression in 
acute pain (OR = 3.010; p = .005) and chronic pain (OR = 4.544, p < .001). In addition, 
linear regression analyses showed that acute and chronic pain intensity, disability, 
and multisite pain were associated with several biopsychosocial determinants of 
which anxiety was most pronounced. Further research could focus on the temporal 
relationship between anxiety, late-life depression, and pain. 
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Introduction
 Depression and chronic pain are both highly prevalent in later life. Meta-analytic 
reviews report prevalence rates of 1.8% for major and 10.2% for minor depressive disorders 
in community-dwelling persons of 55 years and older (Beekman et al., 1999) and of 7.2% for 
major depressive disorders in patients of 75 years and older if institutionalized older people 
are also taken into account (Luppa et al., 2012). Prevalence rates of chronic pain are strongly 
dependent on the definition used (Gagliese & Melzack, 1997). The International Association 
for the Study of Pain has defined chronic pain as ‘pain that persists past the normal time of 
healing’ (International Association for the Study of Pain, 1986; Merskey & Bogduk, 1994) and 
suggests framing chronic pain as pain that is present for three months or longer. Taking the 
rather arbitrarily chosen definitions of chronic pain in clinical research into account, between 
29% and 50% of older persons suffer from chronic pain in the Western world (Eriksen et al., 
2003; Jakobsson, 2010). 
 Interestingly, depression and pain more often co-occur than can be explained by 
chance (Bair et al., 2004; Fishbain et al., 1997). The association between pain and depression 
in later life seems to be reciprocal, although the evidence that pain predisposes depression 
is more consistent than vice versa (Arola et al., 2010; Campbell et al., 2003; Fishbain et al., 
1997; Hilderink et al., 2012; Turk et al., 1995). From a clinical perspective, knowledge of pain in 
late-life depression is important, as pain has not only a negative impact on the natural course 
of depression (Chou, 2007), but also on treatment outcome (Bair et al., 2004) and quality 
of life (Jakobsson et al., 2007). Knowledge on determinants of pain in late-life depression, 
therefore, may facilitate both pain and depression management in depressed older adults 
(Katona et al., 2005). The biopsychosocial model of illness, as introduced by Engel (1977), 
combines physical, psychological and social factors to explain illness. As with depression, 
pain is associated with biological, psychological and social factors (Campbell et al., 2003). 
Numerous studies have examined correlates of chronic pain in general and older populations; 
collectively, these studies show consistent associations between chronic pain and female 
gender, lower income, smoking and poor psychological health, such as depressive or 
anxious symptoms (e.g. Hogg-Johnson et al., 2008; Jacobs et al., 2006; Tripp et al., 2006). Less 
consistently reported are determinants like age, partner status and social isolation (Jacobs 
et al., 2006; Tripp et al., 2006). Since many of these determinants are also associated with 
depression, it remains unknown which characteristics are uniquely associated with pain 
in depression. Also, physical, psychological and social determinants of pain in depression 
have never been examined within one study. In addition, although most studies on pain 
and depression focus on chronic pain, the difference between acute and chronic pain has 
seldom been explored in older adults. Lastly, the majority of studies on later-life pain does 
not differentiate between perceived pain intensity and disability due to pain and overlooks 
the importance of multisite pain (Denkinger et al., 2014, Eggermont et al., 2012). These three 
major shortcomings of previous research will be addressed in the present project. 
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 The first objective of the present study is to describe pain characteristics of 
depressed older persons and a nondepressed comparison group. In line with Engel’s (1977) 
biopsychosocial model, our second objective is to explore to what extent physical, lifestyle, 
psychological, and social factors are associated with pain intensity, pain disability, and the 
number of pain locations in depressed older adults with acute and chronic pain separately.
Methods
Study design & procedures
 The Netherlands Study of Depression in Older persons (NESDO) is a prospective cohort 
study that aims to give insight in possible determinants and the course of late-life depression 
(Comijs et al., 2011). In the present study, baseline data were used to answer our research 
questions in a cross-sectional design. There were 378 depressed older adults (>60 years), with 
a diagnosis of Major Depression, Minor Depression, or Dysthymia, according to Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria, included from mental health 
institutions (N=326; 45 inpatients and 281 outpatients) and general practices (N=52) from five 
different regions of the Netherlands. Patients included from general health institutions were 
mostly outpatients. 48.7% Of the approached depressed older adults eventually participated 
in the study. Persons that refused to participate were older and more severely depressed than 
persons that participated in our study, but comparable regarding gender. 
 Also, 132 subjects with no lifetime diagnosis of depression at the age of 60 years or higher 
were recruited from general practices to serve as a nondepressed comparison group; 66.7% of 
the approached controls were willing to participate in our study. Exclusion criteria for both the 
depressed older persons and controls were (suspicion of) dementia or (suspicion of) severe 
cognitive decline, as measured by a Mini Mental State Examination (MMSE) (Folstein et al., 
1975) score <18 (out of 30), and insufficient command of the Dutch language. A more detailed 
description of recruitment and characteristics of the sample are given by Comijs et al. (2011). 
 After giving informed consent, the baseline data were assessed using written 
questionnaires, interviews and physical assessments. Baseline data were assessed 
between 2007 and 2010. The study protocol was authorized by the Ethical Review Board of 
the VU University Medical Center. Also, local feasibility certificates were provided by each 
participating institution. For more details on recruitment and research procedures of the 
NESDO study, see (Comijs et al., 2011). 
Measures
Assessment of pain
 Pain intensity and pain disability were examined by using the Dutch version of the 
Chronic Graded Pain Scale (CGPS) (Von Korff & Miglioretti, 2005; Von Korff et al., 1992). This 
questionnaire aims to chart presence and location of pain, as well as intensity and disability 
due to pain. First, seven possible pain locations were investigated. Also, a general question 
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on the frequency of pain medication use was asked. Subsequently, if patients reported 
pain in more than one location, they were asked which location of pain was most severe 
in the past six months. Additional information for this pain location was asked, such as the 
number of days the patients suffered from this pain in the past six months. Consistent with 
the definitions of chronic and acute pain of the International Association for the Study of Pain 
(International Association for the Study of Pain, 1986) and in line with previous studies (e.g. 
Gerrits et al., 1992), we defined pain as chronic when present for 90 days or more in the past 
six months and as acute pain when present for less than 90 days during the past six months. 
Items on pain intensity and pain disability were assessed for the patient’s most severe pain 
location. In this paper, we use the phrases ‘acute pain in depression’ and ‘chronic pain in 
depression’ for the presence of acute or chronic pain in older people who are also depressed.
 The CGPS has been validated for primary care populations in the United Kingdom and 
the United States, presenting good internal consistency and reliability rates (a= .91) (Smith 
et al., 1997; Von Korff et al., 1992) and significant correlations with clinical variables, such 
as other pain measures, the patient’s disability, the frequency of pain medication use and 
frequency of doctors visits (Klasen et al., 2004). 
Pain Intensity- Three questions were used for examining pain intensity, specifically ‘How 
would you describe your pain at this moment?’, ‘How intense was your worst pain over the 
past six months?’ and ‘How intense was your average pain over the past six months?’. All 
scores were given on a scale from 0 to 10, with score 0 indicating ‘no pain’ and score 10 
indicating ‘worst possible pain’. Pain intensity was calculated by taking the average of the 
three item scores and multiplying it by ten (Von Korff et al., 1992). 
Pain disability-Three items were used for assessing disability due to pain, specifically ‘To what 
extent have you been limited by your chronic pain in carrying out your daily activities over the 
past six months?’, ‘To what extent have you been limited in your spare time, your social life, 
and during family activities because of your chronic pain over the past six months?’ and ‘To 
what extent have you been limited in carrying out your work (housework included) because 
of your chronic pain over the past six months?’. All scores were given on a scale from 0 to 10, 
with score 0 indicating ‘no interference’ and score 10 indicating ‘impossible to carry out the 
action’.  The disability score was computed by taking the average of these three item scores 
and multiplying it by ten (Von Korff et al., 1992). 
Number of pain locations- Seven possible pain locations were asked, using the question ‘Did 
you have -type pain- in the past six months?’ (yes/no). The CGPS specifically asked about 
backache, neck pain, headache or migraine, facial ache, stomachache, joint pain and chest 
pain. The total number of pain locations was calculated and used as an outcome variable. 
Measurements of possible determinants
 Basic demographic characteristics were asked, including age (years), gender and 
education (total years of education). Subsequently, physical, lifestyle, psychological, and 
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social characteristics were explored using Dutch translations of self-report questionnaires 
and structured interviews that are validated in an older population. 
Physical determinants
Chronic diseases- Somatic comorbidity was assessed using a self-report questionnaire that 
was originally developed by Statistics Netherlands (CBS, www.cbs.nl). This questionnaire 
assesses chronic diseases, such as lung disease, cardiac disease, diabetes, arthritis, cancer, 
ulcer, and stroke. Afterwards, a validated algorithm (Kriegsman et al., 1996) was applied, 
resulting in an accurate measure of current or previous presence of chronic diseases. 
Medication use- Per patient all regularly taken medication (>50% of time) in the past month 
was listed. To increase reliability, drug containers were inspected by the researcher. The total 
number of prescribed medication was used as a possible determinant of pain. 
Lifestyle determinants
Physical activity- Physical activity was examined by calculating Metabolic Equivalent of Tasks 
(MET)– minutes for the past week. MET-minutes indicate the ratio between energy expenditure 
and rest in daily life functioning. In this study, MET-minutes were derived from the 7-item 
version of the International Physical Activity Questionnaire (IPAQ) (Craig et al., 2003). A higher 
number of MET-minutes refers to more physical activity in the past week. Criterion validity 
was adequate in older population samples (Tomioka et al., 2011) and test-retest reliability 
rates were good (Spearman’s correlation approx. .80) in younger adults (Craig et al., 2003). 
Body Mass Index- All patients were weighed (in kg) and measured (in cm) using standardized 
protocols. Afterwards, the body mass index was calculated as an indication of human body 
shape by dividing the patient’s weight by the square of the patient’s length. 
Smoking- Smoking was included as being a current smoker at that given moment (yes/no). 
Alcohol consumption- The Alcohol Use Disorders Identification Test (Babor et al., 1989) is a 
10-item screening instrument for identifying potential harmful alcohol consumption. A total 
score was calculated by adding the individual item scores, with higher scores indicating higher 
alcohol consumption. In terms of construct validity, the total score of this questionnaire had 
adequate correlations with other alcoholism screening tests and good test-retest reliability, 
with average Kappa rates of .70 (Babor et al., 1989).
Psychological determinants
Severity of depressive symptoms- The severity of depressive symptoms over the past seven days 
was measured using the 30-item Inventory of Depressive Symptomatology (Trivedi et al., 2004). 
The two items on eating behaviour and the two items on sleeping behaviour were combined 
to make sure participants could only answer one out of two items. Therefore, a total score of 
depressive symptoms’ severity was computed by summing the scores of 28 items, resulting 
in a total score ranging from 0 to 84. A higher total score indicates more severe depressive 
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symptoms. The Inventory of Depressive Symptomatology showed adequate concurrent and 
discriminant validity and good internal consistency rates (a=.92-.94) (Rush et al., 1996). 
Cognitive functioning- General cognitive functioning was measured by the MMSE (Folstein et 
al., 1975). A total score was calculated (maximum 30), with higher scores indicating better 
cognitive functioning. The MMSE showed good reliability rates (Pearson r = .89) and adequate 
concurrent validity (Pearson r=.66-.78) (Folstein et al., 1975). 
Neuroticism- Neuroticism, a personality trait referring to emotional instability, was examined 
by the corresponding subscale of the NEO Five-Factor Inventory (Costa & McCrae, 1995). A 
total subscale score was computed, with higher scores indicating increased presence of 
neuroticism. A British item-level psychometric study showed good internal consistency 
rates for the Neuroticism subscale in a general population; in addition, confirmatory factor 
analyses showed adequate validity for this subscale (Egan et al., 2000).
Number of negative life events in the past year- The Brugha Questionnaire (Brugha et al., 1985) was 
used for measuring the number of negative life events in the past year. This questionnaire charts 
12 negative life events with potential long-term threat, which accounted for 77% of all negative life 
events with potential long-term threat in a general and psychiatric patient sample (Brugha et al., 
1985). By counting the exposure to 12 negative life events with considerable long-term threat in 
the past year, exposure to negative life events was charted.  
Anxiety- The Beck Anxiety Inventory was used for measuring levels of anxiety (Kabacoff et al., 
1997). This questionnaire consists of 21 items; answers are given on a scale from 0 (not at all) to 3 
(severely). A total score ranging from 0 to 63 was calculated, with higher scores indicating higher 
levels of anxiety. In older adults with mixed psychiatric problems, this questionnaire showed good 
internal consistency rates (α=.90), adequate discriminate validity as it discriminated between 
anxiety and non-anxiety disorder groups and good factorial validity (Kabacoff et al., 1997).  
Social determinants
Partner status- Partner status was included as having a long-term relationship at that given 
moment (yes/no). 
Social network size- The size of the social network was measured through the first question 
of the Close Person Inventory (Stansfeld & Marmot, 1992): ‘With how many family members, 
friends and acquaintances do you have regular and important contact?’. Answers were given 
in six ascending response categories, specifically ‘zero to one’, ‘two to five’, ‘six to ten’, ‘eleven 
to fifteen’, ‘sixteen to twenty’ or ‘twenty or more’. 
Loneliness- Loneliness was measured using the Loneliness Scale (Van Tilburg & De Jong-
Gierveld, 1999). A sum score was computed from 11 items with answering categories 0 
(no), 1 (more or less) and 2 (yes). Higher sum scores indicate more feelings of loneliness. 
Need for affiliation- Likewise, the need for affiliation was measured by using the Affiliation 
Scale (Van Tilburg & De Jong-Gierveld, 1999). The scale consists of six items with similar 
answering categories, with higher sum scores indicating a higher need for affiliation. The 
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Loneliness and Affiliation Scale showed good internal consistency rates (a=.84) (Cramer & 
Barry, 1999); construct validity was adequate (De Jong-Gierveld & Kamphuis, 1985).
Statistical analyses
 Sample size calculation showed that, in order to gain a power level of .80 with alpha 
.05, our minimal sample size was set at n=122 for our analyses, according to the criteria by 
Green (1991). The number of missings was acceptable (range 0-7.5%) for all measures, except 
for the International Physical Activity Questionnaire’s MET-minutes scores. Also, these scores 
were not normally distributed. We therefore imputed and transformed these scores similar 
to the work by Wassink-Vossen et al. (2014). For a detailed description of imputation and 
transformation strategies, see Wassink-Vossen et al. (2014).
 To explore objective one, depressed and nondepressed older adults were compared 
on demographic variables and pain characteristics. Differences between both groups were 
explored by calculating descriptive statistics (e.g. means, standard deviations, frequencies) 
and performing t-tests for continuous measures with normal distributions, Mann-Whitney 
U-tests for continuous measures with skewed distributions and Chi-Square tests for 
categorical variables. In order to assess whether the presence of a depressive disorder (yes/
no) was associated with acute and/or chronic pain, multinomial logistic regression analysis 
with no pain as a reference group was performed, adjusted for demographic, physical and 
lifestyle factors. Odds ratio’s (ORs), 95%-confidence interval (CI) values and significance 
values (p-values) of this multinomial logistic regression model are reported.
 Subsequently, to explore the second objective biopsychosocial determinants of pain 
intensity, disability due to pain, and the number of pain locations in depressed patients with 
acute and chronic pain were investigated using multiple linear regression analyses. Analyses 
for acute pain and chronic pain were performed separately. Since correlation matrices and 
variance inflation factors (range 1.019-1.793 for acute pain analyses; range 1.015-1.800 for 
chronic pain analyses) did not show potential multicollinearity problems between any of the 
variables previously described, all possible determinants were included into the regression 
models, after adjustment for demographic variables (age, gender, education). We built four 
separate models. In model 1 determinants related to physical status (chronic diseases, 
medication use, physical activities and cognitive functioning) were examined. In model 2, 
determinants related to lifestyle factors (physical activity, body mass index, smoking, alcohol 
consumption) were examined. In model 3, psychological determinants (severity of depressive 
symptoms, neuroticism, number of negative life events and anxiety) were examined. Lastly, 
in model 4 social determinants (partner status, loneliness, social network size and need 
for affiliation) were examined. For each model, the R2 change values are reported as an 
indication of how much variability in pain intensity, pain disability or the number of pain 
locations can be explained by the specific model in addition to the demographic variables. 
Also, standardized beta’s and significance values (p values) are reported for each specific 
determinant. Thereafter, a final multivariate model was tested entering all determinants 
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of the four different models that were associated with pain intensity, pain disability or the 
number of pain locations at the 10% level (p<.10).
 All statistical procedures were performed using IBM SPSS version 20. Final outcomes 
were considered statistically significant if p-values were <.05. 
Results
Pain characteristics by depression status
 The mean (SD) age of our populations was 70.6 (7.3) years and 331/510 (64.9%) of all 
participants were female.  Table 1 presents all characteristics for depressed and nondepressed 
older adults separately. 
Table 1: Characteristics of the study sample by depression status (N=510).
Characteristics Values
Depressed 
patients
(n=378)
Values
Control 
patients
(n=132)
p valuea 
Demographic 
characteristics
 
Age
 
Mean (SD)
 
70.7 (7.4)
 
70.1 (7.2)
 
.371
Female % (n) 66.1 (250) 61.4 (81) .188
Education Mean (SD) 10.4 (3.5) 12.5 (3.5) <.001
Physical 
characteristics
Number of chronic diseases under treatment Mean (SD) 1.5 (1.2) 1.1 (1.0) .001
Number of current medication Mean (SD) 5.8 (3.3) 3.5 (3.0) <.001
Lifestyle 
characteristics
Physical activities  - METS per week Mean (SD) 2414  
(2542)
3399  
(2996)
.001
Smoking-yes % (n) 26.7 (100) 8.3 (11) <.001
Alcohol use Mean (SD) 2.6 (3.5) 3.6 (2.8) .001
Body Mass Index Mean (SD) 26.3 (4.6) 27.0 (4.1) .112
Psychological 
characteristics 
Severity of depressive symptoms Mean (SD) 30.1 
(13.0)
7.8 (6.4) <.001
Neuroticism Mean (SD) 39.1 (7.0) 24.9 (6.8) <.001
Number of negative life events in the past year Mean (SD) .4 (.8) .4 (.7) .962
Anxiety symptoms Mean (SD) 17.5 
(11.4)
4.1 (5.6) <.001
Cognitive functioning Mean (SD) 27.6 (2.5) 28.3 (1.6) .002
Social 
characteristics
Partner present % (n) 52.4 (198) 75.0 (99) <.001
Loneliness Mean (SD) 6.6 (3.5) 2.0 (2.4) <.001
Social Network Size Mean (SD) 2.4 (1.2) 3.3 (1.7) <.001
Affiliation Mean (SD) 3.8 (2.1) 3.99 (2.0) .345
a Significance values derived from independent samples t-tests, Mann-Whitney U-tests and chi-square tests
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Table 2: Pain frequency and characteristics for depressed and non-depressed older persons.
Pain characteristics Depressed patients Nondepressed 
comparison group 
Statisticsa
Whole sample (n=510) (n=378) (n=132)
Pain present in the past six months % (n) 91.2 (345) 75.8 (100)
Pain locations in the past six months:
•	 Back pain % (n) 56.1 (212) 37.1 (49) <.001
•	 Neck pain % (n) 41.3 (156) 24.2 (32) .002
•	 Headache % (n) 48.9 (185) 32.6 (43) .004
•	 Stomach pain % (n) 42.9 (162) 19.7 (26) <.001
•	 Joint pain % (n) 58.7 (222) 47.7 (63) .055
•	 Pain on the chest % (n) 23.3 (88) 7.6 (10) <.001
•	 Pain in the face % (n) 16.4 (62) 6.1 (8) .010
Participants with pain (n=443) (n=343) (n=100)
Pain intensity score mean (SD) 50.5 (20.6) 38.7 (18.5) <.001
Pain disability score Mean (SD) 38.1 (29.2) 19.2 (23.6) <.001
Number of pain locations mean rank 3.2 (1.7) 2.3 (1.3) <.001
Most severe pain location:
•	 Back pain % (n) 24.6 (93) 18.9 (25) .680
•	 Neck pain % (n) 9.0 (34) 5.3 (7)
•	 Headache % (n) 12.4 (47) 11.4 (15)
•	 Stomach pain % (n) 11.1 (42) 6.8 (9)
•	 Joint pain % (n) 27.2 (103) 28.8 (38)
•	 Pain on the chest % (n) 3.4 (13) 1.5 (2)
•	 Pain in the face % (n) 3.2 (12) 3.0 (4)
Duration of pain (days): Mean (SD) 103.6 (73.5) 73.2 (75.0) <.001
Most severe pain was
•	 Acute pain % (n) 43.4 (149) 62.0 (62)
•	 Chronic pain % (n) 56.6 (194) 38.0 (38)
Use of pain medication (yes) % (n) 64.7 (243) 50.8 (67) .005
Frequency of medication in case of use: (n=243) (n=67)
•	 Few times in the past six months % (n) 33.7 (82) 44.8 (30)
•	 Several times each month % (n) 18.5 (45) 26.9 (18)
•	 Weekly % (n) 14.8 (36) 11.9 (8)
•	 Daily % (n) 32.9 (80) 16.4 (11) .033
a Significance values derived from independent samples t-tests, Mann-Whitney U-tests and chi-square tests
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Biopsychosocial associations with pain in late-life depression
 In this and the following paragraphs, when we use the phrase ‘the outcomes were 
explained by certain variables’, we mean that these variables accounted for a certain 
proportion of the variance in the experience of acute or chronic pain. Detailed information 
about how much of the variance is explained by the model (R2) can be found in the tables. 
 In depressed older adults, 149/378 (39.4%) reported acute pain and 194/378 (51.3%) 
chronic pain vs 62/132 (47%) and 38/132 (28.8%) in the nondepressed comparison group 
(χ2 (2) = 10.7, p=.001). Multinominal logistic regression analysis with outcome pain (no pain/
acute pain/chronic pain), adjusted for demographic, physical and lifestyle characteristics, 
showed increased ORs for depression in acute pain (OR = 3.0; 95% CI = 1.4-6.5; p=.005) and for 
depression in chronic pain (OR = 4.5; 95% CI = 2.0-10.4; p=.001). 
Acute pain- For depressed older adults with acute pain, intensity was explained by socio-
demographic, psychological, and social variables (see table 3). The final model (R2 = .178) 
showed that pain intensity was significantly associated with age (Beta=-.280; p=.002), 
education (Beta=-.187; p=.029), negative life events (Beta=.181; p=.036) and loneliness 
(Beta=.215; p=.012). Higher age, education and more negative life events and loneliness were 
associated with higher pain intensity scores. 
 Disability due to acute pain could not be explained significantly by any of the four 
models (see table 3). In the final model of individual variables (R2 = .065), pain disability 
in depressed older adults with acute pain was only significantly associated with anxiety 
(Beta=.194, p= .021). More symptoms of anxiety were associated with increased disability 
scores. 
 For depressed older adults with acute pain, the number of pain locations could not 
be explained significantly by any of the four models (see table 3). In the final model (R2 = 
.055), only anxiety (Beta=.178, p= .034) was significantly associated with the number of pain 
locations in depressed older adults with acute pain. Higher levels of anxiety were associated 
with more pain locations. 
 A total of 345/378 (91.2%) depressed older adults and 100/132 (75.8%) controls reported 
some level of pain in the past six months, with joint pains most frequently cited by both 
groups. Depressed participants reported more pain locations, more days of pain in the past 
six months, and higher pain intensity and pain disability scores compared to controls. Also, 
they reported a higher frequency of pain medication use compared to the nondepressed 
older adults (table 2). 
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Table 3: Determinants of pain intensity, pain disability, and number of pain locations in depressed 
older adults with acute pain.
         Intensity Disability Number of pain 
locations
Determinants β p β p β p
Basic adjustment
•	 Age -.244 .003 -.124 .138 -.011 .898
•	 Gender .115 .155 -.061 .464 .145 .084
•	 Education -.148 .069 -.076 .364 -.056 .503
Model statistics: ΔR2=.087, p=.004 ΔR2=.022, p=.355 ΔR2=.026, p=.278
Model 1 – Physicala
•	 Chronic diseases -.019 .834 .083 .380 .138 .141
•	 Current medication use .159 .083 .096 .309 .073 .434
Model statistics: ΔR2=.022, p=.172 ΔR2=.024, p=.177 ΔR2=.034, p=.081
Model 2 – Lifestylea
•	 Smoking .015 .865 .031 .736 .091 .321
•	 Alcohol use -.052 .558 -.102 .272 .070 .449
•	 Physical activity -.150 .098 -.086 .362 .003 .976
•	 Body Mass Index .019 .826 .022 .806 .082 .368
Model statistics: ΔR2=.026, p=.486 ΔR2=.019, p=.664 ΔR2=.018,  p=.689
Model 3- Psychologicala
•	 Depressive symptoms .108 .313 -.050 .657 .105 .346
•	 Anxiety .123 .203 .210 .041 .198 .052
•	 Negative life events .197 .017 .028 .744 .002 .979
•	 Neuroticism .028 .787 .050 .646 -.175 .110
•	 Cognitive functioning .058 .491 -.039 .660 -.096 .273
Model statistics: ΔR2=.081, p=.030 ΔR2=.047, p=.252 ΔR2=.059, p=.141
Model 4 – Sociala
•	 Partner status .131 .152 -.007 .940 .031 .751
•	 Network size -.064 .453 .097 .280 .076 .402
•	 Loneliness .207 .018 .220 .017 .077 .407
•	 Affiliation -.075 .360 -.023 .791 -.026 .767
Model statistics: ΔR2=.065, p=.041 ΔR2=.046, p=.172 ΔR2=.009, p=.873
a Additionally adjusted for age, gender and education. 
Chronic pain- For depressed older adults with chronic pain, pain intensity was explained 
by physical and psychological variables (see table 4). The final model  (R2 = .274) showed 
significant associations with medication use (Beta=.135; p=.046), severity of depressive 
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symptoms  (Beta=.210; p=.009) and anxiety (Beta=.301; p<.001) for older adults with chronic 
pain. This means a higher number of current medication, more severe depressive symptoms 
and higher levels of anxiety were associated with higher pain intensity scores in depressed 
older adults with chronic pain.
 For depressed older adults with chronic pain, pain disability was explained by all four 
models, thus by physical, lifestyle, psychological and social variables (see table 4). The final 
model (R2 = .315) showed significant associations between pain disability and the number of 
current medication (Beta=.147; p=.028), the Body Mass Index (Beta=.148, p=.029), and anxiety 
(Beta=.336; p<001). A higher number of current medication, higher body mass index, and 
higher levels of anxiety were associated with increased pain disability scores in depressed 
older adults with chronic pain. 
 The number of pain locations was significantly explained by sociodemographic, 
physical and psychological variables (see table 4). The final model (R2 = .334) showed 
significant associations between the number of pain locations and gender (Beta=.185, p= 
.004), severity of depressive symptoms (Beta=.274, p<.001) and anxiety (Beta=.258, p= .001). 
Female gender, more severe depressive symptoms and higher anxiety levels were associated 
with a higher number of pain locations in depressed older adults with chronic pain.  
Table 4: Determinants of pain intensity, pain disability, and number of pain locations in depressed 
older adults with chronic pain.
         Intensity Disability Number of pain 
locations
Determinants β p β p β p
Basic adjustment
•	 Age -.014 .843 .002 .978 -.099 .158
•	 Gender .066 .360 .124 .092 .292 .000
•	 Education -.183 .011 -.079 .278 -.123 .079
Model statistics: ΔR2=.038, p=.060 ΔR2=.002, p=.236 ΔR2=.102, p=.000
Model 1 – Physicala
•	 Chronic diseases .078 .317 .058 .466 .112 .139
•	 Current medication use .177 .021 .216 .021 .160 .030
Model statistics: ΔR2=.045, p=.012 ΔR2=.056, p=.004 ΔR2=.047, p=.006
Model 2 – Lifestylea
•	 Smoking -.001 .994 .145 .086 .006 .937
•	 Alcohol use -.108 .210 -.139 .106 -.064 .439
•	 Physical activity -.129 .123 .022 .793 -.126 .119
•	 Body Mass Index .055 .506 .194 .020 .033 .686
Model statistics: ΔR2=.032, p=.284 ΔR2=.057, p=.061 ΔR2=.021,  p=.474
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Model 3- Psychologicala
•	 Depressive symptoms .174 .050 .149 .099 .268 .002
•	 Anxiety .292 .001 .370 <.001 .306 .000
•	 Negative life events .061 .366 -.029 .668 .033 .613
•	 Neuroticism .109 .216 .017 .852 -.071 .401
•	 Cognitive functioning .048 .490 -.029 .689 -.064 .342
Model statistics: ΔR2=.233, p<.001 ΔR2=.223, p<.001 ΔR2=.229, p=.000
Model 4 – Sociala
•	 Partner status -.099 .212 -.149 .057 -.039 .609
•	 Network size .011 .890 .014 .863 -.048 .539
•	 Loneliness .068 .414 .200 .016 .072 .372
•	 Affiliation -.072 .346 -.045 .543 .002 .979
Model statistics: ΔR2=.021, p=.438 ΔR2=.073, p=.011 ΔR2=.013, p=.658
a Additionally adjusted for age, gender and education.
Post-hoc analyses
 To explore possible age differences in the biopsychosocial pattern of pain intensity, 
disability and the number of pain sites in depressed older adults, we performed a median 
split on age (median=69.5) and repeated the linear regression analyses for the two age 
groups (60-69.5 years and 69.5> years; from now on referred to as 60-70 years and 70>years). 
Because of a lower number of depressed older patients with acute pain, these models could 
not be analysed by age-group. 
Pain intensity- In our final model of pain intensity (R2 =.169), a significant association with 
anxiety (Beta=.285; p=.008) was found for older depressed adults ages 60-70 years that 
experienced chronic pain. In older depressed persons aged 70 years and up with chronic pain, 
significant associations between pain intensity and chronic diseases (Beta=.165; p=.046), 
neuroticism (Beta=.272; p=.009), anxiety (Beta=.328; p=.001)  and the need for affiliation 
(Beta=-.286; p<.001) were found in the final model (R2 =.517) . 
Pain disability- For depressed older adults aged 60-70 years with chronic pain, our final model 
(R2 =.219) showed significant associations between pain disability and current medication 
(Beta=.214; p=.043), and pain disability and loneliness (Beta=.255; p=.015). In addition, 
depressed older adults aged 70 years and older with chronic pain showed significant 
associations between pain disability and chronic diseases (Beta=.181; p=.040), and pain 
disability and anxiety (Beta=.498; p<.001) in the final model (R2 =.438). 
Number of pain locations- Depressed older adults with chronic pain aged 60-70 years showed 
a significant association between the number of pain locations and the severity of depressive 
symptoms (Beta=.444.; p<.001) in the final model (R2 =.209). However, the final model of older 
depressed adults with chronic pain aged 70 years and over (R2 =.473) showed significant 
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associations between number of pain locations and gender (Beta=.197; p=.014), anxiety 
(Beta=.562; p<.001), and loneliness (Beta=.172; p=.032).
Discussion
Main findings
 Depressed older adults suffered significantly more often from chronic pain compared 
to nondepressed older adults. Also, in case of pain, depressed older adults reported more 
pain locations, higher pain intensity and higher pain disability than nondepressed older 
adults. Among depressed older adults with pain, higher pain intensity, higher pain disability 
and more pain locations were associated with somatic, lifestyle, psychological, and social 
determinants. Nonetheless, in the final multivariate model, psychological characteristics, 
especially anxiety, explained most variance. This association was more pronounced in case 
of chronic pain compared to acute pain. Support for a biopsychosocial perspective of pain 
in depression was found for the oldest old persons (>70 years), with anxiety being the most 
consistent and evident determinant of all included biopsychosocial determinants for the 
older age group. In conclusion, the current findings support a biopsychosocial perspective, 
as previously described by Engel (Engel, 1977), for depressed older persons with chronic pain 
and pain in the oldest-old depressed persons. Therefore, these patient groups need special 
attention in clinical practice, for instance, by adopting a multidisciplinary approach. 
Comparison with literature
 Our finding that depressed older adults experience their pain as more intense than 
nondepressed older adults is in line with previous research (e.g. Jacobs et al., 2006) that has 
shown that poor psychological health is associated with higher pain intensity. In contrast 
to Stubss et al. (2013) and Iliffe et al. (2009), in our final models of acute and chronic pain 
intensity, pain disability and the number of pain sites, we found no significant associations 
with physical activity. Our finding that anxiety is an important determinant in the late-life pain-
depression association is consistent with previous research (e.g. Casten et al., 1995; Creamer 
et al., 1999; Crombez et al., 1999; Feeney, 2004; Smith & Zautra, 2008). When focusing on pain 
intensity, anxiety was only significantly associated with chronic pain in the present study. 
Since the previously mentioned studies were limited to measuring presence and/or intensity 
of pain, our study extends these findings with information regarding to pain disability and 
multisite pain. In our study, pain disability scores and the number of pain locations were 
associated with anxiety symptoms for both older depressed patients with both acute and 
chronic pain. Therefore, exploring determinants of pain disability, which is known to be 
stronger associated with depression than pain intensity (Von Korff & Simon, 1996), and 
exploring determinants of multisite pain, which is known to be strongly associated with 
depression (Denkinger et al., 2014; Eggermont et al., 2012) is a useful addition to previous 
research, in particular because of its clinical applicability. 
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 The significant relationship between anxiety and depression in chronic pain could 
possibly be explained by the partial overlap of both constructs in our study, as we used the 
Beck Anxiety Index to measure anxiety. The Beck Anxiety Index mainly focuses on physical 
symptoms of anxiety, such as palpitations, feeling hot, wobbliness in legs, hand trembling, 
lightheadedness etc. However, as other studies found the same results using different 
questionnaires (e.g. Casten et al., 1995; Creamer et al., 1999; Feeney, 2004; Smith & Zautra, 
2008), this explanation might not be sufficient. 
 Furthermore, regarding to the relationship between anxiety and depression in chronic 
pain, our post-hoc analyses suggest this relationship might be more pronounced in the 
oldest persons (>70 years) compared to younger older persons (60-70 years). Interestingly, in 
the older age group, chronic diseases account for a substantial amount of variance of chronic 
pain intensity and disability in older depressed adults. Possibly, the concept of ‘anxiety’ 
should be interpreted as ‘health worries’ in older depressed age groups with chronic pain, 
which was previously suggested by Blyth et al. (2011). 
 Another explanation for the relationship between anxiety and depression in chronic 
pain, can possibly be found in previous research (Katona et al., 2005) that has suggested 
chronic pain in depression is often medically unexplained. In our study, the number of 
chronic diseases did not significantly contribute to pain intensity and disability scores, which 
is in line with this hypothesis. Also, in the current study, the number of pain locations in 
depressed older adults with chronic pain was significantly associated with anxiety, which is 
in line with research that found medically unexplained symptoms are often multisided (Olde 
Hartman et al., 2004; Wessely et al., 1999). Patients with medically unexplained symptoms 
often suffer from co-morbid depression, and if so, levels of somatization and pain are higher 
compared to non-depressed older persons with medically unexplained symptoms (Hilderink 
et al., 2009). Moreover, the presence of medically unexplained symptoms is associated 
with a higher level of alexithymia (Deary et al., 1997; De Gucht et al., 2004). Patients who 
score high on alexithymia experience difficulties in describing their emotional feelings and 
report physical sensations accompanying emotional states. Further research is needed to 
investigate if presence of alexithymia could partly explain our finding of a higher level of 
anxiety in depressed older adults with chronic pain, which we have measured with Beck 
Anxiety Inventory (Kabacoff et al., 1997) that focuses on physical symptoms of anxiety. 
 Appropriate anxiety treatment might be one option to reduce the perception of pain 
intensity and reduce disability in depressed older patients with chronic pain, which should 
be tested in randomized controlled trails. Previous research has shown older patients with 
both pain and depression are at greater risk of polypharmacy, which in turn is associated 
with negative health outcomes (Hajjar et al., 2007). Psychological interventions targeted 
at modifying irrational beliefs about their pain and challenging presumed negative 
consequences by behavioural experiments, as done in cognitive-behavioural therapy, are 
probably less invasive than pharmacological treatment in older patients and are therefore 
worth considering (Gagliese & Melzack, 1997). 
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Methodological considerations
 The current study has several methodological strengths. First, depressed participants in 
the NESDO study are all diagnosed with formal DSM-IV diagnoses rather than the frequently 
used self-report questionnaires. In addition, the NESDO study covers a wide range of possible 
determinants, making it possible to explore potential biopsychosocial determinants of pain in 
depression collectively in one study. Regarding to the measurement of pain, we disentangled 
acute and chronic pain and differentiated between pain intensity, pain disability and the 
number of pain locations, making our measurement of pain more accurate. For proper 
interpretation, however, methodological considerations should be taken into account.
 First, in the current study, we could not assess all possible contributors to the experience 
and impact of pain; as the included determinants in this study only accounted for a certain 
proportion of the variance in the experience of chronic and acute pain, it would be interesting 
to add other possible contributors to our models, such as falls (Kvelde et al, 2013; Stubbs et 
al., 2014).
 Second, our distinction between acute and chronic pain, based on the duration of 
the most severe pain location, may not reflect clinical practice. As in daily life patients can 
have both acute and chronic pain at the same time, ecological validity of our measurement 
of pain-related outcomes, the CGPS, might be low for older patients. Therefore, cross-
validation of the CGPS and our definitions of acute and chronic pain in an older population 
are important. This limitation, however, may only have affected our results on acute pain 
as patients with both types of pain were categorized as having chronic pain. Moreover, our 
definition of chronic pain was used before in younger adults (e.g. Gerrits et al., 2012) and the 
chronic pain frequency rates in our controls are comparable to those of previous studies in 
older adults (Eriksen et al., 2003; Jakobsson, 2010). 
 Third, because of the cross-sectional nature of our study we could not draw any 
conclusions about the temporal relation between the determinants, pain and depression in 
later life. Therefore, it remains unclear whether anxiety precedes pain in depression or pain 
resulted in having more anxiety symptoms in depressed older adults. 
Finally, multiple comparisons increase the risk of false positive findings (type 1 error), 
whereas correcting for multiple comparisons may subsequently increase the risk for type 2 
errors (Perneger, 1998; Rothman, 1990). Therefore, we decided to present all individual beta-
values and p-values for proper interpretation. 
Future research
 Unraveling the temporal relationships of anxiety, pain, and depression, and examining 
the potential role of alexithymia in the late-life pain-depression association are important 
subjects for further investigation. Our findings support the importance of a biopsychosocial 
approach for chronic pain and the oldest old in late-life depression. However, further research 
is needed to confirm these findings and implement them in, for instance, pain prevention or 
treatment programs for older patients with acute and chronic pain.
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Abstract
Personality dysfunction has been postulated as the most clinically salient problem of 
persons suffering from medically unexplained symptoms (MUS) but empirical studies 
are scarce. This study aims to compare the personality profile of older patients suffering 
from MUS with two comparison groups and a control group. Ninety-six older patients 
with MUS were compared with 153 frequent-attenders in primary care suffering from 
medically explained symptoms (MES), 255 patients with a past-month depressive 
disorder (DSM-IV-TR), and a control group of 125 older persons. The Big Five personality 
domains (NEO-Five Factor Inventory) were compared between groups by multiple 
ANCOVAs adjusted for age, sex, education, partner status and cognitive functioning. 
Linear regression analyses were applied to examine the association between health 
anxiety (Whiteley Index) and somatization (Brief Symptom Inventory). The four groups 
differed with respect to neuroticism (p<.001), extraversion (p<.001), and agreeableness 
(p=.045). Post-hoc analyses showed that MUS patients compared to controls scored 
higher on neuroticism and agreeableness, and compared to depressed patients lower 
on neuroticism and higher on extraversion as well agreeableness. Interestingly, MUS 
and MES patients had a similar personality profile. Health anxiety and somatization 
were associated with a higher level of neuroticism and a lower level of extraversion 
and conscientiousness, irrespective whether the physical symptom was explained or 
not. Older patients with MUS have a specific personality profile, comparable to MES 
patients. Health anxiety and somatization may be better indicators of psychopathology 
than whether a physical symptom is medically explained or not.
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Introduction
 Medically unexplained symptoms (MUS) are physical symptoms that cannot be entirely 
explained by somatic disease (Olde Hartman et al., 2013). Patients with persistent MUS report 
significant decreases in quality of life, impairment in daily functioning, increased high health 
care utilization and often undergo medical examinations and treatments unnecessarily (Barsky 
et al., 2005; Koch et al., 2007; Margalit & El-Ad, 2008). This is especially relevant for frail older 
persons being most vulnerable for iatrogenic damage. Persistent MUS are classified within the 
section of somatoform disorders in the DSM-IV-TR if a psychological origin can be assumed. 
This section has been replaced by somatic symptom disorders in the DSM-5 (APA, 2013). A 
somatic symptom disorder can be classified when physical symptoms are accompanied by 
maladaptive cognitions, emotions or behavior irrespective of whether the physical symptom 
is medically explained or not (APA, 2013). Personality dysfunction has been hypothesized to 
be the most clinically salient problem of patients with a somatoform disorder. The largest 
study on comorbidity rates hitherto showed that 50.6% of patients suffering from MUS or 
somatoform disorders has a comorbid personality disorder when assessed systematically 
with the SCID-II (Bass & Murphy, 1995). Smaller studies that have assessed systematically 
comorbidity rates with personality disorders have reported even higher rates, i.e. 48.0% (Fink 
& Schröder, 2010), 60.6% (Rost et al., 1992), 62.9% (Garcia-Campayo et al., 2007), and 72.0% 
(Stern et al., 1993). This contrasts sharply with clinical data of 283 patients (mean age 41 
years) suffering from a somatoform disorder in which only 4.2% were considered to have 
axis II disorders (Kuwabara et al., 2007). This huge difference can most likely be explained 
by both referral bias in the first studies as well as under-detection of personality disorders in 
routine clinical care in the last study. A bit more data is available on the relationship between 
personality dimensions and somatization. Somatization, the tendency to experience and 
communicate psychological distress in the form of physical symptoms, is considered an 
important psychological mechanism underlying MUS. Somatization has been examined in 
relation to the Big Five personality profile and is, among adults, associated with a higher 
level of neuroticism and a lower level of agreeableness (Noyes et al., 2011; Zunhammer et al., 
2013). The only study conducted in an older sample found that a higher level of somatization 
was associated with a lower level of emotional stability, dominance and vigilance in 126 
community-dwelling healthy older persons (Wongpakaran & Wongpakaran, 2014). 
 In later life, MUS frequently co-occurs with medically explained symptoms (MES) 
(Benraad et al., 2013) and with affective disorders, primarily depression (Hilderink et al., 2009; 
Hilderink et al., 2012; Kroenke, 2003). Therefore, from a clinical point of view, discrimination 
between patients with MUS and patients with either MES or depression seems to be more 
relevant than a scientifically considered healthy control group of community-dwelling 
elderly. Therefore, we have included two comparison groups in addition to a formal control 
group. 
 The prevalence of MES increases with ageing. This contrasts with prevalence rates for 
MUS and somatoform disorders, which decrease after the age of 65 (Hilderink et al., 2013). 
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These lower prevalence rates of MUS and somatoform disorders in later life as compared to 
younger cohorts may be an artifact: physicians might be reluctant to classify symptoms as 
unexplained out of fear of missing a somatic explanation (Hilderink et al., 2013). Interpretation 
of the personality profile of older persons with MUS against a sample of older patients with 
MES who frequently visit their general practitioner is thus relevant (being an important 
differential diagnosis in clinical care). A comparison group suffering from depression can be 
relevant as a depressive disorder amplifies the subjective severity of somatic symptoms and 
is associated with functional impairment (Garcia-Campayo et al., 2007; Dunlop et al., 2003; 
Van Eck et al., 2015). Moreover, depression in later life often has a more somatic presentation 
(Hegeman et al., 2015) and a depressed state may contaminate the personality profile 
(Steunenberg et al., 2009) due to an increase in neuroticism scores and decrease of scores 
on extraversion, openness, and conscientiousness (Costa et al., 2005). In other words, actual 
depressive symptoms seem to amplify the personality profile somewhat.
 The primary aim of this study is to explore the Big Five personality traits in older patients 
suffering from MUS with a control group and two comparison groups, the first being frequent 
attenders in primary care who suffered from MES and the second being depressed older 
persons. The secondary aim was to explore the association between the Big Five personality 
traits and indices of somatization in older patients with MUS and MES and whether this 
differed in the two patients groups.
Methods
Study design and participants
 Using a case-control design, we compared 118 older patients with MUS (cases) with 
132 controls and with two comparison groups. The first comparison group consisted of older 
patients suffering from MES who frequently attend their general practitioner (n=154). The 
second group consisted of patients suffering from a past-month major depressive disorder 
(n=275). 
 Data for the present study were extracted from the Older Persons with medically 
Unexplained Symptoms (OPUS) study (patients with MUS and MES) and the Netherlands 
Study of Depression in Older persons (NESDO) (depressed older patients and controls). Both 
studies will be summarized below.
OPUS study
 OPUS is a case-control study aimed to explore determinants of MUS in later life. The 
recruitment process was designed to compose a sample of older patients with MUS in various 
developmental and severity stages in order to overcome setting-specific findings. Therefore, 
possible participants with MUS and MES were recruited in the community by advertisements 
in local newspapers, in primary care, and in secondary health care. Inclusion criteria were 
1) age of 60 years or above, 2) MUS for at least three months according to their general 
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practitioner (GP), 3) met the definition for MUS of the Dutch College of General Practitioners, 
i.e. physical symptoms that have existed for more than several weeks and for which adequate 
medical examination has not revealed any condition that sufficiently explains the symptoms 
(Olde Hartman et al., 2013). 
 We operationalized ‘several weeks’ as at least three months. Also, patients were included 
if a so-called functional syndrome was present, i.e. fibromyalgia, chronic fatigue syndrome, 
irritable bowel syndrome or a whiplash syndrome (Wessely et al., 1999). Furthermore, as 
part of the study protocol, the unexplained nature of the patient’s symptoms was checked 
by either a comprehensive geriatric assessment conducted by geriatrician (n=70) or an 
additional chart review of the GP for patients that refused a geriatric assessment (n=48). 
 Exclusion criteria were 1) presence of primary psychotic disorder; 2) established 
or suspected diagnosis of dementia; 3) suffering from terminal illness; 4) not sufficiently 
speaking the Dutch language; and 5) severe auditory and/or visual limitations hindering 
reliable data collection. 
 For the MES patient group (comparison group 1) we selected patients frequently 
consulting their primary care physician (top 20% of frequent attenders aged 60 years or 
above based on the medical records) for medically explained symptoms. We chose for 
frequent attenders for two reasons. First, we strive for a comparison group with actual 
severity of the primary physical complaint. This is more likely among MES who frequently visit 
their GP, as patients with stable chronic diseases or multimorbidity do not necessarily have 
actual physical symptoms. Secondly, the discrimination between MUS and MES in frequent 
attenders is most difficult in primary care, resulting in direct clinical relevance of differences 
identified in the OPUS study.
 This resulted in 118 patients with MUS (12 recruited in the community, 77 in primary 
care, 29 in specialized health care) and 154 with MES (11 recruited in the community, 134 in 
primary care, 9 in specialized health care). After obtaining informed consent, data on socio-
demographic, medical, psychological, and social characteristics were collected in two study 
interviews. The Mini-International Neuropsychiatric Interview version 5.1 (MINI) (Sheehan et 
al., 1998), a semi-structured interview, was used to assess psychopathology conform DSM-IV 
criteria. The local Medical Ethics Committee approved the OPUS study.
NESDO study
 NESDO is a multi-site naturalistic cohort study that includes 378 depressed and 132 
non-depressed subjects aged 60 through 93 years (Comijs et al., 2011). Persons with a clinical 
diagnosis of dementia or who were suspected of dementia, persons with a psychotic or 
bipolar disorder and insufficient command of the Dutch language were excluded. Psychiatric 
diagnoses were assessed with the Composited International Diagnostic Interview (CIDI –version 
2.1) (Kessler et al., 2004) according to DSM-IV-R criteria. The CIDI is a fully structured psychiatric 
interview assessment with adequate test–retest reliability and validity (Andrews & Peters, 1998). 
From the NESDO we identified 275 depressed older patients (36 recruited in primary care, 
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239 recruited in specialized mental health care) who met the criteria for a past-month major 
depressive episode based on the CIDI (comparison group 2). Within the NESDO, depressed 
patients in primary care were recruited by a screening program. All patients who visited the 
GP who had a score of 4 or more on the Geriatric Depresion Scale (GDS) were considered 
potentially eligible patients (comparison group 2) and further examined on the presence of 
depression. A random selection (n=198) of screened-negative patients (score below 4 points on 
the GDS) were approached for a phone-screen and those who met the criteria for a control (no 
(history of) depression, mastering the Dutch language) were asked for consent. A total of 132 
controls agreed to participate (for more details, see Comijs et al. (2011).
Personality
 We assessed the Big Five personality domains, i.e. neuroticism, extraversion, 
conscientiousness, agreeableness and openness to experience with the 60-item NEO-Five 
Factor Inventory (NEO-FFI) (Costa & McCrae, 1995). The internal consistencies of all domains 
range from acceptable to good, and are comparable to those of the American version 
(Chapman, 2007). In the present study, Cronbach’a alpha was 0.87 for neuroticism, 0,79 for 
extraversion, 0.65 for openness, 0.71 for agreeableness, and finally 0.77 for conscientiousness.
Covariates
 We included age, sex, level of education, partnership (yes/no), global cognitive 
functioning assessed with the Mini Mental State Examination (MMSE) (Folstein et al., 1975), 
and depressive symptom severity assessed with the 28-item version of the Inventory of 
Depressive Symptomatology Self Report questionnaire (IDS-SR) (Rush et al., 1985) as 
covariates in all analyses. 
MUS (and MES) severity indicators
 Among MUS patients participating in the OPUS study, the severity of MUS was 
quantified with different parameters. First, a somatoform disorder according to DSM-IV-TR 
criteria (as assessed with the MINI). Also the duration of the primary complaint (in years) and 
the severity of the primary complaint over the past month (10 cm Visual Analogue Scale, VAS) 
were explored. 
 For both MUS and MES patients, we assessed the severity of health anxiety with the 
Whiteley Index (WI) and the severity of somatization with the somatization subscale of the 
Brief Symptom Inventory (BSI-53). The WI has 14 items to be rated as yes or no and generally 
exhibits excellent and robust psychometric properties for internal consistency, test–retest 
reliability, convergent validity, and concurrent validity (Speckens et al., 1996a; Speckens et 
al., 1996b). The Cronbach’s alpha in our sample was .71. The Brief Symptom Inventory (BSI-
53) is an abbreviated version of the Symptom Checklist 90-item version (Derogatis & Cleary, 
1977) and assesses seven domains of psychopathology without loss of information (Arrindell 
& Ettema, 2003) with good internal consistency and test-retest reliability (Croog et al., 1986; 
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Aroian & Patsdaughter, 1989; Derogatis, 1993). The somatization subscale (Cronbach’s alpha 
is .77 in our sample) consists of seven items referring to the severity of physical symptoms, i.e. 
dizziness, chest pain/discomfort, nauseous, shortness of breath, hot flushes, paresthesia’s, 
and faintness/general weakness. The numbers of such physical symptoms have been proven 
a valid and reliable correlate of somatization in younger persons (Kroenke et al., 2010).
Analyses
 First we compared the Big Five personality domains (dependent variable) across the 
four groups (independent variables) with separate analyses of covariance (ANCOVA), adjusted 
for age, sex, level of education, partnership (yes/no), depressive symptom severity (IDS sum 
score), presence of comorbid psychiatric disorder (yes/no) and global cognition (MMSE 
score). Since we tested five personality dimensions separately, we applied a Bonferroni 
correction for the group effect, which means that p-values less than .01 (.05/5) are considered 
significant. In case of significant findings, LSD-post hoc tests were conducted in order to 
compare patients suffering from MUS with either patients suffering from MES, depression or 
with control patients. Since results may be driven by comorbid psychiatric disorders other 
than somatoform disorders (in the MUS group) and depressive disorder (in the depressed 
group), we performed a sensitivity analysis restricted to patients in either group without any 
psychiatric comorbidity.
 Next, multiple linear regression analyses were applied to the OPUS sample to examine 
the association of the Big Five personality domains (dependent variables) with MUS (and 
MES) severity indicators (see above) as independent variables adjusted for age, sex, level 
of education, partnership and global cognitive functioning. Since health anxiety (WI) 
and somatization (BSI somatization scale) are available for both MUS and MES patients, 
interaction of group with health anxiety (WI) as well as interaction of group with somatization 
(BSI) were explored to examine whether the associations with personality dimensions differ 
between patients with MUS and MES. These results were considered statistically significant if 
p-values were below .01. All analyses were conducted in SPSS version 22 (IBM Corp, 2013).
Results
Patient characteristics
 Data on the NEO-FFI were missing for 22/118 (18.6%) MUS patients, 1/154 (0.6%) MES 
patients, 20/275 (7.3%) depressed patients, and 7/132 (5.3%) controls (Χ2=33.0; df=3, p<.001). 
In- and excluded study participants did not differ significantly with respect to any of the 
covariates under study. 
 The mean age of the included patients was 70.1 (SD 6.4) years for the MUS patients, 
73.4 (SD 7.8) years for the MES patients, 70.5 (SD 7.2) years for the depressed patients and 
70.1 (SD 7.0) years for the control group. The severity of the primary complaint over the past 
month did not differ between patients with MUS and patients with MES (5.0 (1.9) versus 4.6 
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(2.6), t=1.1, df=223, p=.222). In all groups, two-thirds of the participants were female, except 
in the MES group where only 43.1% were females (X2=21.6, df=3, p<.001). Table 1 presents 
the characteristics of the study population. Also the other demographic variables as well as 
covariates differed significantly across the four groups (see table 1).
Table 1: Characteristics of study population.
Characteristics MUS MES Depressed Control Statistics
(n=96) (n=153) (n=255) (n=125)
Socio-demographics:
Age (years) mean (SD) 70.1 
(6.4)
73.4 
(7.8)
70.5 
(7.2)
70.1 
(7.0)
F=7.2, df=3,625, p<.001
Female sex n (%) 64 
(66.7)
66 
(43.1)
164 
(64.3)
77 
(61.6)
X2=21.6, df=3, p<.001
Level of education
•	 Basic n (%) 24 
(26.7)
26 
(17.2)
57 
(22.4)
8 
(6.4)
X2=36.0, df=6, p<.001
•	 Intermediate n (%) 48 
(53.3)
96 
(63.3)
148 
(58.0)
66 
(52.8)
•	 High n (%) 18 
(20.0)
29 
(19.2)
50 
(19.6)
51 
(40.8)
Partner, yes n (%) 55 
(60.4)
91 
(60.3)
128 
(50.2)
95 
(76.0)
X2=23.3, df=3, p<.001
Cognition (MMSE) mean (SD) 28.0 
(2.4)
28.2 
(1.9)
27.6 
(2.1)
28.4 
(1.4)
F=4.9, df=3,611, p=.002
Depression (IDS) mean (SD) 21.0 
(12.0)
15.2 
(9.2)
32.8 
(12.4)
7.7 
(6.4)
F=183.6, df=3,621, p<.001
Health anxiety (WI) mean (SD) 4.0 
(2.8)
2.1 
(2.4)
n.a. n.a. F=30.2, df=1,241, p<.001
Somatization (BSI-53) mean (SD) 0.82 
(0.65)
0.52 
(0.50)
n.a. n.a. F=16.4, df=1,244, p<.001
Personality traits:
Neuroticism mean (SD) 32.9 
(8.8)
29.6 
(7.8)
39.9 
(6.9)
24.9 
(6.7)
F=135.5, df=3,623, p<.001
Extraversion mean (SD) 37.7 
(6.1)
38.7 
(5.9)
33.1 
(6.6)
42.0 
(5.6)
F=65.2, df=3,623, p<.001
Openness mean (SD) 28.9 
(5.3)
28.1 
(4.7)
29.1 
(5.5)
30.6 
(4.8)
F=5.2, df=3,616, p=.002
Agreeableness mean (SD) 45.5 
(5.2)
44.5 
(5.1)
44.2 
(5.1)
45.6 
(5.6)
F=2.7, df=3,620, p=.045
Conscientiousness mean (SD) 38.2 
(5.9)
40.3 
(5.2)
36.1 
(5.6)
41.8 
(4.9)
F=36.7, df=3,622, p<.001
Abbreviations: n.a., not available; MUS, medically unexplained symptoms; MES, medically explained symptoms; SD, 
standard deviation; MMSE, mini mental state examination; IDS, Inventory of depressive symptoms; WI, Whiteley Index.
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Personality profiles from the four groups
 Of the five personality dimensions tested, significant group differences were only 
found for neuroticism (F=11,6, df=3,596, p<.001) and extraversion (F=9.6, df= 3,595, p<.001), 
but not for openness (f=1.7, df=3,590, p=.161), agreeableness (F=2.7; df=3,593; p=.045), or 
conscientiousness (F=1.6; df=3,594; p=.193). Interestingly, no differences were found between 
older patients with MUS and MES on any personality trait (see figure 1). Please note that the 
difference with respect to agreeableness (LSD post hoc test: p=.035) cannot be interpreted as 
the overall group difference did not achieve the Bonferroni-adjusted statistical significance 
level (p=.045). 
 As shown in figure 1, patients with MUS exhibited only significantly higher levels of 
neuroticism compared to the control group. When compared to depressed older persons, 
MUS patients had a significantly lower level of neuroticism and a significantly higher level of 
extraversion. 
Figure 1: Big Five Personality traits of older MUS-patients, older MES-patients, depressed older 
patients and controls.
 For the sensitivity analysis, we excluded 184 patients with a psychiatric disorder other 
than a somatoform disorder, i.e. 39 MUS patients, 38 MES patients, 106 depressed patients 
and finally 1 control person who suffered from a generalized anxiety disorder. Results with 
respect to neuroticism, extraversion, openness and conscientiousness did not substantially 
differ with the findings reported in figure 1, except that the group difference with respect to 
agreeableness achieved significance (F=3.9, df=3,417, p=.009). Post-hoc tests showed that 
MUS patients had a significantly higher level of agreeableness compared to MES patients 
(p=.003) and control patients (p=.005).
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Associations between personality dimensions and MUS severity indices
 Table 2 presents the associations between the different severity indices of MUS and 
the Big Five personality traits. The Big Five personality traits were neither associated with 
the presence of a somatoform disorder according to DSM-IV-TR criteria, nor with the severity 
and duration of the primary complaint (except for an association between duration of the 
complaint and the level of agreeableness). 
Table 2: Multiple linear regression analyses exploring the association between indices for the 
severity of MUS (n=96) and personality traits, as well as indices of health anxiety (MUS, n=96 and 
MES, n=153) with personality traits *.
Neuroticism Extraversion Openness Agreeableness Conscientious-
ness
β p β p β p β p β p
MUS patients:
MUS severity indicators:
 -  Somatoform disorder (yes) .08 .496 -.18 .109 -.09 .410 -.17 .150 -.03 .785
 -  Duration of MUS (years) -.07 .586 -.03 .784 -.03 .780 .30 .009 .17 .146
 -  Severity of primary complaint .03 .771 .20 .101 .19 .100 -.02 .835 .17 .148
Indicators of health anxiety:
 -  Hypochondriacal beliefs (WI) .40 <.001 -.33 .004 -.13 .249 -.17 .150 -.27 .022
 -  Level of somatization (BSI) .32 .005 -.14 .233 -.07 .558 -.13 .233 -.17 .139
MUS and MES patients combined:
Indicators of health anxiety:
 -  Hypochondriacal beliefs (WI) .48 <.001 -.17 .010 -.04 .507 -.12 .067 -.24 <.001
 -  Level of somatization (BSI) .36 <.001 -.17 .014 -.02 .820 -.09 .161 -.23 <.001
* Adjusted for age, sex, level of education (dummies), partner status, and cognition (MMSE)
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Associations of personality dimensions with health anxiety and somatization
 We also examined the association between health anxiety (Whiteley Index) and 
somatization (subscale BSI-53) with personality traits within the whole study population of 
the OPUS study. Higher levels of health anxiety as well as somatization were associated with 
a higher level of neuroticism and a lower level of extraversion and conscientiousness (see 
table 3). These associations did not significantly differ in strength among MUS versus MES 
patients (as indicated by non-significant interaction terms with group status; all p-values 
between .104 and .685).
Discussion
Main findings
 Our findings suggest a specific personality profile for older somatizing patients. With 
respect to neuroticism MUS patients scored in between our control group and depressed 
comparison group. Moreover, MUS patients scored significantly higher on extraversion 
compared to depressed patients. Findings with respect to agreeableness were less clear as 
the main overall statistics did not achieve the Bonferroni-adjusted level of significance. Of 
most interest, however, was the finding that the personality profile did not differ between 
patients with MUS or MES. Since previous studies have shown that personality traits are stable 
traits, which are independent of underlying physical illnesses (Steunenberg et al., 2005), the 
lack of any differences between MUS and MES patients implies that personality traits are 
no predisposing factors for the development of MUS in later life. Below we will discuss all 
findings in more detail.
Comparison with controls
 In line with findings in younger age groups (Noyes et al., 2001) our study shows that 
older persons suffering from MUS have a higher level of neuroticism compared to controls. 
This might be important as neuroticism itself is consistently identified as an independent 
predictor of health status and even mortality (Bogg & Roberts, 2013; Smith & MacKenzie, 
2006). Nonetheless, restricting the analyses to patients without psychiatric comorbidity, we 
did not find any differences anymore. This implies that the higher level of neuroticism can be 
fully explained by comorbid psychiatric disorders and depressive symptoms. 
 Studies in younger MUS patients suggest that higher neuroticism and lower 
agreeableness contribute to somatization by increased symptom reporting and care-seeking 
behavior (Noftle & Fleeson, 2010). Among older MUS patients, we did not find a lower level of 
agreeableness, which may point to an age-effect. Our data even points to an opposite effect 
in older MUS patients. The main analyses with respect to agreeableness lost significance after 
Bonferroni correction, while the sensitivity analyses restricted to patients without psychiatric 
comorbidity remained highly significant. Whether this finding points to a higher level of 
adaptive functioning in older patients with MUS can be debated. On the one hand, research 
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on partly unexplained chronic pain (Kaye et al., 2010) has showed that older patients tend to 
expect and accept pain, and compared to younger patients are more hesitant to complain 
and have a stronger will to ‘keep on going’ (Sofaer et al., 2005). Studies have shown that 
similar levels of somatization are associated with significantly less psychological distress in 
older compared to younger patients (Goulia et al., 2012), indicating that older patients may 
experience illness as a consequence of aging and/or be more resilient regarding the presence 
of somatic symptoms. This might suggest that MUS may open up positive personality 
dimensions in older patients. On the other hand, it may be maladaptive as it fits with our 
clinical experience that older patients with MUS are generally very pleasing (agreeing) to 
other people at the cost of their own health.
Comparison with MES
 We did not find any difference between patients suffering from MUS and patients 
suffering from MES, except for the level of agreeableness similarly to the comparison with 
the control group. Although one might hypothesize that personality characteristics change 
in the presence of a somatic disease, this is not grounded by empirical evidence (Goodwin & 
Friedman, 2006) and thus cannot explain the lack of differences we found. Neuroticism, for 
example, is a stable personality trait that can be measured reliably across the lifespan and is 
not significantly affected by physical health variables in later life (Steunenberg et al., 2005). 
 Interestingly, among patients suffering from MUS, the presence of a somatoform 
disorder according to DSM-IV-TR criteria was not associated with any of the personality 
dimensions. The lack of any difference between MUS and MES patients supports the new 
classification in DSM-5 where the distinction between unexplained versus explained 
physical symptoms is not a criterion anymore. This decision is, among others, made on 
studies showing that the number of physical symptoms is more important for quality of life 
or the presence of comorbid psychiatric disorders than the fact whether symptoms can be 
medically explained (Kisely et al., 1997; Escobar et al., 2010; Joustra et al., 2015). Furthermore, 
it is increasingly recognized that medically unexplained symptoms are often accompanied 
by somatic symptoms that are directly attributable to general medical illnesses, blurring the 
line between disorders characterized by medically unexplained or explained symptoms (Van 
Eck et al., 2015).
 We also found similar associations between all personality dimensions and either 
health anxiety or somatization in patients with MUS and in patients with MES. Comparable 
to findings in younger age samples (Noyes et al., 2001) we found an association between a 
higher level of somatization and a higher level of neuroticism, but not with a lower level of 
agreeableness. In our study, somatization was measured by the somatization subscale of the 
Brief Symptom Inventory (based on the symptom checklist (SCL) 90 item version), which uses 
‘simple’ symptom counting. The number of physical symptoms, irrespective whether this 
symptom is medically explained, can be considered as an index of somatization (Tomenson 
et al., 2013; Creed, 2016). Moreover, the SCL-90 somatization score correlates significantly 
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with physical quality of life in several long-term conditions (Hyphantis et al., 2013). Consistent 
with these literatures, our data shows that personality dimensions are associated with this 
measure of somatization, while not with group status. 
 Health anxiety was highly associated with increased levels of neuroticism and 
decreased levels of extraversion and conscientiousness. In line with the new perspective of 
the DSM-5, the fear of being ill may be more relevant to personality traits than whether a 
physical symptom is medically explained or not.
Comparison with depression
 Despite high levels of comorbidity between depression and MUS, the personality profile 
differs between both groups. Depressed patients scored significantly higher on neuroticism 
and lower on extraversion. It is known that the presence of a concurrent depressive disorder 
amplifies the personality profile of people prone to depression (Costa et al., 2005; Ormel et al., 
2004). Nonetheless, after recovery of depression, the overall shape of the personality profile 
did not change (Costa et al., 2005; Santor et al., 1997). Furthermore, the relationship between 
change in personality and change in depressive symptoms is at most moderate (Costa et al., 
2005; Ormel et al., 2004; Santor et al., 1997; Spinhoven et al., 2014). Since mood disorders, 
anxiety disorders and somatoform disorders partly overlap and are often comorbid to each 
other, it is often assumed that personality characteristics act in the same direction for these 
disorders (Van Noorden et al., 2012). Our findings, however, confirm this, often implicit, idea.
Methodological considerations
 Important strengths of our study are the two comparison groups in addition to a 
traditional control group as well as the large number of older persons with MUS, recruited 
within different echelons of the health care system. In clinical practice, patients with MUS 
and/or somatoform disorders are present in different settings in the health care system. 
Studies on clinical samples of patients with somatization are therefore even more difficult to 
generalize (Hilderink et al., 2015). 
 For proper interpretation, some methodological issues should be taken into account. 
Firstly, due to the complex recruitment strategy, we do not have data on the number of eligible 
patients who refused study participation. Secondly, the pooling of data from two studies. 
Because the OPUS study have been a priori matched with the NESDO study, measures of 
health anxiety were not available for participants of the NESDO study. On the one hand, 
selection bias aggravating differences cannot be fully excluded. Our results might be partly 
biased if indeed we have missed some MUS patients who did not consult a doctor, because 
they see pain or physical complaints as an inevitable part of ageing. Furthermore, depressed 
patients were more often recruited in specialized mental health care, which may also have 
resulted in larger differences. One the other hand, within NESDO we did not explicitly measure 
MUS within the depressed group and the control group, which might result in conservative 
estimates of our group differences. Thirdly, analyses were adjusted for depressive symptom 
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severity since depressive symptoms may amplify the personality profile as assessed with the 
NEO-FFI as already mentioned in the introduction (Lucas & Donnellan, 2011; Mooi et al., 2006). 
Therefore, this adjustment results in a more valid comparison of patients with MUS and MES. 
Nonetheless, the IDS sum score might reflect different constructs in patients suffering from 
depression and patients suffering from MUS, resulting in more conservative estimates of the 
differences between these groups.
Conclusion
 Despite the findings of a specific personality profile for older patients suffering from 
MUS compared to depressed older patients and healthy controls, we could not demonstrate 
any difference with patients suffering from MES. In contrast, personality dimensions were 
significantly associated with health anxiety and somatization. This stresses the importance 
that, in line with the DSM-5, these measures may be more relevant to maladaptive personality 
traits in later life than whether a physical symptom is medically explained or not (APA, 2013). 
We argue that personality pathology should receive more attention in research as well as 
routine medical care outside the scope of mental health, as health anxiety and somatization 
are dimensional constructs potentially relevant for all persons with physical symptoms. 

8.
Illness cognitions in later life: Development and validation of 
the extended Illness Cognitions Questionnaire (ICQ-Plus).
Van Driel, D., Hanssen, D., Hilderink, P., Naarding, P., Lucassen, P., Rosmalen, J., & Oude Voshaar, R. 
(2016). Illness cognitions in later life: Development and validation of the extended Illness 
Cognitions Questionnaire (ICQ-Plus).
Psychological Assessment, 28(9), 1119-1127. 
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Abstract
Illness cognitions are mediators between illness and wellbeing in patients with physical 
symptoms. The Illness Cognitions Questionnaire (ICQ) explores these illness cognitions, 
but has not been validated in older persons. This study aimed to validate the ICQ in 
adults aged 60 years and above and to develop an extended version (ICQ-plus) suitable 
for older persons.
Qualitative interviews were conducted to explore illness cognitions in 21 older persons 
suffering from physical symptoms. The items in the original ICQ and items of these 
interviews that potentially reflect dimensions not covered by the original ICQ, were 
combined in the ICQ-plus. Then the ICQ-plus was administered to 220 older patients with 
physical symptoms and its factor structure was explored by Maximum Likelihood factor 
analyses. Analysis of covariance (ANCOVA) was performed to assess differences in illness 
cognitions between older persons suffering from Medically Explained and Medically 
Unexplained Symptoms. The interviews had generated 26 new items. Factor analysis 
confirmed the three factor structure of the original ICQ, including factors covering 
helplessness, disease benefits and acceptance. In addition, exploratory factor analysis 
on the ICQ-plus items revealed four additional factors including cognitions referring 
to perseverance, illness anxiety, avoidance and catastrophizing. Patients with MUS 
scored significantly lower than patients with MES on acceptance and disease benefits 
and higher on helplessness and illness anxiety. We concluded that older patients with 
physical symptoms express illness cognitions, which are relevant for treatment but are 
not covered by the ICQ and recommend to use the extended ICQ-plus in studies in older 
persons. 
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Introduction
 Illness cognitions are the personal meanings given to somatic complaints (Hagger 
& Orbell, 2003). They are important mediators between chronic somatic diseases and 
patients’ wellbeing (Evers et al., 2001). In other words, the way people think about their 
disease accounts for their health-related quality of life and way of living (Evers et al., 2001). 
Targeting maladaptive illness cognitions, as done in cognitive-behavioural therapy (CBT), 
may therefore improve quality of life in patients suffering from physical symptoms (Maas et 
al., 2009; Speckens et al., 1995).
 The Illness Cognition Questionnaire (ICQ) has been developed to measure three 
categories of illness cognitions, that is, acceptance, disease benefit, and helplessness. On 
the basis of an extensive literature review, these categories were presumed to reflect the 
different ways of reevaluating the aversive character of a chronic condition (Evers et al., 
2001; Lauwerier et al., 2010). The ICQ was originally developed in a sample of middle-aged 
patients suffering from either rheumatoid arthritis (n=263; mean age = 58.1 years) or multiple 
sclerosis (n=167; mean age = 40.6 years) (Evers et al., 2001). Cross-validation of the ICQ has 
also confirmed the three-factor structure also in middle-aged patients with unexplained 
chronic pain (n=821; mean age = 50.8 years) and chronic fatigue (n=295; mean age = 40.3 
years) (Lauwerier et al., 2010). The three categories of illness cognitions can thus be found in 
both medically explained symptoms (MES) and medically unexplained symptoms (MUS).
 In clinical practice, many physical symptoms cannot be ascribed to an explained somatic 
condition. Up to a third of physical symptoms presented in primary care and approximately 
half presented in secondary health care remain unexplained (Burton, 2003; Escobar et al., 
2010; Olde Hartman et al., 2009). Illness cognitions may even be more important with respect 
to quality of life in patients suffering from MUS. The association between physical symptoms 
and health-related quality of life is stronger in patients suffering from MUS than in patients 
with MES (Hilderink et al., 2015). 
  Our study addresses two aspects that have been neglected hitherto, that is, the validity 
of the ICQ in old age and the implicit assumption of its completeness. Cross-validation 
in populations suffering from other diseases or differing on critical aspects is important 
before recommending the ICQ in routine clinical care (Logie et al., 2007). Age may be such 
a critical aspect and is especially relevant acknowledging the steep increase of physical 
symptoms with age (Tomenson et al., 2013). Previous studies in both psychiatric and somatic 
disorders have indeed shown that illness cognitions change across the life span (Griez et 
al., 2007; Hendriks et al., 2010; Pinquart & Duberstein, 2007). Furthermore, the ICQ has been 
developed specifically to cover three predefined categories, especially with respect to age-
specific cognitions in the oldest-old. Knowledge of specific illness cognitions in older people 
is important to improve effectiveness of CBT for older patients. Hitherto, CBT has been the 
most promising treatment strategy for patients with maladaptive cognitions in medically 
explained and unexplained symptoms (Allen et al., 2006; Escobar et al., 2007; Henningsen 
et al., 2007; Kroenke, 2007; Speckens et al., 1995). Unfortunately, CBT has not been formally 
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tested in older patients suffering from physical symptoms (MUS and MES). For this purpose, 
better insight and completeness of potentially maladaptive cognitions is crucial.
 The primary aim of this study is validate and extend the ICQ in a sample of older persons. 
First, we explore in a qualitative study the illness cognitions of older people with physical 
symptoms explained and/or unexplained using a semi-structured interview. Subsequently, 
these cognitions are translated into items that are added to the ICQ and validated in a large 
sample of older patients suffering from MUS and MES.
Methods
The Illness Cognition Questionnaire
 The Illness Cognition Questionnaire (ICQ) is an 18-item scale that measures the 
personal perception of an individual’s own illness and ability to function (Evers et al., 
2001; Lauwerier et al., 2010). The ICQ has three subscales, that is, Acceptance (Cronbach’s 
α = 0.90 in Rheumatoid Arthritis (RA) patients and 0.91 in Multiple Sclerosis (MS) patients), 
Disease Benefit (Cronbach’s α = 0.84 and 0.85 in RA and MS patients respectively), and finally 
Helplessness (Cronbach’s α = 0.88 in both RA- and MS patients) (Evers et al., 2001). For each 
item, four response options are given, ranging from 1 (disagree) to 4 (strongly agree). Item 
scores were totaled for each of the three subscales. Each subscale contains 6 items and the 
same maximum score. A high score on the Acceptance and Disease Benefit subscales reflect 
positive cognitions regarding one’s illness. A high score on the Helplessness subscale reflects 
negative cognitions regarding one’s illness.
Item selection for the extended version, the ICQ-plus
 For the first aim of our study, namely the exploration of illness cognitions in later life, we 
interviewed a consecutive sample of 21 older persons who had received a multidisciplinary 
diagnostic procedure by a geriatrician, psychiatrist, and psychologist at our outpatient 
clinic for older persons with medically unexplained symptoms. In order to include an older 
population and to preclude contamination by early dementia, we applied the following 
inclusion criteria: 1) an age of 65 years or older, 2) adequate cognitive functioning as indicated 
by a Mini Mental State Examination (MMSE; Folstein et al., 1975) score of 24 points or higher, 
and 3) a primary diagnosis of medically unexplained symptoms or a somatoform disorder 
according to criteria of the Diagnostic and Statistical Manual of Mental Disorders  (4th edition, 
text. rev.; APA, 2000) in addition to medically explained symptoms. During the diagnostic 
process, the clinical psychologist (TvD) explored all illness cognitions of these 21 patients 
by applying a semi-structured interview starting with six standardized questions. These 
questions were as follows:
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 On the basis of the initial answers given, cognitions were explored in more depth using 
a so-called Socratic dialogue. Answers on all questions were written down literally. Two 
psychologists registered as supervisors for the Dutch Society of Cognitive Behavioural Therapy, 
extracted all cognitions from the interview. Both psychologists subsequently checked which 
cognitions belonged to one of the ICQ subscales (Disease Benefit, Helplessness, Acceptance). 
Cognitions that were not captured by this classification system were coded in the category 
‘other’. Cohen’s kappa was calculated as a measure of inter-rater agreement. Disagreement 
between the two raters was resolved in discussion with a third rater (RCOV) who made the 
decision. 
 Cognitions in the category ‘other’ were reformulated as new items that could be added 
to the original ICQ. These items had to meet the following scale construction criteria: be 
positive and unidirectionally formulated in simple, clear language (unambiguous) in less 
than 20 words. Subsequently, all new items were given to patients and an expert panel of 
researchers and health care professionals for comments and suggestions to improve the 
items. This finally resulted in 26 new items that were added to the original ICQ, resulting in 
the ICQ-Plus. These new items had to be rated in a manner similar to that of the original ICQ-
items on a four-point likert scale ranging from 1 (disagree) through 4 (strongly disagree). 
Validation of the ICQ-Plus
 In the second part of the study, the ICQ-Plus was validated within the Older Persons 
with medically Unexplained Symptoms (OPUS) project. As part of the OPUS project, a case-
control study aimed at exploring biopsychosocial determinants of MUS in later life, was 
conducted. This study is summarized as follows:
 Individuals were included at baseline if they 1) were 60 years or older; 2) gave informed 
consent; and 3) met the Dutch College of General Practitioner definition for MUS, that is, 
physical symptoms that have existed for more than several weeks and for which adequate 
medical examination has not revealed any condition that sufficiently explains the symptoms 
(Olde Hartman et al., 2013). We operationalized ‘several weeks’ as at least three months. 
Patients suffering from so-called functional syndromes, including fibromyalgia, chronic 
fatigue syndrome, irritable bowel syndrome or a whiplash syndrome, were also considered 
as suffering from MUS (Wessely et al., 1999). To assure patients met the definition of MUS, 
the General Practitioner (GP) was contacted to check whether the criteria for MUS were met. 
1) What do you think is wrong with your body? 
2) What do you think is causing your symptoms? 
3) What do the people around you think about your symptoms? 
4) What do you consider to be the worst symptom? 
5) What are your thoughts when the symptoms get worse? 
6) Did you have similar symptoms earlier in your life?
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Exclusion criteria were 1) presence of primary psychotic disorder; 2) presence of cognitive 
impairment, defined as a Mini Mental State Examination (MMSE; Folstein et al., 1975) total 
score below 19 or an established or suspected diagnosis of dementia by the geriatrician or 
old age psychiatrist; 3) suffering from terminal illness; 4) not sufficiently mastering the Dutch 
language; and 5) severe auditory and/or visual limitations hindering reliable data collection. 
Compared to the inclusion and exclusion criteria of the qualitative study prior to the OPUS 
project, these inclusion and exclusion criteria were more liberal. First, we applied an age 
cutoff of 60 years, which is traditionally used for studies on late-life affective disorders (Blazer, 
2003). Second, we applied an MMSE of 19 or above because patients were also assessed by 
a geriatrician and an old age psychiatrist and excluded when suspect for having a cognitive 
disorder. Hereby we were able to recruit a sample of MUS patients in various developmental 
and severity stages. 
 The control group consisted of older persons with medically explained physical 
symptoms. Inclusion criteria for this group were 1) 60 years or older; 2) informed consent; and 
3) the presence of physical complaints for three months or longer that could be fully explained 
by the presence of at least one chronic somatic disease, for example rheumatoid arthritis or 
asthma. The patient’s GP needed to reconfirm the explained nature of the symptoms. The 
exclusion criteria were similar to those applied for the patients. 
 The recruitment process was designed to compose a sample of older patients with MUS 
in various developmental and severity stages in order to overcome setting-specific findings. 
Therefore, possible participants with MUS and MES were recruited in the community through 
advertisements in local newspapers, in primary care, and in secondary health care. To assist 
general practitioners with selecting possible participants in primary care, we extracted the 
top 20% of older frequent attending patients in their own practice from the GP Information 
System. Subsequently, the GP manually selected possible participants using the definition 
of MUS and MES and our previously described exclusion criteria. This selection method was 
chosen on the basis of previous research projects on MUS and other high utilizing patient 
groups in primary care (Katon et al., 2001; Smits et al., 2009). The local Medical Ethics 
Committee approved the OPUS study.
 A total of 118 patients with MUS (12 recruited in the community, 77 in primary care, 29 
in specialised health care) and 154 patients with MES (11 recruited in the community, 134 
in primary care, 9 in specialised health care) gave informed consent after having received 
written and oral information about the study procedures. Data on sociodemographic, 
medical, psychological and social characteristics were collected in two study interviews that 
each lasted between 1.0 and 1.5 hours about one week apart. 
 The ICQ was administered in the second interview, which took place at the patients’ 
home. Because 26 MUS patients and 16 MES patients were too ill to complete the second 
interview, the ICQ data were available for 92 MUS patients (78%) and 138 MES patients 
(89.6%). The development of the 26 additional items was not yet finished at the time the 
recruitment of the OPUS project had started. Therefore, the first 10 patients recruited within 
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the OPUS project only completed the original ICQ items, leaving 83 MUS patients (70.3%) and 
137 MES patients (90.0%) who completed the ICQ-Plus. 
 In addition to the ICQ-Plus, several other questionnaires were completed. For the 
present study, data on the primary physical complaint, sociodemographic characteristics, 
health-related quality of life, depression, and health anxiety were used.
 Physical health- and mental health-related quality of life was investigated by asking the 
standard version of the MOS 36-Item Short-Form Health Survey (SF-36, Ware & Sherbourne, 
1992). The 30-item version of the Inventory of Depressive Symptomatology Self-Report (IDS-
SR) questionnaire (Rush et al., 1996) was used to assess severity of depressive symptoms. 
And finally, the hypochondriacal cognitions and somatization symptoms were measured 
with the Whitely Index (WI, Pilowsky, 1967). These additional questionnaires were selected 
on the basis of good psychometric properties established in an older population.
Statistical analyses
 First, patient characteristics of the older MUS patients and older MES patients who 
completed the ICQ were compared by independent-sample t-test for the normally distributed 
variable (age), a Mann Whitney-U test for the variable that was not normally distributed 
(duration of symptoms), and chi square tests for categorical variables (sex, education, partner 
status). 
Internal structure of the ICQ 
  To determine whether the ICQ three-factor structure was also applicable for older MES 
and MUS patients, we performed a confirmatory maximum-likelihood factor analysis on 
the ICQ data with an extraction based on a preset number of factors (three) and an oblique 
rotation method (Promax). The root-mean-square error of approximation (RMSEA) is reported 
as a measure of goodness of fit. 
 Furthermore, to assess whether there were additional categories of illness cognitions 
in older MUS and MES patients, we performed a series of exploratory maximum-likelihood 
factor analyses based on the eigenvalue > 1 principle, using oblique rotation methods 
(Promax) on all items of the ICQ and the 26 additional items. After each analysis, the RMSEA 
was calculated. In order to determine whether or not an additional factor analysis was 
needed, we studied the p-value of the factor solution, the RMSEA and the factor structure. 
In case of a p-value <.05 and an RMSEA>.05, the item that had the lowest factor loading was 
removed from the analysis. This process was repeated until a p-value >.05 or a p-value <.05 
with an RMSEA <.05 was reached. If at this point the factor structure was clinically meaningful, 
no further analyses were performed. The final factor structure was used to create illness 
cognition subscale scores. 
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Known group validity 
 Analyses of covariance (ANCOVAs) were performed to compare illness cognitions 
in patients with MUS and patients with MES, adjusted for age, sex, education, and partner 
status. If p-values were <.05, differences were considered statistically significant. All statistical 
analyses were performed using IBM SPSS 19.0. 
Construct validity
 In order to examine construct validity, we explored Pearson’s correlations between 
the ICQ subscale scores with the health-related quality of life, depressive symptoms, and 
hypochondriacal beliefs, as measured with the SF-36, IDS-SR, and WI, respectively.
Results
Item development of ICQ-Plus
 The semistructured interview of the 21 patients revealed a total of 134 illness cognitions, 
ranging from two through 12 illness cognitions per patient (mean=6.4, SD=2.6). The first and 
second CBT therapists’ interrater agreement of the classification of items as belonging to 
one of the three original ICQ categories was good (kappa= .73). The third rater (RCOV) had to 
classify 20 cognitions (14.9%). 
 A total of 62 out of 134 (41.3%) cognitions could be classified within the three generic 
categories of the ICQ (Helplessness, Acceptance and Disease Benefit). The 72 out of 134 
‘other’ cognitions were considered of interest for extension of the ICQ. These 72 cognitions 
were translated in items, which resulted in 26 unique items on the basis of consensus within 
the research group, consultations of experts in the field, and comments of patients (see table 
1).
Patient characteristics OPUS study
  Table 2 presents the characteristics of the 230 participants of the OPUS study who 
completed the ICQ. Patients suffering from MUS were significantly more often female and 
significantly younger compared to patients with MES, whereas no differences were found with 
respect to marital status, education, and primary symptoms. The median of the duration of 
primary complaints was 5.0 years in MUS patients versus 2.0 years in MES patients (p<.001), 
with either 91.6% and 62.3% of the MUS and MES patients, respectively, having complaints 
for over one year. 
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Table 1: Items of the ICQ-plus.
Item
1. I am afraid that I have a serious illness.
2. I can influence the severity of my physical symptoms.
3. Despite my physical symptoms I do my utmost to finish the activities in which I am 
involved.
4. I am aware that others make decisions about my physical condition.
5. Because of my physical symptoms I see myself in a different way.
6. I am afraid that the doctor has missed something.
7. It is a relief to talk about my physical symptoms.
8. Only when something can be done about my physical symptoms will I take action.
9. Despite my physical symptoms, I prefer to do things myself rather than ask for help.
10. I think that I am a burden to others because of my physical symptoms.
11. I believe that my physical symptoms influence how I look.
12. I worry about the consequences of my physical symptoms every day.
13.          Extra rest reduces my symptoms.
14. Despite my physical symptoms I do my utmost to continue with activities in which I am 
involved.
15. I think that others consider my physical symptoms as affectation.
16. I believe that my physical symptoms influence how I take care of myself.
17. I expect that because of my medical state I will become dependent.
18. Distraction helps me to deal with my physical symptoms.
19. It is best to wait and see what the future brings regarding my health problem.
20. Despite my physical symptoms I do my utmost to do those activities well in which I have 
been involved.
21. I think that my physical symptoms influence the lives of the people around me.
22. I  worry about how my physical symptoms will develop in the future.
23. By avoiding pressure my physical problem is reduced.
24. I believe that people around me understand my physical problem.
25. I expect that my physical symptoms will get worse steadily.
26. I am hoping that a wonder cure will make my medical problem disappear.
Internal structure of the ICQ
 A confirmatory maximum-likelihood factor analysis with oblique rotation on the 
original 18 items of the ICQ showed that the original factor structure fitted fairly well (RMSEA 
= .055).  The internal consistencies for Helplessness (Cronbach’s α =.920), Disease Benefit 
(Cronbach’s α =.874), and Acceptance (Cronbach’s α =.901) were high.
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Internal structure of the ICQ-plus
 Table 3 shows the result of the maximum-likelihood factor analysis with oblique 
rotation for the 44 potential items of the Illness Cognition Questionnaire-Plus (ICQ-Plus) in 
older persons with MUS and MES. The RMSEA is .018 (p= .212) indicating an acceptable model 
fit. The three factors of the original ICQ, that is, Helplessness (Cronbach’s α =.889), Disease 
Benefit (Cronbach’s α =.865) and Acceptance (Cronbach’s α =.896) were identified. A total of 
two original items did not load substantially on any factor and were removed from the list. 
These items were ‘dealing with my illness has made me a stronger person’, and ‘my illness 
controls my life’. Furthermore, 10 new items originating from the interviews were removed. 
Also, four additional factors were identified (see table 3). 
Table 2: Patient characteristics of the study sample (N=230), specified for older persons with 
Medically Unexplained Symptoms (MUS) and older persons with Medically Explained Symptoms 
(MES).
Older persons 
with MUS
Older persons 
with MES
Characteristics (n=93) (n=137) p valuea
Patient characteristics:
Age Mean (SD) 70.0 (6.3) 73.0 (7.8) .002
Female sex % (n) 66.7 (62) 42.3 (58) <.001
Level of education
•	 Lower % (n) 27.3 (24) 16.3 (22) .141
•	 Middle % (n) 46.6 (41) 53.3 (72)
•	 Higher % (n) 26.1 (23) 30.4 (71)
Partner status (yes) % (n) 61.8 (55) 61.5 (83) .962
Physical complaint:
Primary complaint
•	 Pain % (n) 50.8 (60) 44.8 (69)
•	 Fatigue % (n) 5.1 (6) 4.5 (7)
•	 Palpitations % (n) 2.5 (3) 1.9 (3)
•	 Constipation or diarrhea % (n) 1.7 (2) 1.3 (2)
•	 Many diffuse complaints % (n) 1.7 (2) 20.9 (31)
•	 Dizziness % (n) 0.8 (1) 2.7 (4)
•	 Shortness of breath % (n) 0.8 (1) 6.5 (10)
•	 Other % (n) 9.3 (11) 14.2 (22)
•	 Unknown % (n) 5.9 (7) 3.9 (6)
Duration of complaints (years) Median (IRQ) 5.5 (10.0) 2.0 (10.0) <.001
a Significance values derived from independent samples t-tests, Mann-Whitney U-tests and chi-square tests
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Table 3: Factor loadings (Maximum Likelihood Factor Analysis with oblique rotation) for the ICQ 
and ICQ-Plus items in older persons with physical symptoms (n=220).
Item
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1. I have learned to live with my illness* .879 -.019 .037 -.052 .038 -.026 .085
2. I can cope effectively with my illness* .850 -.086 -.031 .039 .146 .075 -.146
3. I can accept my illness well* .826 -.124 -.012 -.102 .097 .070 -.035
4. I can handle the problems related to my 
illness* .771 -.136 -.082 .095 -.078 -.057 .067
5. I have learned to accept the limitations 
imposed by my illness* .751 .128 .128 .016 -.072 -.088 .016
6. I think I can handle the problems related to my 
illness, even if the illness gets worse* .491 -.198 .254 .070 -.040 .051 -.022
7. I believe that people around me understand my 
physical problem. .358 .095 .039 .138 -.164 .024 .193
8. My illness prevents me from doing what I 
would really like to do* .038 .869 .018 -.037 .011 .051 -.021
9. Because of my illness, I miss the things I like to 
do most* .027 .835 -.040 .087 .099 .010 -.025
10. My illness limits me in everything that is 
important to me* -.063 .718 .026 .023 -.072 .012 .125
11. My illness frequently makes me feel helpless* -.221 .584 .144 -.044 .088 -.018 .030
12. My illness makes me feel useless at times* -.108 .556 .019 -.008 .107 .030 .032
13. My illness has helped me realize what’s 
important in life* .055 -.067 .844 -.052 .033 -.022 .075
14. My illness has taught me to enjoy the moment 
more* .123 .021 .756 -.115 .062 -.018 -.059
15. My illness has made life more precious to me* .032 .022 .697 .098 -.027 .057 -.109
16. I have learned a great deal from my illness* .090 .171 .677 .050 -.030 -.037 -.019
17. Looking back, I can see that my illness has also 
brought about some positive changes in my 
life*
-.114 -.011 .667 .020 -.158 -.001 -.027
18. Despite my physical symptoms I do my utmost 
to continue with activities in which I am 
involved. 
-.127 .019 .015 .967 .043 -.046 -.100
19. Despite my physical symptoms I do my utmost 
to do those activities well in which I have been 
involved.
.077 .031 -.095 .868 .039 .027 .035
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20. Despite my physical symptoms I do my utmost 
to finish the activities in which I am involved. -.044 -.121 .171 .688 .016 -.081 .047
21. Despite my physical symptoms, I prefer to do 
things myself rather than ask for help. .240 .119 -.090 .474 -.047 .114 .087
22. I am aware that others make decisions about 
my physical condition. .043 .069 -.119 .037 .588 .111 -.198
23. I am afraid that the doctor has missed 
something. .014 .141 -.058 .055 .587 -.113 -.027
24. I am afraid that I have a serious illness. .061 .067 .034 -.060 .503 -.256 .229
25. Because of my physical symptoms I see myself 
in a different way. .061 -.021 -.014 .012 .351 .225 .201
26. It’s a relief to talk about my physical symptoms. -.205 -.195 .149 .060 .307 .192 .094
27. Extra rest reduces my symptoms. -.025 -.016 -.081 .013 -.110 .817 .037
28. By avoiding pressure my physical problem is 
reduced. .122 .198 .051 -.083 .049 .551 -.061
29. Distraction helps me to deal with my physical 
symptoms. -.139 -.039 .261 .085 .092 .335 .058
30. I worry about how my physical symptoms will 
develop in the future. -.081 -.085 -.067 .012 .127 .042 .796
31. I expect that my physical symptoms will get 
worse steadily. .158 .259 -.066 .055 -.139 -.063 .544
32. I expect that because of my medical state I will 
become dependent. .004 .219 .045 -.072 -.061 .152 .421
 * Part of the original Illness Cognitions Questionnaire 
 On the basis of the substantive similarities between the items within these additional 
factors, we labeled them as follows. Factor 4 (Cronbach’s α =.835) was labeled as Perseverance 
and included, among others, the item ‘Despite my illness, I exert myself to the fullest to keep 
on doing my activities’. ‘I’m afraid the doctor is overseeing something’ is an example of an 
item of the fifth factor (Cronbach’s α =.600), which we labeled Illness Anxiety. The sixth factor 
(Cronbach’s α =.610) could be labeled as Avoiding; an example of an item in this factor is ‘Extra 
rest reduces my symptoms’. We labeled the last factor (Cronbach’s α =.691) Catastrophizing. 
An item of this factor is ‘I’m worried how my illness will be in the future’.
 Bivariate associations by Pearson’s correlation coefficients showed that the subscale 
Acceptance correlated moderately to high with Helplessness (rho=-.55), Disease Benefit 
(rho=.41), Perseverance (rho=.30), and Illness Anxiety (-.43; all p-values <.001). Furthermore, 
the subscales Illness Anxiety and Helplessness correlated moderately high (rho=.39, p<.001) 
as did the subscales Disease Benefit and Avoidance (rho=.38, p<.001). All other correlations 
were below .30.
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Illness cognitions scores of the ICQ-plus in MUS and MES patients (group validity)
 We also compared the illness cognitions between patients with MUS and MES (see 
table 4). ANCOVAs showed that patients with MUS scored significantly higher on the subscale 
Helplessness, and the new category Illness Anxiety. Patients with MUS scored significantly 
lower on Acceptance and Disease Benefit compared to patients with MES, when adjusted for 
age, sex, educational level, and partner status.
Table 4: Unadjusted and adjusteda mean values (with standard error of the mean) of illness 
cognitions of the ICQ plus scales by ANCOVA’s.
Analysis
Older persons 
with MUS 
(N=83)
Older persons 
with MES 
(N=137) p-value
Acceptance Unadjusted 17.89 (0.63) 20.51 (0.48) .001
Adjusted 18.22 (0.68) 20.16 (0.50) .025
Helplessness Unadjusted 9.82 (0.37) 8.67 (0.30) .018
Adjusted 9.97 (0.42) 8.79 (0.33) .031
Disease benefit Unadjusted 10.47 (0.45) 11.63 (0.36) .045
Adjusted 10.55 (0.51) 11.52 (0.39) .141
Perseverance Unadjusted 12.27 (0.37) 12.35 (0.28) .868
Adjusted 11.98 (0.41) 12.41 (0.29) .397
Illness anxiety Unadjusted 8.30 (0.27) 7.20 (0.21) .001
Adjusted 8.24 (0.30) 7.27 (0.22) .012
Avoidance Unadjusted 6.33 (0.25) 5.89 (0.20) .159
Adjusted 6.47 (0.29) 5.90 (0.21) .123
Catastrophizing Unadjusted 6.62 (0.22) 6.44 (0.17) .520
Adjusted 6.64 (0.24) 6.56 (0.18) .780
note Adjusted for age, sex and duration of complaints.
 
Construct Validity
 Table 5 presents the correlations between all ICQ-Plus subscale scores with both 
physical health- and mental health-related quality of life, depressive symptom severity, 
hypochondriacal beliefs, and duration of disease. Age did not correlate with illness cognitions, 
with one exception: age correlated with Avoidance (Pearson r=-.14, p=.042). Student’s t tests 
revealed no significant difference between male and female participants on any of the 
subscales. 
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Table 5: Pearson’s correlation coefficienta of all ICQ-plus subscale with health related quality of 
life (QoL), depressive symptom severity, health anxiety and duration of disease.
Health Related QoL (SF-36) Depression Health 
anxiety
ICQ-plus subscales Physical 
health related 
QoL
Mental 
health 
related QoL
Inventory of 
Depressive 
Symptoms
Whitely 
Index
Duration 
of 
disease#
Original subscales ICQ:
Acceptance .39** .53** -.59** -.49** .07
Helplessness -.48** -.49** .55** .43** .11
Disease benefit .02 .23** -.24** -.18* -.04
Additional subscales ICQ-plus:
Perseverance .13 .07 -.12 -.04 .13
Illness anxiety -.34** -.43** .46** .60** -.03
Avoidance -.16* -.08 .09 .05 .15*
Catastrophizing -.23** -.16* .16* .20* .17*
a Correlation with duration of disease (skewed distribution) was explored by Spearman rank correlations
* p<.05; ** p<.001
Abbreviations: SF-36, Short-Form 36; Qol, Quality of Life; ICQ, Illness Cognition Questionnaire
Discussion
Main conclusions
      Our study confirmed the factor structure of the Illness Cognition Questionnaire 
in older patients suffering from physical symptoms. Furthermore, our qualitative study 
identified 26 illness cognitions that could not be categorized as belonging to one of the 
established categories of illness cognitions; of those, 16 cognitions together resulted in 
four new categories, which could be labeled as Perseverance, Illness Anxiety, Avoidance and 
Catastrophizing. Compared to patients with MES, patients with MUS reported a higher level 
of Helplessness and lower level of Acceptance. Of the new categories, only the level of Illness 
Anxiety differed between MUS and MES patients, with it being highest in MUS patients. 
Comparison to existing literature
 The ICQ was originally based on a theoretical model of illness cognitions in patients 
suffering from long-term somatic conditions. The questionnaire was developed as a measure 
of giving meaning to a long-term somatic condition and consequently focused on cognitive 
components related to depression and adjustment problems in these populations. The 18 
items were thereby selected on their a priori chance of fitting one of the three predefined 
categories of this model (Evers et al., 2001). This scientifically sound procedure, however, may 
have missed important cognitions. In our study, we did the opposite, by applying an empirical 
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approach starting with a qualitative interview exploring all possible illness cognitions. This 
has resulted in four additional categories not captured by the original ICQ. Construct validity 
analyses showed that Illness Anxiety correlated highly with quality of life, depression, and 
health anxiety comparable to the original subscales Acceptance and Helplessness. The other 
three new subscales did not, comparable to the original subscale Disease Benefit, and thus 
contribute to a more-comprehensive picture of the patient. 
 Three new categories collectively reflect anxiety in the broadest sense, including 
cognitive (Catastrophizing), physiological (Illness Anxiety) and behavioral (Avoidance, 
Perseverance) components. Moreover, construct validity analyses support the idea that these 
scales indeed reflect different aspects of anxiety. These anxiety-related components refer to 
ideas patients have about their future and directly interfere with actual levels of quality of 
life.  Furthermore, because high anxiety levels and associated behavior place persons at risk 
for the development of psychopathology, the model also seems to contribute to explaining 
why chronic somatic conditions predispose patients to psychopathology. Moreover, the 
subscale Perseverance points to a coping strategy partially based on nonacceptance of 
the symptoms. Nonetheless, construct validity shows that the subscales Acceptance and 
Perseverance are different constructs and thus complement each other. Composing a study 
sample of older patients suffering from either MUS or MES, irrespective of underlying somatic 
and/or psychiatric disorders maximizes heterogeneity of patients for several reasons. First, 
it is generally presumed that heterogeneity between people increases with age (Eisdorfer 
& Lawton, 1973; Hazelhof & Verdonschot, 2000; Kalish, 1975). As a consequence, illness 
cognitions may also become more heterogeneous. Second, the ICQ does not capture 
cognitions related to anxiety. Anxiety is often present with somatic symptoms, which is not 
always recognized as anxiety by doctors or patients themselves (Bekhuis et al., 2015; Simms 
et al., 2012; Viljay et al.,  2014). Especially in later life, psychological distress is often expressed 
in somatic terms. For example, compared to their younger counterparts, older persons more 
often have a somatic presentation of their depression (Hegeman et al., 2012). Finally, the 
prevalence of somatic disorders and physical frailty increases with age. Multimorbidity and 
physical frailty are often considered the ‘next to last’ stage of life by patients, which results 
in specific psychological challenges and cognitions related to their physical functioning 
(Fillit & Butler, 2009). In summary, we probably selected a population with a high chance 
of detecting a wide range of cognitions related to their physical functioning. Whether these 
illness cognitions are specific for old age, however, cannot be deducted from this study. After 
all, the categories Perseverance, Avoiding, Catastrophizing, and Illness Anxiety may be also 
important cognitions in younger populations and may thus not be age-specific. Moreover, 
the sum scores of the original scales of the ICQ were not associated with age (Evers et al., 
2001). In our population of older patients, we also did not find an association with age of the 
scores on the original and new subscales.  Nonetheless, cross-validation of the ICQ-Plus is 
warranted in younger populations before definitive conclusions can be drawn.
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 The four new categories of illness cognitions are probably clinically relevant. 
Catastrophic and hypochondric misinterpretation is seen as the central psychological 
determinant in the development and maintenance of somatic complaints (Bekhuis et al., 
2015; Brown, 2004; Buitenhuis & de Jong, 2011; Rief & Isaac, 2007) and refers to a patient’s 
affective state, primarily the level of anxiety. For example, cognitions about avoidance are 
associated with the level of disability in older patient groups with low back pain (Basler et al., 
2008).
 The additional categories Perseverance and Avoidance refer to thoughts about coping 
with illness. Perseverance, defined as ‘keep going on’, is an important definition in coping 
with chronic pain in later life (Sofaer-Bennett et al., 2007). 
 However, we also found interesting differences between both groups. Patients with 
MUS experienced more Helplessness and more Illness Anxiety compared to MES patients. 
This may be explained by the high co-morbidity between MUS and affective disorders such 
as depression and anxiety disorders (Hilderink et al., 2009). Furthermore, MUS patients 
mentioned less acceptance cognitions and disease benefits which suggests a lack of coping 
skills. The high co-comorbidity with affective disorders and the lack of coping skills in MUS 
patients can explain the stronger impact of somatic symptoms in MUS on health-related 
quality of life in patients suffering from MUS than in patients with MES (Hilderink et al., 2015). 
Methodological considerations
 A strength of our study is a bottom-up exploring of illness cognitions in a population 
that can be considered as highly relevant for a clinical practice where many patients are 
old. Subsequently, we validated these illness cognitions in a large sample of older patients 
suffering from explained and/or unexplained physical symptoms. Nonetheless, for proper 
interpretation of our results, some methodological limitations should be taken into account. 
 First, the qualitative study did not include patients suffering from MES only. This a priori 
choice was based on the fact that we expected the highest variability and most maladaptive 
cognitions among MUS patients. Acknowledging the minimal differences between MUS- and 
MES patients, MES patients were at least as relevant to include. Moreover, it is possible that 
we have not captured the most relevant illness cognitions of patients with MES only. Second, 
new categories are based on only a low number of items per subscale, that is, 4, 5, 3, and 3 
items respectively. On the basis of face validity for potentially clinical relevance, we decided 
to accept the low number of items per subscale as well as the fact that three items of the ICQ-
Plus (item 25, 26 and 29) also cross-loaded on other subscales. This may explain the relatively 
low level of reliability of the subscales Illness Anxiety, Avoiding, and Catastrophizing, although 
Cronbach’s alpha for these three subscales was still above 0.60, which is acceptable for 
(very) short scales. Further research, however, is needed to confirm these subscales in other 
samples. Investigators specifically interested in these subscales should preferably conduct 
a confirmatory factor analysis on their data and check the reliability estimates. Ideally, each 
subscale should be extended with additional items to make it more robust. 
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 Secondly, although we extended the ICQ in an older sample and we a priori thought to 
find age-specific cognitions, most cognitions do not seem to be age-specific at face value. 
This is in line with previous studies on the ICQ in which no correlations with age have been 
found (Evers et al., 2001; Lauwerier et al., 2010). Nonetheless, comparison with a younger 
sample is needed for definitive conclusions.
Implications and conclusion
      In this study, we identified additional cognition categories for older patients with 
physical symptoms (explained and/or unexplained) that are not captured by the ICQ. For 
this reason, we propose an extension of the scale, which we call the ICQ-Plus. The ICQ-
Plus may help therapists in exploring all potential cognitions that need to be challenged 
during cognitive-behavioural therapy for treating MUS and MES in later life. In future studies, 
especially the predictive validity with respect to symptom course, treatment response, and 
quality of life should be examined.

 
Part IV.
Social characteristics of medically unexplained symptoms 
in later life.
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Abstract
Although previous studies have underlined the protective role of social support for 
physical and psychological health, no self-report questionnaires are validated for 
measuring social support in psychiatric epidemiological studies. In the current study 
we aim to validate the Dutch version of the Close Persons Questionnaire (CPQ) in 
psychiatric patients (n=1891) and controls (n=1872), a questionnaire that measures 
both social support received from the partner (CPQ-p) and from a close friend/family 
member (CPQ-f). Using multigroup confirmatory factor analyses, a four-factor model 
proved to be the best fitting model for both the CPQ-p and CPQ-f. The resulting subscales 
-emotional support, practical support, negative support experiences, inadequacy of 
support- showed moderate to good reliability for both the CPQ-p and the CPQ-f, and 
were all correlated with other social measures in the expected directions. The Dutch 
CPQ proves to be a valid and reliable measure of social support for both psychiatric 
patients and controls. 
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Introduction
 Many studies have underlined the protective role of social support for physical health 
outcomes, such as fatigue (Kwag et al., 2011), diabetes and hypertension (Tomaka et al., 
2006), coronary heart disease and heart failure (Lett et al., 2005; Luttik et al., 2005), and 
mortality (Lyyra & Heikkinen, 2006; Holt-Lunstad et al., 2010). Also, a higher level of social 
support is associated with positive psychological outcomes, such as fewer symptoms of 
depressive and anxiety disorders (George et al., 1989; Moak & Agrawal, 2009; Leavy, 1983), 
lower severity of posttraumatic stress disorder (Schumm et al., 2006), and fewer suicide 
attempts (Kleiman & Liu, 2013). The association between social support and health seems to 
be complex and reciprocal, as social support is a protective factor for health (e.g. Kwag et al., 
2011; Tomaka et al., 2006), but at the same time good health is a precondition for maintaining 
social relationships (van Tilburg & Broese van Groenou, 2002). Given the important role of 
social support for (mental) health, it is necessary to have valid and reliable measures of social 
support. 
 Throughout the years many definitions of social support have been proposed. 
Researchers have distinguished practical or instrumental support from emotional 
support (House, 1981), and have suggested additional components of social support, 
such as informational support, appraisal support (House, 1981), and adequacy of support 
(Henderson et al., 1981), but so far no consensus has been reached regarding the definition 
of social support (Vangelisti, 2009; Langford et al., 1997; Thoits, 1982). Nonetheless, several 
self-report questionnaires are available for measuring social support for research purposes, 
such as the Norbeck Social Support Questionnaire (Norbeck et al., 1981), the Social Support 
Questionnaire (Sarason et al., 1983), the MOS Social Support Survey (Sherbourne & Steward, 
1991), and the Close Persons Questionnaire (CPQ; Stansfeld & Marmot, 1992). 
 This last questionnaire has been developed as a measure for both quantitative and 
self-perceived qualitative aspects of social support, keeping in mind different types of social 
support. Three types of social support were distinguished (emotional support, instrumental 
support and negative aspects of social support), with good reliability rates and moderate 
to good criterion and construct validity (Stansfeld & Marmot, 1992). A slightly adapted and 
translated version of this CPQ was used as a measure of social support in several Dutch 
epidemiological studies (NESDA, Penninx et al., 2008; NESDO, Comijs et al., 2011; OPUS, 
Hanssen et al., 2016). This Dutch version of the CPQ consists of a version to measure social 
support received from the partner (CPQ-p) and a version to measure social support received 
from a close friend or family member (CPQ-f). The CPQ is a short questionnaire that can 
be administered in about ten minutes, making it an efficient self-report test that can be 
especially useful for large-scale studies that aim to investigate a wide range of measures. 
However, validity and reliability rates of the Dutch version of the CPQ are as yet unknown. 
 Therefore, in the current study we aim to validate the Dutch version of the CPQ-p 
and CPQ-f , and to determine the reliability of the subscales of the CPQ-p and CPQ-f using 
data from the Netherlands Study of Depression and Anxiety (NESDA; Penninx et al., 2008), 
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the Netherlands Study of Depression in Older persons (NESDO; Comijs et al., 2011), and 
the Older Persons with medically Unexplained Symptoms study (OPUS; Hanssen et al., 
2016). First, we will explore whether the three-factor structure of the original Close Persons 
Questionnaire is also suitable for the Dutch version of the CPQ (CPQ-p and CPQ-f) using 
multigroup confirmatory factor analyses with relevant subgroups, specifically mental health 
patients versus controls. If this three-factor model does not fit the CPQ data, we aim to find 
the best fitting factor structure for both the CPQ-p and CPQ-f. Based on these findings, we will 
determine reliability rates for the corresponding subscales of the CPQ-p and CPQ-f. Finally, 
we aim to study the construct validity of the CPQ-p and CPQ-f subscales by examining their 
relationships with other social measures, such as social network size, loneliness, and need 
for affiliation. 
Methods
 In the current study, we determine reliability and validity of the Dutch version of the 
CPQ, for which we used data from three Dutch prospective cohort studies about the course 
and determinants of depressive and anxiety disorder and medically unexplained symptoms.
Data sources
The Netherlands Study of Depression and Anxiety (NESDA)
 NESDA aims to study the clinical, biological, and psychosocial determinants and 
consequences of depressive and anxiety disorders in adults (18-65 years) (Penninx et al., 
2008). In this multisite, longitudinal, naturalistic cohort study, 1701 participants with an 
anxiety and/or depressive disorder in the past six months, 907 participants with a life-time 
diagnosis of depressive and/or anxiety or subthreshold depressive and/or anxiety disorders, 
and 373 healthy controls with no history of anxiety or depressive disorder, were included 
from community, primary care, and mental health organizations. Exclusion criteria were the 
presence of other primary, clinically overt diseases such as psychotic disorder, obsessive-
compulsive disorder, bipolar disorder, or severe addiction disorder, and language problems 
that could disturb reliable data collection. A more detailed description of the study sample 
and procedures can be found in Penninx et al. (2008). 
The Netherlands Study of Depression in Older persons (NESDO)
 NESDO aims to study neurobiological, physical, and psychosocial determinants and 
the course of late-life depression in a multisite, naturalistic, prospective cohort study (Comijs 
et al., 2011). The NESDO study sample consists of 378 older (>= 60 years) participants with 
a 6-months diagnosis of (major or minor) depression or dysthymia and 132 older (>= 60 
years) participants without a history of depression (non-depressed controls). Depressed 
participants were recruited from mental health care institutes and general practices. Non-
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depressed controls were recruited from general practices only. Exclusion criteria were a 
diagnosis of dementia and insufficient command of the Dutch language. A more detailed 
description of the NESDO study can be found elsewhere (Comijs et al., 2011). 
The Older Persons with medically Unexplained Symptoms (OPUS) Study
 The OPUS Study aims to explore bio-psycho-social determinants and the course of 
late-life Medically Unexplained Symptoms (MUS), using quantitative and qualitative research 
techniques (Hanssen et al., 2016). As part of this study, 118 older (>= 60 years) persons with 
chronic MUS and 154 older (>= 60 years) persons with Medically Explained Symptoms (MES) 
were recruited via advertisements, general practices, and a specialized clinic for treating late-
life MUS. Exclusion criteria were the presence of a psychotic disorder, dementia, suffering 
from terminal illness, not sufficiently mastering the Dutch language, and severe auditory 
and/or visual limitations that could hinder reliable data collection. 
Sample of the current validation study
 The data of the three previously described epidemiological studies were used 
to compose a total study sample. In order to explore the possible impact of a current 
psychiatric disorder on the factor structure and reliability of the CPQ, the sample was split in 
1891 participants with a current (i.e. a past-month), diagnosis of depressive disorder, anxiety 
disorder, and/or somatoform disorder, and 1872 controls without a current psychiatric 
diagnosis, some of whom suffered from psychiatric disorder in the past. Since the CPQ is only 
relevant in case a partner or a close relative is present, the number of eligible patients and 
controls drop to respectively 1162 and 1311 for the CPQ-p and 1345 and 1354 for the CPQ-f. In 
total 1102 (94.8%) patients and 1227 (93.6%) controls completed all items of the CPQ-p and 
1281 (95.2%) patients and 1346 (99.4%) controls completed all items of the CPQ-f. 
Measures
Dutch version of the Close Persons Questionnaire: partner version (CPQ-p) and closest family 
member/friend version (CPQ-f)
 The Dutch CPQ is a slightly adapted and translated version of the CPQ (Stansfeld & 
Marmot, 1992). The key changes compared to the original questionnaire concern 1) translation 
into Dutch language, 2) the number of items (2 x 15 items in the original questionnaire versus 
2 x 10 items in the Dutch CPQ, see table 2), 3) the number of response alternatives (4 in the 
original list: not at all, a little, quite a lot, a great deal to 5 in the Dutch CPQ: never, seldom, 
sometimes, often, very often), 4) questions aimed at the two closest persons, regardless of 
the social relationship, in the original CPQ versus questions specifically aimed at the partner 
(CPQ-p) and the closest friend/family member (CPQ-f) in the Dutch version of the CPQ. 
Whether or not the CPQ-p and CPQ-f are administered is determined by asking respectively 
whether the participant is in a stable relationship at the time (yes/no) and whether the 
CHAPTER 9
142
participant has an important friend or family member (yes/no). Copies of the Dutch version 
of the CPQ-p and/or CPQ-f are available from the authors on request.
General and social characteristics
 General measures were age (in years, at time of interview) and gender. The following 
measures were used to investigate construct validity: 
Social network size - The social network size, defined as the number of family members, 
friends, and close acquaintances (>=18 years) that one has frequent and important contact 
with, was measured using a multiple choice question with six ascending response alternatives 
(‘0-1’, ‘2-5’, ‘6-10’, ’11-15’, ’16-20’, and ‘more than 20’). 
Loneliness - Loneliness was measured using the Loneliness Scale (De Jong-Gierveld & 
Kamphuis, 1985), an 11-item questionnaire with response alternatives ‘no’ (score 0), ‘more 
or less’ (score 1), and ‘yes’ (score 1). The sum score (max. 11) was used as a measure of 
loneliness, with higher sum scores indicating higher levels of loneliness. 
Need for Affiliation - The 6-item version of the Need for Affiliation Scale (Van Tilburg, 1988) 
was administered as a measure of the participant’s need for engaging in social relationships. 
Answering categories were ‘no’ (score 0), ‘more or less’ (score 1), and ‘yes’ (score 1). A sum 
score (max. 6) was used as a measure of the need for affiliation, with higher scores indicating 
a higher need for social affiliation. 
Data-analyses
 The data of the CPQ-p and CPQ-f were analyzed separately. As stated before, only 
respondents with no missing values on all ten items of the scale studied, were included in 
the analyses. 
 Given that the CPQ is supposed to measure three factors -emotional, practical, negative 
support- (Stansfeld & Marmot, 1992), we hypothesized that the ten items measuring social 
support from partner, respectively from closest friend / family member, would indeed consist 
of those three factors Emotional support, Practical support, and Negative support. For each 
scale, items 1, 2, 4, and 7 were expected to load on Emotional support, items 8 and 9 on 
Practical support, and items 3, 5, 6, and 10 on Negative support. 
 For both social support scales multigroup confirmatory factor analyses were conducted 
on the raw data using LISREL 8.80 (Jöreskog & Sörbom, 2006). First, configural invariance was 
tested to investigate whether the structure of social support can be conceptualized in the 
same way for the patient and control group (Steenkamp & Baumgartner, 1998). To this end, 
we tested whether the same pattern of fixed and free factor loadings would hold for the two 
groups.
 Next, metric invariance and scalar invariance across the patient and control group 
were tested. Metric invariance and scalar invariance are necessary requirements if one wants 
to compare groups with respect to their mean scores on a measurement scale, such as 
comparing means of the social support subscales between a patient and a control group 
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(Byrne et al., 1989; Ellis, 1993; Reise et al., 1993; Steenkamp & Baumgartner, 1998). When 
metric invariance holds, this is taken to indicate that the items measure the same latent 
constructs across different groups. Scalar invariance indicates that group differences in the 
means of the items can be attributed to group difference in the means of the underlying 
constructs (Steenkamp & Baumgartner, 1998). To test metric invariance, the factor loadings 
of the patient and control group were constrained to be equal in both groups. In order to test 
scalar invariance, in addition to the invariant factor loadings across groups, the intercepts of 
the items were constrained to be invariant across the patient and control group (See footnote 
1).
 For all factor analyses, maximum likelihood was used to estimate the parameters of 
the models. In order to define the metric of each latent scale, for each factor the loading 
of the first item expected to load on that factor was fixed to 1 in each group (e.g., item 1 on 
Emotional support). The loadings of the other items expected to load on a specific factor (e.g., 
item 2, 4, and 7 on Emotional support) were allowed to be free. Each item was allowed to load 
on only one factor and its loadings on the remaining factors were fixed to zero. 
 Factor variances, covariances between the factors, and the error variances of the items 
were all allowed to be free. The error covariances between the items were all fixed to zero. In 
addition, to be able to test scalar invariance, the factor means in the patient group were fixed 
to zero and the factor means in the control group were allowed to be free (e.g., see Reise et 
al., 1993; Steenkamp & Baumgartner, 1998).
 To test the overall fit of the different models chi-square tests were performed. In addition, 
the fit of the configural invariance model was compared to the fit of the more restrictive 
metric invariance model and the fit of the metric invariance model was compared to the fit 
of the more restrictive scalar invariance model. To this end, for each model comparison we 
performed chi-square difference tests by computing the difference between the chi-squares 
and degrees of freedom of both models (Byrne et al., 1989; Reise et al., 1993; Steenkamp & 
Baumgartner, 1998). Because both the overall chi-square tests and the chi-square difference 
tests have been shown to be too strict with large sample sizes (e.g., even minor violations of 
a model will be significant when the sample is large enough), it is generally recommended 
to use two or more ‘practical’ goodness-of-fit indexes to evaluate a model in addition to the 
chi-square goodness-of-fit index (Bentler & Bonett, 1980; Browne & Cudeck, 1992; Reise et 
al., 1993; Steenkamp & Baumgartner, 1998). We therefore used three practical goodness-of-
fit-indexes to evaluate the different models: the root mean square error of approximation 
(RMSEA; Steiger, 1990), the nonnormed fit index (NNFI; Bentler & Bonett, 1980), and the 
comparative fit index (CFI; Bentler, 1990). The fit of a model is considered good if the RMSEA 
is equal to or smaller than 0.05 and is considered acceptable if the RMSEA is larger than 0.05 
but equal to or smaller than 0.08. Values higher than 0.08 are indicative of poor fit (Browne 
& Cudeck, 1992). For the NNFI and the CFI, values higher than 0.95 indicate good fit of a 
model, values ranging from 0.90 to 0.95 indicate acceptable fit, and values lower than 0.90 
are considered to be indicative of poor fit (Hu & Bentler, 1999).
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 Based on the results of the factor analyses, subscales were constructed to measure 
the different aspects of social support. Reliability analyses were performed to determine 
the reliability (Cronbach’s Alpha) of each subscale for the patient group and control group 
separately and for the total group. As a last step, correlations between the newly developed 
subscales and social network size (Spearman’s correlation), loneliness (Pearson’s correlation), 
and need for affiliation scores (Pearson’s correlation) were calculated. 
Results
Sample characteristics
 Table 1 shows general and social characteristics for each study (NESDA/NESDO/OPUS), 
and separately for patients with a current psychiatric diagnosis (depression, anxiety disorder 
or medically unexplained symptoms) and controls. 
Table 1: General and social characteristics of psychiatric patients and controls presented by study.
NESDA NESDO OPUS P a
G
en
er
al
 c
ha
ra
ct
er
is
ti
cs
Psychiatric 
patients 
% (n) 49.0 (1460) 61.4 (313) 43.4 (118) <.001
Age Total M (SD) 41.86 (13.09) 70.57 (7.34) 72.17 (7.44) <.001
Psychiatric patients M (SD) 41.92 (12.35) 70.50 (7.32) 70.54 (6.72)
Controls M (SD) 41.81 (13.74) 70.69 (7.39) 73.42 (7.74)
Female Total % (n) 66.4 (1979) 64.9 (331) 52.6 (143) <.001
Psychiatric patients % (n) 66.3 (968) 64.9 (203) 64.4 (76)
Controls % (n) 66.5 (1011) 65.0 (128) 43.5 (67)
CPQ-p 
completed
Total % (n) 63.9 (1905) 51.8 (264) 58.8 (160)
Psychiatric patients % (n) 60.7 (886) 47.0 (147) 58.5 (69)
Controls % (n) 67.0 (1019) 59.4 (117) 59.1 (91)
CPQ-f 
completed
Total % (n) 71.0 (2116) 62.4 (318) 71.0 (193)
Psychiatric patients % (n) 69.0 (1008) 65.2 (204) 58.5 (69)
Controls % (n) 70.8 (1108) 57.9 (114) 80.5 (124)
So
ci
al
 c
ha
ra
ct
er
is
ti
cs
Social 
network size 
Total M (SD) 2.74 (1.13) 2.72 (1.24) 4.30 (1.61) <.001
Psychiatric patients M (SD) 2.49 (1.03) 2.41  (1.06) 3.99 (1.70)
Controls M (SD) 2.97 (1.18) 3.22 (1.36) 4.51 (1.51)
Loneliness
score
Total M (SD) 5.36 (3.70) 5.42 (3.80) 2.61 (2.96) <.001
Psychiatric patients M (SD) 5.98 (3.57) 6.88 (3.36) 3.19 (3.40)
Controls M (SD) 2.93 (3.18) 3.18 (3.31) 2.20 (2.52)
Affiliation
score
Total M (SD) 4.49 (1.63) 4.23 (1.66) 3.09 (1.78) <.001
Psychiatric patients M (SD) 4.26 (1.67) 4.16 (1.70) 3.21 (1.84)
Controls M (SD) 4.69 (1.57) 4.35 (1.60) 3.01 (1.74)
a Significance values derived from one-way ANOVAs and chi-square tests
MEASURING SOCIAL SUPPORT IN PSYCHIATRIC PATIENTS AND CONTROLS: 
VALIDATION AND RELIABILITY OF THE DUTCH VERSION OF THE CLOSE PERSONS QUESTIONNAIRE. 
145
Ch
ap
te
r 9
Construct validity: internal structure
The three-factor structure of the CPQ-p 
 First, an optimal baseline model was estimated for both groups to test configural 
invariance (Byrne et al., 1989). Because the error variance of item 9 was initially negative in 
the patient group, in following analyses this error variance was fixed to a positive value of 
0.01. In addition, the modification index of the error covariance between item 5 and item 10 
was very high in both groups (completely standardized expected change respectively 0.30 
for the patient group and 0.32 for the control group). Therefore, in following analyses, the 
error covariance between item 5 and 10 in both groups was allowed to vary freely. These 
adjustments did not change the estimates of the factor loadings, the (co)variance of the 
factors or the error variances of the items, but significantly improved the statistical fit of the 
model (∆ c2 (2) = 279.47, p < .001) and the practical fit of the model (from acceptable to good 
for all three fit indexes; ∆RMSEA = 0.028, ∆NNFI = 0.05, and ∆CFI = 0.04). In both groups the 
error covariance between item 5 and item 10 was significant (both p’s < .001).
 The fit of the configural invariance model was satisfactory. Although the statistical 
fit index was significant (c2 (63) = 249.52, p < .001), the fit of this model can be considered 
good according to all three goodness-of-fit indexes (RMSEA = 0.050, NNFI = 0.97, and CFI = 
0.98), indicating that the same structure of fixed and free factor loadings can be assumed to 
hold for both groups. Next, the metric invariance model was tested to see whether the factor 
loadings could be considered equal across both groups. The difference between the fit of the 
configural invariance model and the metric invariance model was not significant (∆c2 (7) = 
11.40, p = .12), indicating that factor loadings could be seen as invariant across groups. The 
statistical fit of the total metric invariance model was significant (c2 (70) = 260.92, p < .001), 
but all fit indexes indicated good fit of this model (RMSEA = 0.048, NNFI = 0.97, and CFI = 0.97). 
In the last step, scalar invariance was tested by also constraining the intercepts of the items 
to be equal across both groups. Although the difference in fit between this scalar invariance 
model and the metric invariance model was significant (∆c2 (7) = 107.4, p < .001), the fit of 
the scalar invariance model could still be considered satisfactory, with practical fit indexes 
ranging from acceptable (RMSEA = 0.057) to good (NNFI = 0.96 and CFI = 0.96; c2 (77) = 368.32, 
p < .001).
 In conclusion, the findings above suggest that for the CPQ-p the same three-factor 
model holds across both groups and that both metric invariance and scalar invariance across 
groups can be reasonably assumed (See footnote 2). 
 For the scalar invariance model, all factor loadings were significantly different from zero 
(all p’s <.001) and most completely standardized factor loadings were higher than 0.50 (16 
out of 20). Item 5 and item 10 both had relatively low factor loadings on the factor Negative 
support (ranging from 0.30 to 0.40). All correlations between the factors were significantly 
different from zero (all p’s <.001). The correlations between the factors Emotional support 
and Practical support were positive (r = .49 and r = .28 for the patient and control group 
respectively), and the correlations between the factor Negative Support and the other two 
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factors were all negative (r = -.71 with Emotional support and r = -.30 with Practical support 
for the patient group and r = -.63 with Emotional support and r = -.10 with Practical support 
for the control group). Correlations between the factors were significant smaller (i.e., less 
positive or less negative) for the control group than for the patient group (all p’s < .001).
 
The three-factor structure of the CPQ-f
 Similar to the analyses with the CPQ-p, first the optimal baseline model was estimated 
for both groups. Again, the modification index of the error covariance between items 5 
and 10 was very high in both groups (for the patient group the completely standardized 
expected change was 0.33 and for the control group it was 0.42) and in following analyses 
the error covariance between these items were allowed to vary freely for both groups. These 
adjustments did not change the parameter estimates of the model substantially, but the 
statistical fit of the model was significantly improved (∆c2 (2) = 328.34, p < .001), as were the 
practical fit indexes (∆RMSEA = 0.022, ∆NNFI = 0.09, and ∆CFI = 0.06). In both groups the error 
covariance between item 5 and item 10 was significantly different from zero (both p’s < .001).
 The statistical fit of the configural invariance model was significant (c2 (62) = 498.55, 
p < .001), and acceptable according to two of the practical fit indexes (RMSEA = 0.073 and 
CFI = 0.91). The third index indicated a fit slightly less acceptable (NNFI = 0.87). Next, the 
metric invariance model was significant (c2 (69) = 513.18, p < .001), and also the fit differed 
significantly from the fit of the configural invariance model (∆c2 (7) = 14.63, p = .04). The 
practical fit indexes remained the same or improved slightly (RMSEA = 0.070, NNFI = 0.88, 
and CFI = 0.91). Finally, the scalar invariance model was tested (c2 (76) = 615.39, p < .001). The 
difference in fit between this scalar invariance model and the metric invariance model was 
significant (∆c2 (7) = 102.21, p < .001), and the practical fit indexes worsened slightly with two 
indexes below the acceptable value (acceptable fit RMSEA = 0.074; below acceptable fit NNFI 
= 0.87 and CFI = 0.89). 
 Given the findings above, for the CPQ-f metric invariance and scalar invariance were not 
supported. In fact, even the assumption of the same structure of fixed and free factor loadings 
across groups could be doubted, since the configural invariance model was not more than 
acceptable according to two practical fit indexes and even unacceptable according to the 
third fit index.
Testing an alternative model: the four-factor structure of social support
 There were several reasons to test an alternative four-factor model for the two social 
support scales. Most importantly, the three-factor model did not fit the data of the CPQ-f 
satisfactorily. In addition, for both scales, model fit improved significantly when the errors of 
item 5 and 10 (assumed to form a subscale with item 3 and 6 to measure Negative support) 
were allowed to correlate, suggesting that item 5 and 10 share more in common than 
could be explained by the underlying factor Negative support. Also, the results of the factor 
analyses showed that for both the CPQ-p and the CPQ-f, the factor loadings of item 5 and 10 
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on the factor Negative support were small (ranging from 0.19 to 0.40). Together, these results 
suggested that it might be wise to split up the factor Negative support into two separate 
factors. Inspection of the content of the items further supported this suggestion; whereas 
item 3 and 6 measure negative effects of contact with the social support giver (e.g. ‘How often 
did he/she give you stress or worries?’), item 5 and 10 instead measure not having enough 
(thus inadequacy of) social support (e.g. ‘How often would you have liked to trust him/her 
more?’). Actually, in the original factor analyses of the CPQ Inadequacy of support initially 
came out as a separate factor, but for sake of parsimony this factor was combined with the 
negative effects factor (Stansfeld & Marmot, 1992). Therefore, for both social support scales, 
an alternative four-factor model was tested. In this model, the factors Emotional support and 
Practical support were the same as in the three-factor model, but the factor Negative support 
was split up into two distinct factors, Negative experiences (item 3 and 6) and Inadequacy 
of support (item 5 and 10). Similarly to the analyses of the three-factors models, configural, 
metric, and scalar invariance across groups was tested for both social support scales. For 
none of the scales, additional adjustments had to be made in order to arrive at an optimal 
baseline model for both groups. 
 CPQ-p: The fit of the configural invariance model was satisfactory (c2 (58) = 225.65, 
p < .001), with practical fit indexes indicating good fit of the model (RMSEA = 0.050, NNFI 
= 0.97, and CFI = 0.98). Constraining the factor loadings to be invariant across groups did 
significantly alter the fit of the model (∆c2 (6) = 13.19, p = .04), however the practical fit 
indexes remained the same or improved slightly. Overall, the metric invariance model was 
considered satisfactory (c2 (64) = 238.84, p < .001; RMSEA = 0.048, NNFI = 0.97, and CFI = 0.98). 
Although constraining the intercepts across groups to be equal changed the fit of the model 
significantly (∆c2 (6) = 68.85, p < .001), the practical fit indexes of the overall scalar invariance 
model indicated an acceptable to good fit of the scalar invariance model (RMSEA = 0.054, 
NNFI = 0.96, and CFI = 0.97; overall statistical fit of the model: c2 (70) = 307.69, p < .001). Given 
these results, metric invariance and scalar invariance across the patient and control group 
for the four-factor model can be considered plausible (See footnote 3).
 In table 2, for the scalar invariance model completely standardized factor loadings are 
given. All factor loadings were significantly different from zero (all p’s < .001), and all completely 
standardized factor loadings were higher than 0.50. In table 3, the correlations between the 
factors are shown for each group separately. Emotional support positively correlated with 
Practical support, and negatively with Negative experiences and Inadequacy of support. 
Practical support correlated negatively with Negative experiences and the correlation with 
Inadequacy of support was negligible for both groups (although significantly different from 
0 for the patient group). The correlation between Negative experiences and Inadequacy of 
support was positive. Most correlations between the factors were significantly smaller (i.e., 
less positive or less negative) for the control group than for the patient group, except for the 
correlations between Emotional support and Inadequacy of support and between Negative 
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experiences and Inadequacy of support, which were not significantly different between the 
two groups.
Table 2: Completely standardized factor loadings of the 10 items of the CPQ-p on the factors 
Emotional support, Practical support, Negative experiences, and Inadequacy of support for the 
patient and control group based on the scalar invariance model.
 Patients Controls
Itemsb E
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1. How often did he/she make you feel 
good about yourself?
.78 - - - .71 - - -
2. How often do you share hobbies or 
other pleasant things together? 
.61 - - - .57 - - -
3. How often did he/she give you stress 
or worries? 
- - .63 - - - .61 -
4. How often do you trust him/her 
with your most private problems? 
.66 - - - .62 - - -
5. How often would you have liked to 
confide in him/her more? 
- - - .58 - - - .58
6. How often did you feel bad after 
talking with him/her? 
- - .78 - - - .82 -
7. How often did he/she share personal 
problems with you? 
.61 - - - .58 - - -
8. How often did you need his/her 
practical assistance with important 
matters? 
- .66 - - - .67 - -
9. How often did you actually receive 
this practical assistance with important 
matters from him/her? 
- .97 - - - .90 - -
10. How often did you want more 
practical assistance from him/her?
- - - .69 - - - .73
a Note that the constraints of equal factor loadings in the metric invariance model and the scalar variance model 
were made on the unstandardized factor loadings. Because the groups differ with respect to the variances of the 
factors and the variances of the items, the completely standardized factor loadings are not exactly the same for 
both groups. 
b Items are translated from Dutch to improve readability. 
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Table 3: Correlations between the factors Emotional support, Practical support, Negative 
experiences and Inadequacy of support of the CPQ-p based on the scalar invariance model. 
Below the diagonal the correlations for the patient group are given, above the diagonal are the 
correlations for the control group.
Emotional 
support
Practical 
support
Negative 
experiences
Inadequacy of 
support
Emotional support - .29 -.62 -.36
Practical support .50 - -.11 .05*
Negative experiences -.69 -.31 - .48
Inadequacy of support -.41 -.08 .49 -
* Not significant at the .01 level; all other correlations were significant at the .01 level.
 CPQ-f: For the configural invariance model the statistical fit index was significant (c2 
(58) = 367.39, p < .001) and practical fit indexes indicated acceptable fit of the model (RMSEA 
= 0.064, NNFI = 0.90, and CFI = 0.94). The fit of the metric invariance model was significantly 
worse than the fit of the configural invariance model (∆c2 (6) = 21.12, p = .002), but the practical 
fit indexes changed only slightly. The overall metric invariance model was still satisfactory (c2 
(64) = 388.51, p < .001), with practical fit indexes indicating acceptable fit (RMSEA = 0.062, 
NNFI = 0.91, and CFI = 0.93). Although the difference in fit between the metric invariance and 
the scalar invariance model was significant (∆c2 (6) = 61.38, p < .001), the practical fit indexes 
barely changed. Consequently, also the fit of the scalar invariance model was considered 
acceptable (c2 (70) = 449.89, p < .001), with practical fit indexes indicating acceptable fit 
(RMSEA = 0.064, NNFI = 0.90, and CFI = 0.92). Given these results, metric invariance and scalar 
invariance across the patient and control group for the four-factor model can be considered 
plausible (See footnote 4).
 In table 4, for the scalar invariance model completely standardized factor loadings 
are given. All factor loadings were significantly different from zero (all p’s < .001) and most 
completely standardized factor loadings were higher than 0.50 (15 out of 20, minimum 
loading 0.45). The correlations between the factors are given in table 5. Emotional support 
positively correlated with Practical support and negatively with Negative experiences. The 
correlation between Emotional support and Inadequacy of support was negligible. Practical 
support correlated with Inadequacy of support, but the correlation with Negative experiences 
was negligible. The correlation between Negative experiences and Inadequacy of support was 
positive. Most correlations between the factors were similar across groups, except for the 
correlation between Emotional support and Negative experiences, which was more negative 
for the patient group than for the control group (p <.001).
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Table 4: Completely standardized factor loadings of the 10 items of the CPQ-f on the factors 
Emotional support, Practical support, Negative experiences, and Inadequacy of support for the 
patient and control group based on the scalar invariance model.
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1. How often did he/she make you 
feel good about yourself?
.57 - - - .57 - - -
2. How often do you share hobbies 
or other pleasant things together?
.47 - - - .46 - - -
3. How often did he/she give you 
stress or worries?
- - .49 - - - .45 -
4. How often do you trust him/her 
with your most private problems?
.60 - - - .60 - - -
5. How often would you have liked 
to confide in him/her more?
- - - .49 - - - .54
6. How often did you feel bad after 
talking with him/her?
- - .91 - - - .90 -
7. How often did he/she share 
personal problems with you?
.54 - - - .56 - - -
8. How often did you need his/her 
practical assistance with important 
matters?
- .89 - - - .90 - -
9. How often did you actually 
receive this practical assistance with 
important matters from him/her?
- .82 - - - .77 - -
10. How often did you want more 
practical assistance from him/her?
- - - .75 - - - .87
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Table 5: Correlations between the factors Emotional support, Practical support, Negative 
experiences and Inadequacy of support of the CPQ-f based on the scalar invariance model. Below 
the diagonal the correlations for the patient group are given, above the diagonal are the correlations 
for the control group.
Emotional 
support
Practical 
support
Negative 
experiences
Inadequacy of 
support
Emotional support - .29 -.23 -.03 *
Practical support .20 - .00 * .29
Negative experiences -.35 .08 - .25
Inadequacy of support -.07 * .29 .25 -
* Not significant at the .01 level; all other correlations were significant at the .01 level.
Reliability analyses
 Based on the analyses above, we recommend constructing four different subscales 
(Emotional support, Practical support, Negative experiences, and Inadequacy of support) for 
both the CPQ-p and the CPQ-f, by summing the subscale items. For each of these subscales 
reliability analyses were conducted for the total group and separately for the patient and 
the control group. The reliabilities (Cronbach’s alpha) for the subscales of the CPQ-p ranged 
from .571 to .788, with the highest reliability for the Practical support subscale. Reliabilities 
(Cronbach’s alpha) ranged from .519 to .845 for the different subscales of the CPQ-f, with 
again the highest reliability scores for the Practical support subscale (see table 6).
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Table 6: Mean scores and Cronbach’s Alpha values of the four subscales of the CPQ-p and the CPQ-f, 
for the total group and separately for the patient and control group.
Subscales Mean (SD) Cronbach’s 
Alpha
C
P
Q
-p
Emotional support Total 15.26 (2.87)* .749
Psychiatric patients 14.65 (3.09) .758
Controls 15.81 (2.53) .714
Practical support Total 6.58 (2.30) .768
Psychiatric patients 6.66 (2.33) .788
Controls 6.50 (2.28) .757
Negative experiences Total 4.45 (1.74)* .668
Psychiatric patients 4.80 (1.85) .651
Controls 4.14 (1.56) .662
Inadequacy of support Total 4.87 (2.03)* .598
Psychiatric patients 5.34 (2.07) .571
Controls 4.45 (1.90) .587
C
P
Q
-f
Emotional support  Total 15.11 (2.45)* .624
Psychiatric patients 14.97 (2.50) .621
Controls 15.23 (2.41) .626
Practical support Total 5.62 (2.52) .827
Psychiatric patients 5.73 (2.54) .845
Controls 5.52 (2.50) .811
Negative experiences Total 3.49 (1.45)* .595
Psychiatric patients 3.66 (1.55) .611
Controls 3.32 (1.33) .563
Inadequacy of support Total 4.27 (1.12)* .580
Psychiatric patients 4.60 (1.86) .519
Controls 3.95 (1.72) .622
* Between-group differences: p<.01 
Construct validity: relationships to other measures
 When compared to controls, psychiatric patients scored significantly lower on the 
Emotional support scales of the CPQ-p and CPQ-f, but significantly higher on the Negative 
experiences scales and Inadequacy of support scales. No significant between-group 
differences were found for the Practical support scales of the CPQ-p and CPQ-f (table 6). 
Both CPQ-p and CPQ-f Emotional support scales were positively correlated with the size of 
the social network, indicating that more emotional support is associated with a larger social 
MEASURING SOCIAL SUPPORT IN PSYCHIATRIC PATIENTS AND CONTROLS: 
VALIDATION AND RELIABILITY OF THE DUTCH VERSION OF THE CLOSE PERSONS QUESTIONNAIRE. 
153
Ch
ap
te
r 9
network. No significant correlation was found between both Practical support scales and 
social network size. The Negative experiences and Inadequacy of support scales of the CPQ-p 
and CPQ-f were negatively associated with social network size, indicating that more negative 
experiences and experiencing more inadequate support are associated with a smaller social 
network (table 7). 
Table 7: Correlations between the Emotional support, Practical support, Negative experiences and 
Inadequacy of support subscales and Social network size, Loneliness scores and Need for affiliation 
scores.
Social network 
sizea
Lonelinessb Need for 
affiliationb
Partner
Emotional support .21* -.40* .15*
Practical support .03 -.08* .07*
Negative experiences -.15* .36* .03
Inadequacy of support -.24* .36* .00
Closest friend/family member
Emotional support .10* -.24* .17*
Practical support .03 .01 .04
Negative experiences -.12* .19* .03
Inadequacy of support -.21* .29* .01
a Spearman’s rho
b Pearson’s r
* Correlation is significant at the .01 level.
 The CPQ-p and CPQ-f Emotional support subscales were negatively correlated with 
loneliness scores, meaning that higher scores on emotional support are associated with 
lower loneliness scores. The correlations between the two Practical support scales and the 
loneliness scores were negligible (although significantly different from 0 for the CPQ-p). The 
Negative experiences and Inadequacy of support scales of the CPQ-p and CPQ-f all positively 
correlated with loneliness scores, meaning that more negative experiences and higher 
inadequacy of support are associated higher loneliness scores (table 7). 
 Low, but statistically significant correlations were found between the need for affiliation 
scores and all CPQ-p and CPQ-f subscales, except for the Emotional support subscales. The 
positive correlations between these Emotional support subscales and need for affiliation 
scores indicate that higher emotional support scores are associated with a higher need for 
affiliation (table 7).   
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Discussion
Structure of the Dutch version of the CPQ
 The current validation study aimed to validate the Dutch version of the CPQ, that 
measures respectively social support received from the partner (CPQ-p) and social support 
received from a close friend or family member (CPQ-f). The evidence so far supports the 
construct validity of the Dutch version of the CPQ to measure social support.
 Results of the multigroup confirmatory factor analyses indicated that both the CPQ-p 
and CPQ-f could best be seen as scales consisting of four subscales. In line with the literature 
on social support (Henderson et al., 1981; Stansfeld & Marmot, 1992), each subscale is 
taken to measure a different aspect of social support. The first subscale is taken to measure 
Emotional support, with higher scores indicating more feelings of understanding from the 
support giver. The second subscale measures Practical support, with higher scores indicating 
more instrumental help (e.g., help with household activities) from the support giver. The 
subscale Negative Experiences measures the degree to which one has experienced negative 
consequences as a result of contact with the person, with higher scores indicating more 
negative support experiences. Finally, the subscale Inadequacy of Support refers to the 
question whether more support is desired, with higher scores indicating that the participant 
perceives the amount of social support as inadequate. 
 At first glance it might seem surprising that, although the Dutch version of the CPQ is 
only slightly adapted compared to the original CPQ, the factor structure of the Dutch CPQ 
is somewhat different from that of the original CPQ (Stansfeld & Marmot, 1992). In both 
the Dutch CPQ and the original CPQ factors measuring Emotional support and Practical 
support were identified. Furthermore, Stansfeld and Marmot point out that in addition to 
a factor measuring negative aspects of support, they found a separate factor that could be 
interpreted as inadequacy of support. Though Stansfeld and Marmot argue that inadequacy 
of support is not the same as negative experiences due to the support giver, they choose a 
three-factor solution in which negative aspects and inadequacy of support were combined 
into one single factor. As the results of our factor analyses showed that the fit of this three-
factor model was not satisfactory for our data, we choose to use the four-factor model with 
separate factors Negative experiences and Inadequacy of support, that actually match the 
original results found by Stansfeld and Marmot (1992). 
 The results of the reliability analyses for the Dutch CPQ-p and CPQ-f demonstrated 
acceptable to good reliability rates for the subscales Emotional and Practical support 
and moderate to acceptable reliability rates for the subscales Negative experiences and 
Inadequacy of support. Reliability rates of the CPQ-p subscales are in general slightly higher 
than those of the CPQ-f subscales. 
 The reliabilities of most of the CPQ subscales are lower than for example the internal 
consistency reliabilities of the subscales of the CPQ (0.63-0.85; Stansfeld & Marmot, 1992), but 
they are still being considered acceptable reliability rates considering the small numbers of 
items included in the different subscales. 
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Construct validity and comparison to previous research
 In validating the social support scales, we also studied the relations between the 
subscales of the Dutch version of the CPQ and other social measures. Results of these 
analyses showed that the social network size was positively correlated with the amount 
of emotional support, and negatively correlated with negative support experiences and 
inadequacy of support. These findings are in line with previous suggestions by Antonucci et 
al. (1997) that quantitative and qualitative measures of social functioning are correlated. A 
study focusing on late-life depressive symptoms in the community (Sonnenberg et al., 2013) 
indeed found a positive association between network size and the amount of social support, 
but only in women. Interestingly, the authors suggest that because of this larger network 
size, the chance of these social relationships also having negative impact increases, which is 
opposite to our findings of negative correlations between social network size and negative 
support experiences/ inadequacy of support. 
 Furthermore, results show that less emotional support, more negative experiences with 
support, and more inadequate support are all associated with higher levels of loneliness. 
These results are in line with the results of previous studies, which show that social support 
and loneliness are related in patient groups (e.g. Stokes, 1985; Jylha & Jokela, 1990; 
Bondevik & Skogstad, 1998; Kim, 1999; Yilderim & Kocabiyik, 2010). In line with Cacioppo 
et al. (2010) loneliness may even be considered a general evaluation of social contacts as 
being inadequate, which in the current study is underscored by the positive correlations 
between loneliness and inadequacy of support. Finally, no or small correlations were found 
between CPQ subscales and the levels of need for affiliation. As far as we know, no research 
has directly studied the relationship between social support and need for affiliation. Overall, 
the correlations between the CPQ subscales and other social measures were (nearly) all in 
the expected directions, providing support for the construct validity of the Dutch version of 
the CPQ.
 In addition, construct validity of the Dutch CPQ was further supported by the observed 
between-group differences on the CPQ subscales. For both the CPQ-p and CPQ-f, psychiatric 
patients reported less emotional support, more negative support experiences and more 
inadequacy of social support than controls without current psychiatric problems. These 
results are in line with previous research about psychiatric patients and social support, such 
as the work from Furukawa et al. (1999) and Ritsner et al. (2000). 
Strengths and limitations of the (Dutch version of the) CPQ
 In sum, the Dutch CPQ-p and CPQ-f are valid scales for measuring four aspects of social 
support received from the partner respectively received from a close friend or family member. 
As the CPQ are able to measure different aspects of social support, they acknowledge the 
multidimensionality of the concept ‘social support’. Also, the CPQ seems to be a suitable 
measure of social support for large-scale studies, because of the limited amount of time 
that is needed to evaluate different aspects of social support. Furthermore, in the current 
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study we showed that the CPQ are convenient measures for measuring social support in 
epidemiological studies with psychiatric samples, as the presented four-factor model was 
tenable for both a sample of psychiatric patients and a sample of controls without a current 
psychiatric diagnosis. 
 However, several limitations of the CPQ-scales should be mentioned. First, we use a 
relatively small amount of items to measure a complex and multidimensional concept. As 
a consequence, we have to accept the relatively low reliability rates for some of the scales, 
especially the Inadequacy of support scale. Also, as the Dutch version of the CPQ only 
measures social support given by the patient’s partner or closest friend/family member, social 
support is not measured when one or both of these close persons are absent. Therefore, the 
presented social support levels in this paper are restricted to patients that have a partner 
and/or other close person, and therefore are most likely underestimations of the perceived 
social support measures in a general population of mental health patients. Furthermore, 
although the CPQ are promising instruments to assess social support in research settings, 
we have not examined the application of the scales in clinical practice. Therefore, future 
research could focus on usability in clinical practice and the predictive value of the scales, 
for instance to assess the association between the CPQ subscales and future care needs of 
psychiatric patients. At this moment, extensive research is being performed to examine the 
association between the four social support constructs and other important psychiatric and 
psychological measures. With this research we intend to contribute to a better understanding 
of the relationship between social support and psychiatric disorders.  
Footnotes
Footnote 1
 Ideally, subpopulation invariance should hold for any possible division of the population 
into mutually exclusive subpopulations (e.g. see Ellis, 1993). However, in practice it is not 
realistic to test subpopulation invariance for every possible division. Given the planned 
future applications of the two scales in medical research, the comparison between patients 
and controls with respect to social support is one of major importance. We therefore choose 
to report the results of the multigroup confirmatory factor analyses based on a patient group 
and a control group. In addition, we also tested subpopulation invariance for groups based 
on gender and for groups based on age (age < 60 years versus age >= 60 years).
Footnote 2
 The results of the multigroup confirmatory factor analyses based on gender and age 
showed similar results to the ones described for the patient and control group. For both 
gender and age, the fit of the scalar invariance model could be considered acceptable to 
good (for gender: c2 (78) = 363.98, p < .001, RMSEA = 0.056, NNFI = 0.96, CFI = 0.97; and for age: 
c2 (78) = 327.14, p < .001, RMSEA = 0.052, NNFI = 0.97, CFI = 0.97).
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Footnote 3
 Based on the subpopulations male and female, the fit of the scalar invariance model is 
acceptable (RMSEA = 0.055) to good (NNFI = 0.96; CFI = 0.97; c2 (71) = 323.87, p < .001). 
Also the multigroup confirmatory factor analyses based on age groups showed an acceptable 
(RMSEA = 0.052) to good fit (NNFI = 0.97; CFI = 0.97; c2 (72) = 296.58, p < .001) for the scalar 
invariance model. The pattern of completely standardized factor loadings and correlations 
between the factors for the separate groups (male versus female and young versus old) were 
fairly similar to the loadings and correlations in the patient and control group. 
Footnote 4
 The fit of the scalar invariance model across the different age groups is acceptable 
(RMSEA = 0.069, NNFI = 0.89; CFI = 0.91; c2 (70) = 510.34, p < .001). Also the fit of the scalar 
invariance model based on gender showed an acceptable fit (RMSEA = 0.064, NNFI = 0.91; CFI 
= 0.93; c2 (70) = 440.79, p < .001).
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Social characteristics and care needs of older persons with 
medically unexplained symptoms: a case-control study.
Hanssen, D.J.C., Oude Voshaar, R.C., Naarding, P., Rabeling-Keus, I.M., Olde Hartman, T.C., & 
Lucassen, P.L.B.J. (2016). Social characteristics and care needs of older persons with 
medically unexplained symptoms: a case-control study
Family Practice, 33(6), 617-625.
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Abstract
Research in younger patients with Medically Unexplained Symptoms (MUS) has shown 
impairments in social functioning, such as loneliness and a reduced quality of the 
patient-doctor relationship. As far as we know, no studies have been performed on 
social functioning in older MUS patients; self-reported care needs of older MUS patients 
remain unknown. The objective of the current study is to explore social characteristics 
and care needs of older persons with chronic MUS, when compared to older persons 
with chronic Medically Explained Symptoms (MES). Patient characteristics of 107 older 
persons (>60 years) with chronic MUS were compared to 150 older persons with chronic 
MES in a case-control design. Participants were recruited via advertisements, general 
practices and a specialized clinic. All participants completed questionnaires on social 
functioning; the Camberwell Assessment of Need for the Elderly was used to draw up 
care needs. Linear regression analyses were performed to explore the association 
between social characteristics and group (MUS/MES), adjusted for demographic and 
physical determinants. Multiple chi-square tests were performed to detect between-
group differences regarding care needs. After adjustments, older MUS patients were 
slightly but significantly lonelier, reported a somewhat lower quality of their patient-
doctor relationship, but reported equal social support levels when compared to 
MES patients. MUS patients more often reported unmet care needs regarding health 
and information provision about their health status. Only small differences in social 
functioning were found between older MUS- and MES patients. Possibly, training future 
doctors in giving acceptable explanations for the patient’s complaints could improve 
the unmet care need of information provision in older MUS patients.
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Introduction
 Medically Unexplained Symptoms (MUS) – physical symptoms for which no (sufficient) 
somatic cause can be found after adequate medical examination (Olde Hartman et al., 2013) 
- are common in later life, with prevalence estimates between 4.6 and 18 percent in a general 
population of 65 years and older (Hilderink et al., 2013). A recent pilot study has shown 
that MUS in later life are particularly complex because of frequent psychiatric comorbidity 
-especially with depressive, anxiety and substance related disorders (Hilderink et al., 2009)- 
and because of their mixture with explained physical symptoms (Benraad et al., 2013). 
 Apart from this pilot study (Hilderink et al., 2009; Benraad et al., 2013), little research 
has been performed on late-life MUS. Research in comparatively younger patient groups 
has shown that MUS are associated with negative consequences, such as a decreased 
health-related quality of life (HRQoL; e.g. Dirkzwager & Verhaak, 2007). Also, having MUS is 
associated with negative physical (e.g. Carson et al., 2000) and psychological outcomes (e.g. 
Deary et al., 1997). In addition, younger adults with MUS report higher levels of loneliness 
(Dirkzwager & Verhaak, 2007) when compared to other frequently attending primary care 
patients. Some MUS patients report a deficiency of social support (Nettleton, 2006), as well as 
a problematic patient-doctor relationship (Page & Wessely, 2003). Hence, in younger adults, 
MUS are not only associated with physical and psychological characteristics, but with social 
characteristics as well. 
 As far as we know, there are no research findings available regarding social characteristics 
of older MUS patients. This is unfortunate, as we know that the quality and size of the social 
network change with increasing age (Carstensen, 1995), resulting in a higher risk for loneliness 
(Savikko et al., 2005). Also, the presence of (symptoms of) psychiatric disorder is found to be 
associated with negative social outcomes in later life (e.g. Barg et al., 2006). In turn, negative 
social characteristics, such as loneliness and social isolation, are associated with poor health 
status and mortality in older persons (e.g. Luo et al., 2012), which underlines the importance 
of exploring social characteristics in older MUS patients. 
 Furthermore, because of the assumed complex interplay between physical, 
psychological, and social difficulties in older MUS patients –the biopsychosocial model 
(Engel, 1977) of late-life MUS- it is rather challenging to determine what care needs are 
most prominent in this patient group. However, since MUS patients are among the most 
costly patient groups in our health care system (Reid et al., 2002), tailored care programs 
for older MUS patients are needed. As far as we know, no studies have focused on self-
reported care needs of MUS patients. Nevertheless, some previous studies (e.g. McNulty et 
al., 2003) have demonstrated the importance of exploring care needs in older psychiatric 
patient groups apart from exploring care needs in younger patients. Knowledge about social 
characteristics and unmet care needs of older MUS patients could furthermore contribute to 
the development of new interventions for this patient group, which are necessary to improve 
reduced levels of perceived HRQoL in this patient group (e.g. Hilderink et al., 2015). 
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 Physicians might act with restraint in classifying symptoms as unexplained out of 
fear of missing a somatic explanation (Hilderink et al., 2013). Since medically explained 
symptoms (MES) is an important differential diagnosis in clinical practice, interpretation of 
the characteristics of older persons with MUS against a sample of older patients with MES 
seems relevant. Therefore, in this hypothesis-generating study, we aim to explore social 
characteristics of older persons with chronic MUS, when compared to older persons with 
chronic MES. Our second aim is to explore the (un)met care needs of older persons with MUS 
versus older persons with chronic MES. 
Methods
Study design
 The Older Persons with medically Unexplained Symptoms (OPUS) study aims to explore 
biopsychosocial determinants of late-life MUS and to develop suitable treatment programs 
for late-life MUS. One part of this study concerns a case-control study, in which 118 older 
persons (>60 years) with chronic MUS (cases) are compared to 154 older persons with chronic 
MES (controls). 
 In accordance with the definition of MUS provided by the Dutch College of General 
Practitioners, all older persons with MUS had unexplained physical symptoms for at least 
3 months, or a combination of unexplained and explained physical symptoms for at least 3 
months (Benraad et al., 2013) as confirmed by their general practitioner (GP) and/or medical 
specialist. All older MES patients had an evident physical diagnosis -such as asthma, COPD, 
or rheumatoid arthritis- that was confirmed by the patient’s GP and was present for at 
least 3 months. Exclusion criteria for both the cases and the controls were 1) the presence 
of a primary psychotic disorder; 2) cognitive impairment, defined as an Mini Mental State 
Examination (MMSE; Folstein et al., 1975) score < 19 or a clear diagnosis of dementia; 3) 
terminal illness; 4) not sufficiently speaking and/or understanding Dutch; 5) auditory and/or 
visual limitations that could hinder data collection. 
 Patients were recruited in primary care (via advertisements and via six general 
practices), and in specialized mental health care (a specialized clinic for late-late MUS). The 
six general practices (convenience sample) were located in both rural and urban settings in 
the Netherlands and accommodated a total of 13 GP’s. Participants from primary care were 
selected based on the frequency of visiting their general practitioner, in accordance with 
earlier research on highly utilizing patient groups (e.g. Katon et al., 2001; Smits et al., 2009). 
After selection via this frequent attenders method, the GP manually selected participants 
that fulfilled the definition of MUS and MES and checked the exclusion criteria.
 Older persons with MUS were offered a multidisciplinary screening at the specialized 
clinic for late-life MUS, consisting of a screening by a geriatrician, an old-age psychiatrist, and 
a psychologist. Afterwards, these MUS patients were visited at home by a researcher in order 
to assess social characteristics, cognitive functioning, and care needs. If older persons with 
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MUS were not able to or were unwilling to take this screening (40.7%; N=48), they were offered 
two home-visits during which a researcher assessed all measures. Likewise, all controls were 
offered two appointments at their own homes to assess all measures. A total of 107 persons 
with MUS (90.7%) and 150 persons with MES (97.4%) completed the questionnaires regarding 
social characteristics and care needs. 
 The OPUS study was approved by the local Medical Ethics Committee. All participants 
signed an informed consent form prior to the first interview. A local feasibility certificate was 
issued by the specialized clinic for late-life MUS. 
Measures
General measures
 Demographic variables were the participant’s age (in years) at moment of inclusion, 
gender, and (lower, average, higher) level of education. The severity of somatic comorbidity 
was measured using the self-report version of the Charlson Index (Charlson et al., 1987). 
This questionnaire aims to assess 16 categories of somatic comorbidities, such as diabetes, 
congestive heart failure, and cancer, using yes/no questions. When scoring this questionnaire, 
weights based on the risk of mortality are assigned to each of these categories (Charlson et 
al., 1987), resulting in a score that reflects the severity of somatic comorbidity, with higher 
scores indicating more severe somatic comorbidity. Also, the MMSE (Folstein et al., 1975) was 
assessed to get an overall impression of cognitive functioning for each patient. This measure 
consists of questions and assignments to explore several areas of cognitive functioning, such 
as executive functioning and working memory. A higher total score (range 0-30) indicates 
better cognitive functioning. The presence of co-morbid mood- and/or anxiety disorders 
according tot DSM-IV-TR criteria (Sheehan et al., 1998) was measured using a semi-structured 
interview: the Mini International Neuropsychiatric Interview (MINI, version 5.0; Sheehan et al., 
1998). In the current study, we classified the specific DSM-IV-TR diagnoses into the presence 
of a mood disorder (major depressive disorder, and/or dysthymia) and the presence of an 
anxiety disorder (panic disorder, agoraphobia, social phobia, obsessive-compulsive disorder, 
posttraumatic stress disorder, and/or general anxiety disorder). 
Measures of social characteristics
Loneliness
 The Loneliness Scale (De Jong-Gierveld & Kamphuis, 1985) was used to assess levels of 
loneliness - a lack of (quality of) social relationships - in all participants. This scale, designed 
for measuring loneliness in scientific research settings, consists of 11 items with response 
alternatives ‘no’ (score 0), ‘more or less’ (score 1), and ‘yes’ (score 1). The scores on the 11 
items are combined into one score, after mirroring the scores of the six items that were 
negatively formulated, resulting in a sum score with a maximum score of 11; higher sum 
scores indicate higher levels of loneliness. 
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Need for affiliation 
 The six-item version of the Need for Affiliation Scale (Van Tilburg, 1988) was assessed 
as a measure for the participant’s need for engaging in social relationships. Response 
alternatives are ‘no’ (score 0), ‘more or less’ (score 1), and ‘yes’ (score 1). Two items were 
negatively formulated. Therefore, these scores were mirrored before calculating the sum 
score (maximum score: 6). A higher score indicates a higher need for social affiliation. 
Quality of patient-doctor relationship
 The Patient-Doctor Relationship Questionnaire (PDRQ-9; Van der Feltz-Cornelis et al., 
2004) was used to assess the quality of the relationship between the participant and his/her 
GP. This nine-item questionnaire has response alternatives from 1 (‘not at all) to 5 (‘fully 
agree’). A total score was calculated by adding the scores on all individual items, resulting in 
a maximum score of 45 points. A higher total score indicates a better relationship between 
the participant and his/her GP. 
Social network size
 The social network size was assessed with the question: ‘With how many family 
members, friends, and close acquaintances do you have frequent and important contact? 
Only count persons of 18 years and older, and don’t take household members into account’. 
Response categories were ‘0-1’, ‘2-5’, ‘6-10’, ’11-15’, ’16-20’, and ‘more than 20’.  
Social support
 A slightly adapted version of the Close Persons Questionnaire (CPQ) (Stansfeld & 
Marmot, 1992) was assessed to explore the quality of social support received from the partner 
(if present) and the quality of social support received from the closest friend or family member 
(if present). The complete test consists of 20 items (10 partner-questions and 10 closest friend/ 
family member questions), with five response alternatives each (1 = ‘never’ to 5 = ‘very often’). 
 Sum scores for the social support subscales are calculated separately for the partner 
questions and the closest friend/family member questions, resulting in 8 sum scores for the 
following subscales: emotional support (4 items, score range 4-20), practical support (2 items, 
score range 2-10), negative experience (2 items, score range 2-10), and inadequacy of support 
(2 items, score range 2-10) received from respectively the partner or the closest friend/family 
member. Higher scores indicate, respectively, more emotional support, more practical 
support, more negative experiences and a higher inadequacy of support. 
Care needs
 The Camberwell Assessment of Need for the Elderly (CANE; Reynolds et al., 2000) 
was designed to explore the care needs of older persons with mental problems. With this 
assessment tool, 24 domains of care needs were explored, such as: Does the participant 
have an appropriate place to live? (‘accommodation’); Does he/she get treatment for present 
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physical complaints? (‘physical health’); Does the participant get enough information 
about his/her health status and treatment? (‘information’); Does he/she feel psychological 
distressed? (‘psychological distress’); Does he/she experience a lack of company (‘company’) 
or intimacy (‘intimate relationships’)?. 
 For each domain, a researcher asked the participant to answer multiple, pre-printed, 
open questions in order to explore whether there is either no current care need on that 
specific domain, a met care need, or an unmet care need, according to the patient. In this 
way, we made an overview of unmet care needs of older persons with MUS and MES. 
Statistical analyses
 First, we generated descriptive statistics -mean scores and standard deviations or 
percentages- for demographic, physical, psychological, and social characteristics. We 
performed t-tests for independent samples for the continuous variables and chi-square tests 
for categorical variables to explore between-group differences. 
 Multiple linear regression analyses were performed to explore the association between 
‘group’ (MUS/MES) and social characteristics (loneliness, affiliation, quality of the patient-
doctor relationship, social support from partner, social support from the closest friend/
family member), adjusted for demographic (age, gender, education) characteristics and the 
level of cognitive functioning. Education was dummy coded (2 dummies) before entering it 
into the regression models. Also, multiple linear regression analyses were performed with 
additional correction for the level of somatic comorbidity, as it is known that late-life MUS 
is often presented as a mixture between medically unexplained and medically explained 
physical symptoms (Benraad et al., 2013). Last, the regression analyses were repeated with 
additional correction for psychological diagnoses (the presence of a mood disorder and 
the presence of an anxiety disorder). As none of the outcome variables were convincingly 
normally distributed and transformation of these variables did not improve the normality of 
the distributions, we performed bootstrapping (1000 samples) to generate bias corrected and 
accelerated confidence intervals and p-values for the regression coefficients, which do not 
rely on the assumption of normality (Wright et al., 2011). As we have a reasonable sample size 
and the conclusions about the effects of group based on the bootstrapping procedures were 
similar to those of the regression analyses, in the current paper we choose to present only 
the results of the linear regression analyses. For all regression analyses, b-values, standard 
errors, standardized b-values, and p-values will be reported for the relevant predictor ‘group’. 
R2-values will be reported for all models. 
 The total number of unmet care needs was counted, and its between-group difference 
was tested using an independent samples t-test. To assess whether or not there were 
differences between older MUS and MES patients regarding (un)met care needs, chi-square 
tests were performed for most care need domains of the CANE (Reynolds et al., 2000). Fisher’s 
exact tests were performed for those domains that had expected values below five in one or 
more cells. 
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 For most statistical tests, a difference was regarded statistically significant when the 
corresponding p-value was smaller than the significance level of .05. For the statistical tests 
about care needs, p-values smaller than .002 were regarded as statistically significant, as 
a result of a Bonferroni correction for multiple testing (significance level α divided by the 
number of tests=.05/24). 
 All statistical analyses were performed using IBM SPSS version 20.
Results
General sample characteristics 
 General characteristics of older MUS patients versus older MES patients are presented in 
table 1. Older persons with MUS were approximately three years younger than older persons 
with MES (t(255) = -3.23; p = .001) and were more often female (c2(1) = 10.90; p = .001). Older 
MUS patients reported slightly less somatic comorbidity than older MES patients (t(252) = 
-2.20;  p = .029), but report a higher percentage of co-morbid anxiety disorders (c2(1) = 5.51; 
p = .019). The primary physical complaints of older MUS- and MES patients are presented in 
Table 2. 
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Table 1: Patient and social characteristics of the study sample, consisting of older persons with MUS 
(n=107) and older persons with MES (n=150) that were recruited between September 2011 and March 
2014 in primary and secondary care institutions.
 
 
 
 
Characteristics
Maximum 
score
Cases
Older 
persons 
with MUS
(n=107)
Controls
Older 
persons 
with MES
(n=150)
p 
valuea 
Patient 
characteristics
 
Age
 
Mean (SD)
 
70.33 (6.60)
 
73.31 (7.75) 
 
.001 
Female % (n) 63.6 (68) 42.7 (64) .001
Education 
-Lower 
-Average 
-Higher
 
% (n) 
% (n) 
% (n)
 
26.4 (28) 
45.3 (48) 
28.3 (30)
 
17.6 (26) 
52.7 (78) 
29.7 (44) 
 
.223 
 
Somatic comorbidity Mean (SD) 1.20 (1.52) 1.69 (1.90) .029
Cognitive 
functioning
30 Mean (SD) 28.16 (2.13) 28.19 (1.90) .910
Presence of a mood 
disorder
% (n) 25.2  
(27) 
20.1  
(30)
.333
Presence of an 
anxiety disorder
% (n) 17.8  
(19)
8.1  
(12)
.019
Social 
characteristics
Social network size 
- 0-1 persons 
- 2-5 persons 
- 6-10 persons 
- 11-15 persons  
- 16-20 persons 
- > 20 persons
 
% (n) 
% (n) 
% (n) 
% (n) 
% (n) 
% (n)
 
5.7 (6) 
20.8 (22) 
17.0 (18) 
15.1 (16) 
10.4 (11) 
31.1 (33)
 
0.7 (1) 
12.8 (19) 
16.1 (24) 
14.8 (22) 
14.8 (22) 
40.9 (61)
 
 
 
 
 
.059
Loneliness 11 Mean (SD) 3.19 (3.40) 2.20 (2.52) .008
Affiliation 6 Mean (SD) 3.22 (1.84) 3.01 (1.74) .373
Quality of the 
patient-doctor 
relationship 
45
Mean (SD)
36.84 (7.98) 39.86 (7.14) .002
Partner: Partner present % (n) 66.0 (70) 61.6 (90) .474
Emotional support 20 Mean (SD) 15.45 (2.93) 16.26 (2.78) .078
Practical support 8 Mean (SD) 6.36 (3.00) 6.19 (3.05) .729
Negative support 
experiences 
8 Mean (SD) 3.97 (1.85) 3.46 (1.77) .076
Inadequacy of 
support 
8 Mean (SD) 2.85 (1.70) 2.49 (1.22) .116
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Important 
other:
Important friend/
family member 
present 
% (n)
69.5 (73) 84.5 (125) .005
Emotional support 20 Mean (SD) 14.52 (2.95) 14.28 (2.84) .578
Practical support 8 Mean (SD) 5.77 (2.96) 5.63 (3.01) .746
Negative support 
experiences  
8 Mean (SD) 2.93 (1.29) 2.79 (1.29) .469
Inadequacy of 
support 
8 Mean (SD) 2.50 (1.03) 2.42 (1.08) .594
a Significance values derived from independent samples t-tests, and chi-square tests
Table 2: Primary physical complaints of older persons with MUS (n=107) and older persons with MES 
(n=150).
 
 
 
Primary physical complaint
Cases
Older persons 
with MUS
(n=107)
Controls
Older persons 
with MES
(n=150)
Pain % (n) 64.5 (69) 45.3 (68)
Dizziness % (n) 0.9 (1) 2.7 (4)
Palpitations % (n) 3.7 (4) 2.0 (3)
Shortness of breath % (n) 0.9 (1) 6.7 (10)
Constipation % (n) 1.9 (2) 1.3 (2)
Nausea % (n) 0.9 (1) .7 (1)
Fatigue % (n) 5.6 (6) 4.7 (7)
Problems with sleeping % (n) 0.9 (1) 1.3 (2)
Other physical complaints % (n) 10.3 (11) 12.7 (19)
Diffuse, fluctuating complaints % (n) 2.8 (3) -
Other % (n) 7.5 (8) 22.7 (34)
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Table 3: Exploring the associations between group (MUS/MES) and social measures, using multiple 
linear regression analyses.
Social characteristics B (SE) Beta p valuea R2
Loneliness 
Group (MUS/MES) Model 1a -.815 (.394) -.140 .039 .029
Model 2b -.795 (.394) -.137 .045 .030
Model 3c -.732 (.386) -.126 .060 .088
Affiliation 
Group (MUS/MES) Model 1a -.196 (.239) -.054 .412 .086
Model 2b -.217 (.242) -.059 .370 .088
Model 3c -.223 (.244) -.061 .361 .091
Quality of the patient-doctor  
relationship
Group (MUS/MES) Model 1a 2.895 (1.033) .187 .005 .052
Model 2b 2.979 (1.048) .191 .005 .053
Model 3c 2.793 (1.052) .179 .009 .068
Emotional support (partner)d 
Group (MUS/MES) Model 1a .743 (.482) .128 .125 .081
Model 2b .643 (.491) .110 .193 .084
Model 3c .680 (.490) .117 .167 .106
Practical support (partner)d 
Group (MUS/MES) Model 1a .077 (.495) .013 .876 .120
Model 2b -.101 (.497) -.016 .840 .158
Model 3c -.127 (.498) -.021 .798 .170
Negative support experiences 
(partner)d 
Group (MUS/MES) Model 1a -.380 (.314) -.102 .229 .048
Model 2b -.393 (.319) -.105 .221 .057
Model 3c -.390 (.314) -.104 .217 .102
Inadequacy of social support 
(partner)d 
Group (MUS/MES) Model 1a -.262 (.248) -.088 .292 .075
Model 2b -.266 (.251) -.089 .291 .084
Model 3c -.284 (.247) -.096 .252 .126
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Emotional support (close 
friend/family member)e 
Group (MUS/MES) Model 1a .130 (.453) .022 .774 .084
Model 2b .137 (.460) .023 .767 .084
Model 3c .102 (.465) .017 .827 .087
Practical support (close friend/
family member)e 
Group (MUS/MES) Model 1a -.245 (.492) -.039 .620 .023
Model 2b -.324 (.495) -.051 .514 .044
Model 3c -.318 (.498) -.050 .524 .053
Negative support experiences 
(close friend/family member)e
Group (MUS/MES) Model 1a -.050 (.207) -.019 .810 .042
Model 2b -.098 (.208) -.036 .640 .062
Model 3c -.058 (.207) -.022 .779 .093
Inadequacy of social support 
(close friend/family member)e
Group (MUS/MES) Model 1a .009 (.169) .004 .958 .041
Model 2b -.002 (.171) -.001 .990 .042
Model 3c .007 (.172) .003 .967 .052
a Adjusted for socio-demographic variables (age, gender, education) and MMSE total score
b Adjusted for socio-demographic variables (age, gender, education), MMSE total score and somatic comorbidity
c Adjusted for socio-demographic variables (age, gender, education), MMSE total score, somatic comorbidity and 
psychiatric comorbidity 
d Only assessed for those persons with a partner
e Only assessed for those persons with a close friend/family member
Social characteristics of older MUS patients versus older MES patients
 Older MUS patients reported higher levels of loneliness (t(255) = 2.67; p = .008) and 
a lower quality of the relationship with their GPs than older MES patients (t(253) = -3.17; p 
=.002). Older MUS patients did not differ from older MES patients regarding levels of affiliation 
(t(255) = 0.89; p =.373). The social network size was not statistically different, but showed a 
difference at trend-level (c2(5) = 10.66; p = .059), indicating older MUS patient possibly have a 
smaller social network than older MES patients (table 1).
 About 60-65 % of both the MUS- and the MES patients had a partner. Social support 
received from their partners (t(157) = -1.77; p = .078) and negative support experiences (t(157) 
= 1.78; p = .076) did not statistically differ between both groups, but showed a difference at 
trend-level. No between-group differences were found for levels of practical partner support 
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(t(155) = 0.35; p = .729), and inadequacy of social support received from the partner (t(157) = 
1.58; p = .116) (table 1). 
 MUS patients less often had a close friend or family member as compared to MES 
patients (c2(1) = 8.05; p = .005). Nevertheless, if a close friend/family member was present, 
MUS- and MES patients did not differ regarding perceived emotional support (t(193) = 0.56; p 
= .578), practical support (t(191) = 0.32; p = .746), negative support experiences (t(195) = 0.73; 
p = .469), and levels of inadequacy of support (t(195) = 0.53; p =.594) received for that closest 
friend/family member (table 1).
 When adjusted for demographic variables, somatic comorbidity and cognitive 
functioning, the associations between group (MUS/MES) and the quality of the patient-
doctor relationship (beta=0.191, p=.005, R2=.053) and the relation between group (MUS/
MES) and loneliness (beta=-0.137, p=.045, R2=.030) remained statistically meaningful. After 
additional corrections for psychological diagnoses, only the relation between group (MUS/
MES) and the quality of the patient-doctor relationship (beta=.179,p=.009,R2=.068) remained 
statistically meaningful (table 3). 
(Un)met Care Needs of older MUS patients versus older MES patients
 Percentages of (un)met care Needs are presented in Table 4. Overall, older MUS patients 
reported approximately one unmet care need more than older MES patients (t(249) = 4.82; 
p<.001).  
 Older persons with MUS more often reported the unmet care needs ‘physical health’ 
(c2(1) = 26.15; p<.001), and ‘information about health status and treatment’ (c2(1) = 11.90; p = 
.001) than older persons with MES. The care need ‘psychological distress’ showed between-
group differences at trend-level (c2(1) = 10.04; p = .002). 
CHAPTER 10
172
Table 4: Unmet care needs of older persons with Medically Unexplained Symptoms (MUS) (n=107) 
and older persons with Medically Explained Symptoms (MES) (n=150).
Care need
% (n) 
Older persons 
with MUS with 
unmet care need
(n=107)
% (n) 
Older persons 
with MES with 
unmet care need
(n=150)
p-value
Environmental Accommodation 8.6 (9) 5.4 (8) .322a
Food 2.9 (3) 2.7 (4) .941b
Household skills 10.5 (11) 4.7 (11) .080a
Money 1.0 (1) 1.4 (2) 1.000b
Benefits 8.6 (9) 4.7 (7) .216a
Caring for someone else 1.0 (1) 1.4 (2) 1.000b
Physical Physical health 32.4 (34) 7.4 (11) <.001a
Medication 6.7 (7) 5.4 (8) .767a
Eyesight/hearing 11.4 (12) 4.7 (7) .046a
Self-care 0.0 (0) 0.0 (0) -
Continence 3.8 (4) 2.0 (3) .454b
Mobility 3.8 (4) 2.0 (3) .454b
Psychological Psychological distress 14.3 (15) 3.4 (5) .002a
Memory 15.2 (16) 8.8 (13) .112a
Behavior 1.0 (1) 0 (0) .415b
Alcohol 1.9 (2) 0.7 (1) .572b
Deliberate self-harm 2.9 (3) 0.7 (1) .310b
Accidental self-harm 1.0 (1) 0 (0) .415b
Psychotic symptoms 1.0 (1) 0.7 (1) 1.000b
Social Information 18.1 (19) 4.7 (7) .001a
Daytime activities 4.8 (5) 4.1 (6) .766b
Abuse/neglect 0 (0) 0.7 (1) 1.00b
Company 15.2 (16) 8.8 (13) .112a
Intimate relationships 14.3 (15) 7.4 (11) .077a
a Significance values derived from chi-square tests
b Significance values derived from Fisher’s exact tests
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Discussion
Summary
 Both MUS- and MES patients reported relatively low levels of loneliness and were 
reasonably satisfied with the quality of the relationship with their GP. Yet, MUS patients 
reported higher levels of loneliness and a lower quality of the relationship with their GP than 
older MES patients. When taking into account co-morbid depressive and anxiety disorders, 
only the association between MUS and the quality of the GP-relationship remained 
statistically significant. However, all proposed models only explained a small amount of the 
variance, strengthening the idea that the observed differences might be statistically, but not 
clinically meaningful. No differences between MUS patients and MES patients were found 
regarding affiliation and social support measures. 
 Even though older MUS patients reported slightly less somatic comorbidity than the 
older MES patients, MUS patients more often reported unmet care needs in the field of 
physical health. Furthermore, MUS patients more often reported unmet care needs regarding 
psychological distress and information about health status and treatment. 
Comparison with existing literature 
 Overall, the results of the current study are in line with previous studies (Dirkzwager & 
Verhaak, 2007; Hilderink et al., 2015) focusing on HRQoL that show (older) MUS patients report 
comparable or even lower HRQoL scores than comparison groups, such as other frequently 
attending primary care patients. These studies suggest that (older) MUS patients are equally 
or stronger affected in daily life by their physical complaints than older patients with MES. 
The current study confirms and extends these findings by showing that social differences are 
comparable to a great extent between both groups, except from levels of loneliness and the 
quality of the patient-doctor relationship.  
 In line with a study in younger MUS patients (Dirkzwager & Verhaak, 2007), the older 
MUS patients felt somewhat lonelier than the older MES patients. Many previous studies have 
shown that loneliness is associated with psychiatric disorders in later life (e.g. Barg et al., 
2006), suggesting that loneliness could be an important determinant or even a risk factor for 
late-life psychopathology. Further research is needed to investigate the causal relationship 
of the association between loneliness and late-life MUS. 
 Not surprisingly, older MUS patients were somewhat less satisfied with the help of their 
GPs than older MES patients, which is in line with research in younger adults (Page & Wessely, 
2003). Previous studies have found that GPs experience problems with control and authority 
during consultation with MUS patients (Wileman et al., 2002). Specifically, GPs feel pressured 
to offer medical examinations and treatment (Salmon et al., 2005), even when MUS patients 
do not request these medical referrals (Ring et al., 2004). If MUS patients do not wish to get 
medical referrals, what do they want from their GPs then?
 The current study indicates that provision of information about their health status 
is important for older MUS patients, which is in line with a previous study on older adults’ 
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(primary) care preferences (Bastiaens et al., 2007). Training and educating GPs and medical 
specialists in giving proper explanations for the patients’ MUS, and recognizing and explaining 
their possible comorbid physical and mental complaints could be the first step in meeting 
this care need. 
Strengths and limitations
 As far as we know, the current study is the first to compare social characteristics and care 
needs between older MUS- and MES patients. With this, we contribute to the research about 
biopsychosocial determinants of MUS in general, and specifically to a better understanding 
of determinants and consequences of MUS in later life. 
 To interpret our results correctly, however, several study limitations should be taken 
into account. As mentioned before, even though we have found a few statistically meaningful 
differences between older MUS- and MES patients, the actual between-group differences are 
small, hereby questioning the clinical relevance of the differences. In addition, data may be 
somewhat clustered, as we have recruited most participants in general practices. As a result, 
the current findings should be interpreted cautiously, in particular because of our relatively 
small sample size. Nonetheless, as far as we know, ours is the largest study in which older 
MUS patients are phenotyped extensively by a multidisciplinary team. Third, because of 
the sensitive nature of research topics such as loneliness, participants might be inclined 
to give socially desirable responses during the interviews, possibly resulting in decreased 
validity of our measurements. By visiting our participants at home and thereby making 
the participants feel comfortable during the interviews, however, we have tried to limit the 
negative consequences of socially desirable responding. Moreover, even though we recruited 
patients across several settings (population, primary care, specialized health care), the study 
sample is a convenience sample, which could restrict generalizability of our findings. 
Implications for research and/or practice
 Previous research has shown that older MES patients and depressed older adults can 
benefit from psychosocial interventions. As older MUS patients report slightly higher levels of 
loneliness compared to MES patients, our results suggest that MUS patients could possibly 
benefit from psychosocial interventions as well. A meta-analysis focusing on the treatment 
of loneliness showed that addressing maladaptive social cognition resulted in the most 
effective treatment of loneliness (Masi et al., 2010). A recent review showed that the currently 
available psychosocial interventions for (younger) MUS patients have not yet proved to be 
beneficial (Allen et al., 2002); however, -as far as we know- none of them specifically focused 
on addressing maladaptive social cognitions, which could be an interesting focus for future 
treatment of late-life MUS, assuming future studies will confirm the finding of more loneliness 
in older MUS patients. Furthermore, loneliness is typically more severe in older age, leaving 
more room for improvement. Evaluating the effect of psychosocial interventions on, for 
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example, HRQoL of older MUS patients could be one next step in establishing an evidence-
based treatment program for older MUS patients. 
 Furthermore, the current study shows that older MUS patients feel like they do not 
get enough information about their health status, indicating current (primary) health care 
is possibly insufficient for older MUS patients. Even more important, after correction for 
somatic and psychological comorbidity, older MUS patients still reported a lower quality 
of the patient-doctor relationship than older MES patients. These results are in line with 
literature focusing on MUS and difficulties in consultation. For instance, one study showed 
that GPs experience difficulties in structuring a MUS-consultation, with the result that 
beliefs and concerns of MUS patients are insufficiently explored during consultation (Olde 
Hartman et al., 2013). Also, chronic pain research indicates that doctors stigmatize patients 
with unexplained chronic pain (Williams, 2016; De Ruddere & Craig, 2016). The current study 
points out that difficulties during consultation and stigmatizing MUS patients may also be 
relevant in consultation with older MUS patients. As treatment programs for late-life MUS 
patients are limited, optimizing non-specific treatment effects seems one way to improve 
treatment outcomes for late-life MUS. Therefore, future research could be aimed at gaining 
a better understanding of communication styles between older MUS patients and their GPs, 
in order to develop suitable training programs for professionals. Especially in vulnerable 
and worrying patients such as older MUS patients a patient-centered approach -including 
adequate patient-doctor communication, mutual decision-making and health promotion 
(Little et al., 2001)- seems necessary. 

11.
Summary and General discussion.
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Summary of the findings & integration with previous research
 In this dissertation, we have first explored the association between general functioning 
and Medically Unexplained Symptoms (MUS) in later life. Subsequently, we have studied 
biopsychosocial determinants and patient characteristics of older persons with MUS. Indeed, 
knowledge about the biopsychosocial model of late-life MUS can inspire us to develop future 
treatments for this patient group. 
General functioning and medically unexplained symptoms in later life: 
Health-related quality of life and meaning in life
Health-related quality of life 
 A comparison between 118 older patients (60 years and over) who suffered from MUS 
for at least three months and 154 older patients with chronic Medically Explained Symptoms 
(MES) showed that the former report a significantly lower Health-Related Quality of Life 
(HRQoL), as measured by the Short-Form 36 (Chapter 2). Interestingly, the difference was 
found for both physical and mental HRQoL. Older MUS patients thus experience a higher 
physical burden of their complaints than older MES patients, of whom it is widely accepted 
that their complaints interact with daily life functioning (e.g. Halbert et al., 2006; Kempen et 
al., 1997; Gorecki et al., 2009; Oster et al., 2005; Dominick et al., 2004). 
 Among MUS patients, both a lower mental and a lower physical HRQoL were associated 
with more hypochondriac cognitions and higher somatization levels. Moreover, all 
differences in HRQoL between MUS- and MES patients disappeared when the analyses were 
additionally adjusted for hypochondriac cognitions and somatization (Chapter 2). Previous 
studies have consistently found that HRQoL (in later life) is decreased in the presence of 
psychiatric diseases like depression or anxiety disorders (e.g. Spitzer et al., 1995; Rapaport 
et al., 2005; Alonso et al., 2004; Bourland et al., 2000). In our study, however, the differences 
between MUS- and MES patients remained significant when adjusted for the presence of a 
depressive disorder. Furthermore, the differences in HRQoL between the older MUS patients 
and older MES patients could (at least partially) be explained by the presence of worrying 
and anxiety about having a physical disease and/or by misinterpretation of physiological 
sensations, which is in line with research on somatization and HRQoL in younger MUS 
patients (Luscombe, 2000) and older adults (Sheehan et al., 2005). Moreover, our findings are 
in line with DSM-5 (APA, 2013) which, contrary to the DSM-IV-TR (APA, 2000), abandons the 
distinction between medically unexplained and explained symptoms, but instead focuses on 
positive criteria, such as disproportionate thoughts about having a serious physical disease. 
 In Chapter 3 we have studied the course of HRQoL in older MUS-and MES patients. 
HRQoL significantly decreased over time in both older MUS- and MES patients, which is 
consistent with studies conducted in relatively younger MUS patients (Ternesten-Hasséus 
et al., 2007, Hansen et al., 2011). In our sample, mental HRQoL of MUS patients at follow-
up is predicted by biopsychosocial characteristics -specifically somatic comorbidity, health 
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anxiety and loneliness- whereas in older MES patients the level of cognitive functioning and 
severity of depressive symptoms were predicting HRQoL at follow-up. 
 Our findings are in line with studies conducted in younger MUS patients. In relatively 
younger adults, lower educational level, unemployment, mental health problems, more use 
of antidepressant medications and somatic attributions for the symptoms were associated 
with increased symptoms of fatigue over time, whereas older age, somatic attributions 
and current depressive symptomatology predicted poorer general functioning over time 
(Schmaling et al., 2003). On the other hand, improvement in psychological symptoms as well 
as the absence of physical examination signs predicted recovery of general dysfunctioning 
in younger chronic fatigue patients (Russo et al., 1998). To our knowledge, none of these 
studies have included measures of health anxiety and loneliness, which seem relevant 
factors for predicting HRQoL over time for older MUS patients. More research on the role of 
psychological factors in recovery over time seems relevant, since patients who somatise are 
less likely to ask help from their general practitioner for emotional problems when compared 
to depressed patients (Kirmayer & Robbins, 1996). As a consequence, they are also less likely 
to receive help from specialized mental health institutions (Kirmayer & Robbins, 1996). 
Meaning in life
 In our qualitative study (Chapter 4) we explored the concept of meaning in later 
life with MUS using in-depth interviews. The participating 16 older MUS patients were 
selected using purposive sampling techniques. We found that whenever a new unexplained 
symptom arises, the person is challenged to cope with the physical complaints, resulting 
in a decreased feeling of control over life. Only those older persons that were able to find a 
personal explanation for their MUS were able to break the vicious circle of losing control over 
life. This is in line with a study that has demonstrated the mediating role of perceived control 
in the association between chronic pain and depression in later life (Turk et al., 1995).
 Interestingly, the personal explanations for the physical complaints given by the MUS 
patients were primarily psychologically focused (Chapter 4), for instance referring to the 
learning experiences in one’s personal history. MUS patients are open for a wide variety of 
explanations beyond a strict biomedical model (Chapter 4; Lidén et al., 2015). However, 
doctors experience difficulties in providing explanations for the patient’s physical symptoms 
and communicating these explanations to the patients (Olde Hartman et al., 2009). Since 
finding meaning in life is in itself is associated with positive health outcomes (Zika & 
Chamberlain, 1992; Reker et al., 1987), our findings argue for better training of physicians in 
providing personalized explanations for MUS in later life. Although not explored in the current 
study, the absence of a clear explanation for the patient’s complaints might provoke health 
anxiety, which is associated with decreased HRQoL (Chapter 2 & Chapter 3).
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Determinants and patient characteristics: 
A biopsychosocial model of medically unexplained symptoms in later life
 In 1977, Engel proposed the biopsychosocial model of disease, in which disease 
is considered the outcome of not only biological and medical determinants, but also of 
psychosocial determinants. Previous studies (Andrasik et al., 2005; Gatchel et al., 2007; 
Tanaka et al., 2011; see ‘General introduction’ for an extensive literature review) have found 
evidence for a multifactorial, biopsychosocial explanatory model of MUS in younger adults. 
In this dissertation we also find support for physical, psychological, and social determinants 
of MUS in later life. 
Physical characteristics of older patients with medically unexplained symptoms
 We first explored physical characteristics of late-life MUS, specifically focusing on the 
experience of pain. Compared to older MES patients and depressed older patients, older 
MUS patients more often suffered from chronic pain. Adjusted for demographic and somatic 
variables, the chance of having chronic pain was about two times higher in older MUS 
patients when compared to older MES patients, but comparable to depressed older persons 
(Chapter 5). Overall, pain characteristics of older persons with either MUS or depression 
were comparable, while compared to MES patients the pain was more intense and disabling. 
 The association between pain and depression has consistently been found in older 
adults (e.g. Onder et al., 2005; Chou, 2007). Katona and colleagues (2005) have hypothesized 
that chronic pain in depression could be considered medically unexplained pain. The 
similarities between chronic pain characteristics of older MUS patients and depressed 
older patients fit in with this hypothesis. Moreover, somatization in older persons is strongly 
associated with depression and only weakly with measures of physical illness (Drayer et 
al., 2005), which is in line with the lower pain intensity and disability in older MES patients. 
Among MUS patients, we found that hypochondriac cognitions as well as somatization 
were associated with a higher number of pain locations (Chapter 5). Whether treating 
hypochondriac cognitions and somatization can reduce the number of pain locations and 
increase HRQoL needs to be tested within a randomized controlled trial. 
 In chapter 6 we explored determinants of acute as well as chronic pain among 378 
depressed older persons. Acute pain was only associated with demographic variables 
and a higher level of anxiety. In contrast, chronic pain was associated with a wider range 
of biopsychosocial determinants. For instance, pain intensity was associated with a higher 
number of prescribed drugs, a higher level of depressive as well as anxiety symptoms; pain 
disability was associated with a higher number of prescribed drugs, higher body mass index 
and higher levels of anxiety. Post-hoc analyses showed that psychosocial determinants of 
chronic pain were even more dominant among the oldest-old patients (>70 years), which 
is remarkably as the prevalence of somatic multimorbidity inevitably increases with age 
(Chapter 6). 
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Psychological characteristics of older persons with medically unexplained symptoms
 Next, we have studied psychological characteristics of late-life MUS, especially 
personality characteristics and illness cognitions. 
 In general, physicians consider MUS patients as difficult patients to cope with 
(Olde Hartman et al., 2013). Therefore, MUS patients can easily be mistaken for patients 
with personality pathology. Among younger MUS patients, the prevalence of comorbid 
personality disorders has been reported to vary between 50.6% and 72%% (Bass et al., 
1995; Fink & Schröder, 2010; Rost et al., 1992; Garcia-Campayo et al., 2007; Stern et al., 1993), 
with the exception of a study that found a prevalence rate of only 4.2% (Kuwabara et al., 
2007).  Furthermore, among relatively younger somatizing patients, the level of somatization 
is associated with a higher level of neuroticism and lower level of agreeableness (Noyes et 
al., 2001; Zunhammer et al., 2013). Therefore, we explored the association between MUS 
in later life and the Big Five personality traits (openness to experience; conscientiousness; 
extraversion; agreeableness; neuroticism) (Chapter 7). 
 In our study, older MUS patients showed higher levels of neuroticism when compared 
to a primary care control group. Compared to depressed older adults, they had a significantly 
lower level of neuroticism and a higher level of extraversion, which could partly explain the 
higher tendency to seek help for their complaints. Opposite of physicians’ clinical experiences 
(Olde Hartman et al., 2013), we found no differences between older MUS- and MES patients on 
any of the Big Five Personality traits. In the combined group of older MUS- and MES patients, 
more health anxiety and higher somatization scores were associated with a higher level of 
neuroticism and a lower level of extraversion and conscientiousness (Chapter 7). Therefore, 
fear of being ill might be more relevant for the association with maladaptive personality traits 
in older adults than whether a physical symptom is medically explained or not. This is once 
again in line with the DSM-5, which abandons the distinction between medically unexplained 
and explained symptoms (APA, 2013).  
 Compared to relatively younger adults, older adults are less inclined to report cognitions 
about their complaints (Hendriks et al., 2010). Besides, illness cognitions in later life probably 
differ from younger cohorts due to both cohort as well as age effects. Therefore, in chapter 8 we 
have studied illness cognitions of older MUS- and MES patients, in the context of developing 
the extended Illness Cognition Questionnaire (ICQ-Plus). In semi-structured interviews with 
older MUS patients, many illness cognitions emerged that were not captured by the three 
dimensions of the original ICQ, i.e. helplessness, acceptance, disease benefits (Evers et al., 
2001). Although the factor structure of the original ICQ appeared to be valid in older MUS 
patients, adding additional items resulted in four new categories of illness cognitions, which 
we named ‘perseverance’, ‘illness anxiety’, ‘avoidance’ and ‘catastrophizing’ (Chapter 8). 
These categories actually refer to the cognitive (catastrophizing), physical (illness anxiety) 
and behavioural (perseverance, avoidance) aspects of anxiety. Although not tested in our 
study, these illness cognitions do not seem to be specific for older persons. 
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 Compared to MES patients, MUS patients reported higher levels of helplessness, lower 
levels of acceptance, and higher levels of health anxiety (Chapter 8). This, once again, 
confirms the importance of hypochondriacal cognitions in older MUS patients, especially 
since we found that these cognitions might be (partially) responsible for the lower HRQoL 
levels in older MUS patients compared to older MES patients (Chapter 2). 
Social characteristics of older persons with medically unexplained symptoms
 Last, we have examined social characteristics of older MUS patients. In the OPUS study, 
social support has been evaluated with a slightly adapted version of the Close Persons 
Questionnaire (CPQ). This adapted version of the CPQ was validated in a Dutch sample of 
psychiatric patients with a current mental illness and a control group, extracted from the 
Netherlands Study of Depression and Anxiety (NESDA, Penninx et al., 2008), the Netherlands 
Study of Depression in Older persons (NESDO, Comijs et al., 2011) and the OPUS sample 
(Chapter 9). Using multigroup confirmatory factor analyses, a four-factor model proved to 
be the best fitting model for the partner and close family member/friend versions of the CPQ. 
The resulting subscales -emotional support, practical support, negative support experiences, 
inadequacy of support- showed moderate to good reliability rated and proved to be valid 
measures of social support in psychiatric patients and controls (Chapter 9). 
 MUS- and MES patients did not differ on any of the social support subscales. Although 
60-65% of all older MUS- and MES patients had a partner, MES patients more often had a 
close friend or family member (84.5% compared to 69.5%). Older patients with MUS felt 
slightly lonelier than older MES patients, which is in line with research in younger MUS 
patients (Dirkzwager & Verhaak, 2007). At the same time, the association between loneliness 
and MUS was weak and, therefore, this between-group difference did not seem clinically 
relevant (Chapter 10). 
 Unsurprisingly, older persons with MUS reported a lower quality of the relationship 
with their GP than older persons with MES. Possibly the quality of the relationship is lowered 
because of experienced difficulties during the consultation (e.g. Olde Hartman et al., 2013) 
and not meeting the specific needs of older MUS patients. Indeed, in line with our results 
regarding lower mental and physical HRQoL levels in older MUS patients (Chapter 2), older 
MUS patients reported more frequently unmet care needs in the field of psychological 
distress, as well as in the field of physical health, when compared to older MES patients. 
Also, MUS patients more often had unmet care needs regarding information provision when 
compared to older MES patients (Chapter 10), which could be in line with the need for 
finding an explanation for their complaints (Chapter 4). 
Promoting health 
 Since our goal is to age as healthy as possible (World Health Organisation, 2015), we 
should stimulate older MUS patients to adapt their selves and manage their lives given 
the physical complaints (Huber et al., 2011). The current dissertation provides ideas about 
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how to promote health of older MUS patients from a biopsychosocial perspective (Wilson 
& Cleary, 1995; Ferrans et al., 2005). At the physical level, one might reduce potential 
harm of the physical complaints by adapting a psychosocial approach (e.g. Chapter 6); 
at the psychological level by encouraging a sense of coherence (Chapter 4) and learning 
how to cope with maladaptive illness cognitions (Chapter 8); finally, at the social level by 
aiming to reduce feelings of loneliness and training doctors in giving proper explanations 
and information to older MUS patients (Chapter 10). These suggestions can help create a 
multimodal treatment program for MUS (Wortman et al., 2016; Hubley et al., 2014; Pieh et al., 
2014) in later life, which is urgently needed.  
Methodological considerations
 As far as we know, the OPUS study contains the largest cohort of well-phenotyped older 
MUS patients in the world. Moreover, in the OPUS study we have combined quantitative and 
qualitative research techniques in order to answer a wide variety of research questions. With 
this mixed methods design, we were able to provide a more complete and comprehensive 
understanding of late-life MUS than could be reached by using either a quantitative or 
qualitative research design alone (Johnson & Onwuegbuzie, 2004).
 As methodological considerations of the separate studies are discussed in the previous 
chapters, the current paragraph focuses on strengths and limitations of the OPUS study in 
general. For study limitations regarding the NESDA study and the NESDO study, we refer to 
Penninx et al. (2008) and Comijs et al. (2011). 
The choice of a control group
 Most case-control studies include a control group consisting of a convenience sample 
(i.e. patients of the same clinical department without the condition) or a population-based 
sample (Mann, 2003). The OPUS control group consists of older persons with MES, which 
means these patients have one or more evident physical complaints that can be fully 
explained by the presence of at least one chronic somatic disease (e.g. asthma, rheumatoid 
arthritis). Although the choice of a control group consisting of (primarily frequent attending) 
older MES patients had several advantages -we fit in with previous studies that emphasize 
the similarities between MUS and MES (e.g. Kisely & Simon, 2006) ánd we take into account 
the increasing chances of having MES in later life-, it hampers the possibility to compare 
our results with other epidemiological research studying MUS. In particular, this might lead 
to underestimations of the effect sizes presented in this dissertation, as demonstrated in 
chapter 7. Rather, comparing our MUS patients to a non-frequent attending control group of 
MES patients, could give us a more general view on differences with MES patients, as in daily 
practice most MES patients are actually non-frequent attending patients.  
 Selection of the instruments for the quantitative case-control study was primarily 
based on suitability for an older population, availability in Dutch and adequate psychometric 
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properties. Where possible we used the same instruments for measuring relevant concepts 
(e.g. CPQ for social support) as used in the NESDO Study (Comijs et al., 2011). This enabled 
adding a second control group consisting of older persons with major depressive disorder, 
such as in chapter 5 and chapter 7. However, we do not know how many of the depressed 
older adults from the NESDO sample had a comorbid somatoform disorder, as this was not 
explicitly measured in the NESDO study. This is especially relevant as among primary care 
patients no less than an estimated 50% of patients meeting the criteria of any depressive 
disorder were diagnosed with a comorbid somatoform disorder (Mergl et al., 2007). 
Sampling bias
 Based on incidence and prevalence rates, one might argue that late-life MUS should 
best be studied in cohort studies. However, no diagnostic screeners are available for validly 
and reliably measuring late-life MUS in cohort studies, mainly because the current measures 
have considerably overlap with common geriatric symptoms (Van Driel et al., submitted). 
Therefore, a case-control design seems appropriate because of the extensive diagnostic 
procedure needed to confirm MUS in older persons.  
 The choice of a case-control design has several disadvantages, however, one of which 
is sampling bias for both cases and controls (Mann, 2003). In the current dissertation, we 
therefore used several recruitment strategies in order to select patients from all echelons 
of our health-care organization. Specially, we included patients via advertisements, via 
general practices, via a multidisciplinary clinic specialized in late-life MUS and the geriatrics 
department of our university hospital (see Chapter 2). Also, we tried to overcome sampling 
bias by adding a second control group consisting of older persons with depression from the 
NESDO cohort (Comijs et al., 2011). However, it is possible that doctors implicitly selected 
those patients for the OPUS study that were experienced as most difficult or challenging 
rather than the patients that met the criteria for inclusion best. If this is the case, outcomes 
might not be predicted by the group a patient belongs to, namely MUS patients or MES 
patients, but rather by the extent to which the doctors finds the patient difficult to deal with, 
herewith reducing the external validity (Carlson & Morrison, 2009). By using a clear definition 
of MUS (see next paragraph) and by discussing inclusion criteria with the doctor when he/she 
was in doubt, we have tried to reduce the risk of systematic errors as much as possible. 
Ecological and external validity
 Unfortunately, there is no globally accepted definition for MUS. In the OPUS study, we 
have chosen the definition of the Dutch College of General Practitioners (Olde Hartman et 
al., 2013). This is a broad definition that allows MUS to be partly unexplained, and includes 
patients that are diagnosed with functional syndromes (Olde Hartman et al., 2004; Wessely 
et al., 1999). Due to this broad definition our study population is rather heterogeneous. We 
did not only select the severe cases of MUS (and MES), but also patients with less severe 
complaints that might experience only a limited decline in general functioning. With this, 
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our study results might have high ecological validity, as our research sample reflects the 
diversity of patients in, for instance, general practices. In contrast to studies conducted in 
more specific patient groups (e.g. MUS patients visiting a neurology department (Carson et 
al., 2000); patients visiting a multidisciplinary clinic for late-life MUS (Hilderink et al., 2009)), 
our study results can be generalized to a broad group of older MUS patients, increasing the 
external validity of our study results. To explore differences between the severity grades of 
late-life MUS, however, supplementary analyses are needed. Recent research has shown that 
instead of selecting patients on the primarily physical complaint, as was the case for the 
OPUS study, counting the number of physical complaints is possibly a more valid way to 
assess health outcomes in patients with unexplained physical complaints (Tomenson et al., 
2013; Escobar et al., 2010). 
Extending the biopsychosocial model of late-life MUS
 Based on the theoretical model of Henningsen et al. (2007), we tried to measure all 
potentially relevant physical, psychological, cognitive, and social determinants of MUS. 
Nonetheless, we have ignored cultural aspects of MUS, while the experience of disease 
is at least partially determined by our cultural context (e.g. Bates et al., 1997). Although 
somatization is considered a cross-cultural mechanism (e.g. Gureje et al., 1997), styles of 
expressing distress, belief systems and the local health care system differ across cultures 
(Kirmayer & Young, 1998). As the OPUS sample consists of predominantly Caucasian people, 
we should be cautious with generalizing the present results to every older person in our 
multicultural society, 
Developing interventions for late-life MUS
 By first exploring determinants and patient characteristics of the patient group before 
developing interventions, the OPUS study fits in with the framework for the development 
and evaluation of interventions in health care, developed by the Medical Research Council 
(MRC, Campbell et al., 2000; Craig et al., 2008). The cyclical MRC framework recommends to 
first explore the theoretical background of health issues, before developing new treatment 
programs or interventions. Although not part of this dissertation, the OPUS study has used 
the MRC framework to develop interventions for late-life MUS in order to improve HRQoL 
and reduce health-care costs in older patients with MUS: 1) a consultation letter for the 
GP and older MUS patient consisting of the outcomes of a multidisciplinary screening and 
tailored treatment advices; 2) a primary care coaching group outside the medical system, 
focusing on empowerment and strengthening functional capacity of the older persons; 3) 
a psychotherapy group based on cognitive behavioural therapy and psychomotor therapy 
directed at the most serious cases of MUS. These interventions have already been evaluated 
in focus group studies (not published). Concerning the use of the consultation letter, we 
found that patients and GPs did not agree about who should initiate the conversation about 
the advices given in the letter: the doctor or the patient (Linnenbank et al., submitted). From 
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this, we learned that more attention is needed for the implementation of this consultation 
letter for late-life MUS in general practices. The other two interventions have already been 
adjusted using the feedback of the participants. To complete the MRC Framework, these 
three interventions for late-life MUS should be evaluated within randomized controlled trials 
(RCTs). Taking into account the importance of age-adapted interventions (Oude Voshaar, 
2013) and differential effects of interventions in younger and older patients with the mental 
disorders (e.g. Wetherell et al., 2013), these RCTs are urgently needed.
 Collectively, the results of the OPUS study provide a solid basis for the next step of the 
MRC framework, namely testing the developed interventions within randomized controlled 
designs. 
Implications for clinical practice
Implications for primary care
 Previous studies have shown that GPs often feel pressured to refer MUS patients for 
further medical examination during consultation (Olde Hartman et al., 2009), even though 
MUS patients mainly seek emotional support during consultation instead of further 
examination (Salmon et al., 2005). A recent meta-analysis (Rolfe & Burton, 2013) showed that, 
when doctors assess the risk of serious disease as ‘low’, further medical examinations do not 
reduce illness concern and health anxiety in the long 
and short term, suggesting medical examination does 
not reassure patients with MUS. Also, the currently 
available psychosocial interventions for MUS patients 
in primary care have not yet proved to be beneficial 
(Allen et al., 2002), and have not been evaluated for 
older MUS patients. So, what can doctors do for this 
patient group? 
 Our research implies that older patients with MUS 
could benefit from having an acceptable explanation 
for their physical complaints. Previous research has 
introduced several explanatory models for MUS, which 
can be used during consultation or therapy (e.g. Van 
Ravenzwaaij et al., 2010; Rief & Broadbent, 2007). 
By using these models, doctors are to some extent 
protected against faulty assumptions about MUS 
patients (Burton, 2014). Though, our results argue for a 
personalized explanation for the physical complaints. 
Doctors and therapists could start with exploring the 
patient’s own possible explanations for the physical 
Example-
Ms. K’s (74 years old) explanation 
for her physical complaints 
“Mom was an anxious woman. 
She gave me a predisposition 
for anxiety and she taught me 
to always please other people. 
Because of the sexual abuse 
by my father, I developed a 
constant sense of alertness. Also, 
I never learned about personal 
boundaries, and needed to cope 
with this all by myself, which still 
makes me very tired. At age 69, I 
needed surgery. After this, I was 
physically weak, but I still wasn’t 
able to set boundaries. I tried to 
please friends and family and, 
with this, crossed my personal 
boundaries. Also, because of my 
alertness, I got anxious about 
bodily changes. This gave me 
headaches and stomach cramps, 
which reinforced the fatigue.” 
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complaints, keeping in mind the available explanatory models from the literature (Burton, 
2013), the developmental perspective and age-related themes (such as retirement, the loss 
of significant others) that are relevant to an older age group (see text box for an example). The 
biopsychosocial characteristics of late-life MUS as described in this dissertation can also be 
useful for discussing and personalizing the explanation together with the patient, for which 
a narrative approach as described by Launer (1999) can be helpful.  We speculate that the 
patient-doctor or patient-therapist relationship can benefit from sharing one explanation 
for the physical complaints; also, ‘providing patients with an illness narrative provides 
information not only about the route into the illness but also the route out’ (p. 160; Hyland 
et al., 2016). With this, the patient might experience an increase of perceived control when 
having an acceptable explanation for the physical complaints, with all its benefits. 
 In sum, the current dissertation strengthens the idea that GPs can play an important 
role in the treatment and counselling of older MUS patients, by giving patients proper 
information about MUS and by exploring illness cognitions and consequences of MUS, in 
order to find an acceptable (biopsychosocial) explanation for the MUS. 
Treatment of severe late-life MUS
 If consultation by the GP proves to be insufficient and patients can be motivated 
for this, additional psychological treatment, such as cognitive behavioural therapy 
(CBT), could be a treatment option for older MUS patients with severe MUS, aimed at e.g. 
targeting hypochondriacal cognitions. CBT has proven to be an evidence-based treatment 
with moderate effects in younger patients with persistent MUS (e.g. Kroenke & Swindle, 
2000; Kleinstäuber et al., 2011; Malouff et al., 2008), however not when performed by the 
general practitioner (Arnold et al., 2009). According to our findings, CBT treatment should be 
adapted for older MUS patients, as illness cognitions of older MUS patients might be more 
differentiated and heterogeneous than illness cognitions in younger age groups (Chapter 
8). Furthermore, we believe CBT should be enriched with psychomotor therapy to enhance 
non-verbal learning; however, more research is needed to confirm the added value of this 
non-verbal therapy. 
 Multidisciplinary revalidation can possibly be helpful for more severe cases of (late-life) 
MUS who are difficult to motivate for psychological therapy alone. A recent study conducted 
in younger adults with chronic fatigue (Vos-Vromans et al., 2016) showed that although CBT 
and a multidisciplinary rehabilitation treatment program were both effective in increasing 
HRQoL, only the multidisciplinary treatment program was able to reduce chronic fatigue in 
the long term. Also, explorative analyses showed that older MUS patients have higher levels 
of physical frailty when compared to older MES patients (Grootaarts et al., 2016). Within the 
group of MUS patients, severity levels of MUS were positively associated with physical frailty, 
possibly implying that late-life MUS are actually reflecting physical frailty. If this is the case, 
multidisciplinary treatment seems adequate. As in chapter 6 we found that among the 
oldest old chronic pain was associated with biopsychosocial determinants, especially for the 
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oldest old MUS patients a multidisciplinary treatment programme might be of added value. 
Of course, more research is needed to test these hypotheses. 
Future directions for research on late-life MUS
 To increase knowledge of the biopsyschosocial model of late-life MUS, our current study 
should be replicated and extended with other determinants, such as measures of perceived 
control. Also, studies comparing the biopsychosocial characteristics of younger and older 
MUS patients are needed to investigate whether or not MUS is truly differently presented in 
later life. Investigating, for example, the impact of late-life MUS on informal caregivers could 
extend our knowledge about the consequences of late-life MUS. 
 As mentioned before, we developed a psychosocial intervention and a CBT treatment 
protocol for late-life MUS within the OPUS study (not part of this dissertation), based on 
the results of our case-control and qualitative study. Following the MRC Framework, our 
interventions have already been piloted; next, our interventions should be evaluated within 
RCTs. 
 Next to effectiveness at group level, more information is needed about the effectiveness 
of interventions on the individual level. Namely, even though scientific research has 
generated more and more information about determinants of MUS in general, research 
aimed at individual patient profiles could help us with achieving personalized treatment (e.g. 
Evers et al., 2014) for older MUS patients. For this, knowledge of e.g. patient profiles, gender 
differences, and age differences is needed. Also, research designs aimed at measuring and 
evaluating changes of e.g. physical symptoms over the day, week or year within one person, 
the so called ‘N-of-1 trials’, could give insight in personal fluctuations of symptoms; also, such 
trials could provide insight in whether or not a patient responds to specific therapies (Lillie et 
al., 2011). 
In conclusion
 Aurelius Arestides and Emma Bovary can easily be mistaken for flat characters: 
persons that can only complain about their physical symptoms. In the same way, doctors 
and therapists can be inclined to see older MUS patients as complaining, attention-
seeking patients (Looper & Kirmayer, 2004). In order to reduce the negative consequences 
of late-life MUS, caregivers should focus on helping patients to find an explanation for the 
unexplained physical symptoms; also, offering psychological treatment aimed at addressing 
hypochondriacal illness cognitions, if needed in a multidisciplinary setting, seems essential 
in case of severe MUS. Therefore, the results of this dissertation challenge doctors and 
therapists to see older MUS patients as round characters, who have to deal with physical, 
psychological, social and age-related changes, in the light of their own personal history of life 
events. 

12.
Samenvatting (Summary in Dutch).
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Introductie
Lichamelijke klachten waarvoor artsen na adequaat lichamelijk onderzoek geen medische 
oorzaak kunnen vinden, zijn van alle tijden. In de hedendaagse Nederlandse, medische 
literatuur noemen we dergelijke klachten ook wel Somatisch Onvoldoende verklaarde 
Lichamelijke klachten, afgekort SOLK (Olde Hartman et al., 2013). 
Als SOLK chronisch worden, kunnen ze een grote lijdensdruk teweegbrengen (Dirkzwager & 
Verhaak, 2007; Koch et al., 2007). Patiënten met SOLK voelen zich vaak onbegrepen, terwijl 
artsen het moeilijk vinden om patiënten met SOLK goed te begeleiden. Artsen voelen zich 
bijvoorbeeld ongemakkelijk bij verwijzingen naar (collega) medisch specialisten, vanuit 
het besef dat (onnodig) medisch onderzoek ook nadelen met zich meebrengt. Denk hierbij 
bijvoorbeeld aan de ongerustheid die kan ontstaan bij patiënten wanneer fout-positieve 
uitslagen gevonden worden in medisch onderzoek. Andere nadelige gevolgen van het 
inzetten van aanvullend medisch onderzoek zijn de mogelijke bijwerkingen van onnodig 
gegeven medicatie en het risico op weefselschade (Ring et al., 2005). Vanuit maatschappelijk 
perspectief, tenslotte, leidt meer medisch onderzoek tot hogere zorgkosten (Barskey et al., 
2005). Zowel patiënt, huisarts en maatschappij zijn daarom gebaat bij betere kennis over 
(begeleiding en behandeling van) SOLK. 
De afgelopen jaren is er al behoorlijk wat wetenschappelijk onderzoek gedaan naar SOLK. 
Zo heeft onderzoek bij volwassenen met SOLK onder andere laten zien dat vrouwen vaker 
last lijken te hebben van SOLK dan mannen (Verhaak et al., 2006). Ook blijkt uit onderzoek 
dat patiënten met SOLK vaker dan patiënten zonder SOLK last hebben van depressies 
en angstklachten (Barskey et al., 2005; Van Boven et al., 2011). Patiënten met SOLK lijken 
vaker alleenstaand te zijn en lijken zich vaker sociaal geïsoleerd te voelen dan mensen met 
lichamelijke klachten waar wél een medische verklaring voor gevonden wordt (Verhaak et al., 
2006; Dirkzwager & Verhaak, 2007). Er is relatief weinig onderzoek gedaan naar somatische 
factoren die kunnen samenhangen met SOLK. In de klinische praktijk wordt echter vaak 
gezien dat SOLK ontstaan na behandeling van een somatische ziekte. Samengevat ontstaat 
op basis van wetenschappelijk onderzoek en klinische indrukken het idee dat er bij SOLK 
sprake is van een complex samenspel tussen lichamelijke, psychologische en sociale 
factoren. 
Hoewel we weten dat SOLK ook op latere leeftijd vaak voorkomen (Hilderink et al., 2013), 
is hier tot op heden nauwelijks onderzoek naar gedaan. In een pilotstudie naar SOLK bij 
ouderen werd gevonden dat SOLK zich op latere leeftijd vaak presenteren als een mengeling 
van onverklaarde en verklaarde lichamelijke klachten (Benraad et al., 2013). Als er sprake is 
van een mengeling van onverklaarde en verklaarde lichamelijke klachten heeft een patiënt 
bijvoorbeeld een somatische aandoening, maar de hierbij gerapporteerde klachten zijn 
veel ernstiger dan men op basis van het ziektebeeld zou verwachten. Ook kwam in deze 
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pilotstudie naar voren dat oudere patiënten met SOLK behoorlijk vaak last hadden van een 
depressieve stoornis, een angststoornis of dat er sprake was van misbruik van middelen, 
zoals pijnmedicatie (Hilderink et al., 2009). 
In onze vergrijzende samenleving is verder onderzoek naar SOLK op latere leeftijd gewenst. 
Er zullen immers de komende jaren méér oudere volwassenen met SOLK zijn dan voorheen. 
Bedenk hierbij dat diagnostiek naar SOLK bij oudere volwassenen complexer is. Immers, met 
het ouder worden is er een toegenomen kans op somatische ziektes. Ook is de interpretatie 
van de oorzaak van de klachten moeilijker vanwege de reeds aanwezige morbiditeit en 
vanwege het gebruik van medicijnen. We weten nog niet goed wat de verschillen zijn tussen 
oudere patiënten met SOLK en oudere patiënten met verklaarde lichamelijke klachten. Ten 
slotte spelen bij het ontstaan en in stand houden van SOLK op latere leeftijd mogelijk andere 
factoren een rol dan bij jongere volwassenen. Zo is er in eerder onderzoek weinig aandacht 
geweest voor zingevingsproblemen bij patiënten met SOLK. Wetenschappelijk onderzoek 
naar de kenmerken van SOLK op latere leeftijd is nodig om deze oudere patiënten in de 
toekomst passende zorg te kunnen bieden. 
Daarom staan in dit proefschrift twee onderzoeksvragen centraal:
 
 1) Hoe functioneren oudere volwassenen met SOLK in vergelijking 
 met oudere volwassenen met verklaarde lichamelijke klachten?
 2) Welke lichamelijke, psychologische en sociale kenmerken hebben 
 oudere  patiënten met SOLK en waarin verschillen deze van oudere 
 patiënten met verklaarde lichamelijke klachten?
 
Deze vragen werden beantwoord aan de hand van data van de ‘Older Persons with medically 
Unexplained Symptoms’ (OPUS) studie. In de OPUS studie werden er bij 118 patiënten met 
SOLK van 60 jaar en ouder vragenlijsten afgenomen om lichamelijke, psychologische en 
sociale kenmerken in kaart te brengen. Dezelfde vragenlijsten werden ook afgenomen bij 
154 oudere patiënten met verklaarde lichamelijke klachten. Omdat onze meetinstrumenten 
grotendeels gelijk waren aan die van de ‘NEtherlands Study of Depression in Older persons’ 
(NESDO), konden we bovendien een vergelijking maken met oudere volwassenen die 
lijden aan een depressieve stoornis. Daarnaast hebben we bij 16 oudere volwassenen met 
SOLK kwalitatieve diepte interviews afgenomen, om zo meer zicht te krijgen op eventuele 
zingevingsproblemen. 
 
Hoe functioneren oudere volwassenen met SOLK in vergelijking met oudere 
volwassenen met verklaarde lichamelijke klachten?
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In hoofdstuk 2 van dit proefschrift bestudeerden we de aan gezondheid gerelateerde 
kwaliteit van leven van oudere volwassenen met SOLK. We vonden dat oudere patiënten met 
SOLK een lagere kwaliteit van leven rapporteerden dan oudere patiënten met verklaarde 
lichamelijke klachten. Dit verschil vonden we zowel voor de lichamelijke aspecten van de 
kwaliteit van leven als voor de mentale aspecten van de kwaliteit van leven. Deze verschillen 
tussen de twee patiëntgroepen bleven aanwezig als we in onze analyses rekening hielden 
met andere verschillen tussen beide groepen, zoals geslacht en de aanwezigheid van een 
stemmingsstoornis of angststoornis. Wanneer gecorrigeerd werd voor de mate van angst 
voor ziekte verdween het verschil in kwaliteit van leven tussen beide patiëntgroepen. Dit 
betekent mogelijk dat het bang zijn voor ziektes één van de verklaringen kan zijn voor de 
verlaagde kwaliteit van leven bij oudere patiënten met SOLK.
 
In hoofdstuk 3 hebben we bestudeerd hoe kwaliteit van leven over de tijd verandert bij oudere 
patiënten met SOLK. De kwaliteit van leven bleek, zowel bij oudere patiënten met SOLK als 
oudere patiënten met verklaarde lichamelijke klachten, af te nemen over de tijd. Een hoger 
opleidingsniveau en depressieve klachten voorspelden een grotere afname van lichamelijke 
kwaliteit van leven. Bij oudere patiënten met SOLK bleek eenzaamheid voorspellend te zijn 
voor een afname van de mentale kwaliteit van leven. Kortom, in hoofdstuk 3 komt naar 
voren dat verschillende lichamelijke, psychologische en sociale kenmerken mogelijk een rol 
spelen bij de daling van de kwaliteit van leven over de tijd heen bij oudere patiënten met 
lichamelijke klachten. 
Omdat uit eerder onderzoek is gebleken dat een gevoel van richting hebben in het leven 
–ook wel ‘zingeving’ genoemd- een positieve invloed heeft op het welzijn op latere leeftijd, 
onderzochten we in hoofdstuk 4 zingeving bij oudere patiënten met SOLK. We vonden dat 
het gevoel controle te hebben over het eigen leven belangrijk is voor oudere patiënten met 
SOLK. Daarentegen bleek het juist voor ouderen met SOLK moeilijk om controle te krijgen over 
het leven als gevolg van telkens wisselende lichamelijke klachten en de moeite die het kost 
hiermee om te gaan. Ouderen met SOLK die wel controle ervoeren over hun leven, gaven aan 
hierbij steun te hebben aan hun eigen narratieve verklaring voor hun lichamelijke klachten. 
In deze verklaringen komen –naast de lichamelijke klachten- vaak ook psychologische en 
sociale aspecten naar voren. 
Als we de bevindingen uit de hoofdstukken 2, 3 en 4 samennemen, blijkt dat bij ouderen 
SOLK tot een groter verlies aan kwaliteit van leven leidt dan lichamelijke klachten waarvoor 
wel een somatische oorzaak wordt gevonden. De kwaliteit van leven neemt bovendien af 
over de tijd, waarbij verschillende lichamelijke, psychologische en sociale factoren een rol 
lijken te spelen. Daarnaast lijkt een verminderd gevoel van controle te kunnen leiden tot 
zingevingsproblemen, welke mogelijk weggenomen kunnen worden door op zoek te gaan 
naar een eigen verklaring voor de lichamelijke klachten.
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Welke lichamelijke, psychologische en sociale kenmerken hebben oudere 
patiënten met SOLK en hoe verschillen deze van oudere patiënten met verklaarde 
lichamelijke klachten?
Lichamelijke kenmerken van SOLK op latere leeftijd
Bij ouderen betreft SOLK in veruit de meeste gevallen pijnklachten (Hilderink et al., 2009). Uit 
onderzoek bij jongere volwassenen (Katona et al., 2005) is bekend dat pijn bij depressie vaak 
onvoldoende verklaard blijft. Daarom hebben we in hoofdstuk 5 pijnkenmerken van oudere 
patiënten met SOLK vergeleken met die van oudere patiënten met verklaarde lichamelijke 
klachten en die van oudere volwassenen met een depressieve stoornis. In deze studie werd 
er gesproken van ‘chronische pijn’ als er in het afgelopen half jaar ten minste op 90 dagen 
pijnklachten aanwezig waren. Oudere patiënten met SOLK bleken twee keer zoveel kans 
te hebben op chronische pijn dan de andere twee patiëntgroepen. Als we hierbij rekening 
hielden met de aanwezigheid van depressieve klachten in de drie groepen, bleken oudere 
volwassen met SOLK nog steeds een grotere kans op chronische pijn te hebben dan oudere 
volwassenen met verklaarde lichamelijke klachten, maar een gelijke kans op chronische pijn 
te hebben als oudere volwassenen met een depressie. Verdiepende analyses lieten zien dat 
ouderen met SOLK en depressieve ouderen nauwelijks verschilden wat betreft de ervaren 
pijn intensiteit, beperkingen door pijn en het aantal pijnlocaties.
 
In hoofdstuk 6 onderzochten we pijn bij depressie op latere leeftijd meer in detail. Oudere 
volwassenen met een depressie bleken zowel meer risico te lopen op het hebben van 
acute pijn als het hebben van chronische pijn. Zowel de intensiteit, als de beperkingen 
door chronische pijn en het aantal pijnlocaties hingen samen met de mate van angst. Meer 
specifiek bleken een hoger medicatiegebruik en meer depressieve klachten samen te hangen 
met een hogere intensiteit van de chronische pijn. Een hoger medicatiegebruik en een hogere 
Body Mass Index hingen samen met meer beperkingen door de chronische pijn. Tenslotte 
bleek het vrouw zijn en het hebben van meer depressieve symptomen samen te hangen met 
het een hoger aantal pijnlocaties. 
Samengevat vonden we in hoofdstuk 5 en 6 aanwijzingen dat de kenmerken van de 
pijnklachten bij SOLK en bij depressie sterk op elkaar lijken. De associatie tussen angstklachten 
en chronische pijn bij depressieve ouderen biedt mogelijk aanknopingspunten voor 
behandeling. Immers, angstklachten zijn goed te behandelen op latere leeftijd. 
Psychologische kenmerken van SOLK op latere leeftijd. 
In hoofdstuk 7 bestudeerden we persoonlijkheidskenmerken van oudere patiënten met 
SOLK, door ze te vergelijken met persoonlijkheidskenmerken van oudere patiënten met 
verklaarde lichamelijke klachten en depressieve ouderen. Ook was er een niet-depressieve 
vergelijkingsgroep zonder actuele lichamelijke klachten. We vonden dat oudere patiënten 
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met SOLK en oudere patiënten met verklaarde lichamelijke klachten niet van elkaar 
verschilden op de eigenschappen extraversie, neuroticisme, open staan voor nieuwe 
ervaringen, consciëntieusheid en altruïsme. Oudere patiënten met SOLK rapporteerden 
wel een lager niveau van neuroticisme en een hogere mate van extraversie in vergelijking 
met depressieve ouderen. Onze onderzoeksresultaten wijzen daarmee op een specifiek 
persoonlijkheidsprofiel voor oudere patiënten met (al dan niet verklaarde) lichamelijke 
klachten. 
Cognitieve gedragstherapie (CGT), een psychologische behandelmethode waarin 
onder andere stilgestaan wordt bij niet helpende gedachten, is van de onderzochte 
behandelmethodes voor SOLK de meest effectieve gebleken (Kroenke & Swindle, 2000). 
Daarom onderzochten we in hoofdstuk 8 gedachten over de lichamelijke klachten 
–zogenaamde ziekte cognities- bij oudere patiënten met SOLK, aan de hand van een door 
ons gevalideerde vragenlijst. We vonden onder andere dat oudere patiënten met SOLK, in 
vergelijking met oudere patiënten met verklaarde lichamelijke klachten, meer gedachten 
hadden met betrekking tot hulpeloosheid, meer gedachten over het niet kunnen accepteren 
van de lichamelijke klachten en meer angstige gedachten over lichamelijke klachten en ziek 
zijn. Met deze kennis over ziekte cognities kan psychologische behandeling, zoals CGT, in de 
toekomst beter afgestemd worden op de oudere patiënt met SOLK.
 
Samengevat laten de hoofdstukken 7 en 8 geen duidelijke verschillen zien tussen de 
persoonlijkheidseigenschappen van oudere patiënten met SOLK en oudere patiënten met 
verklaarde lichamelijke klachten. Er komen, zij het in beperkte mate, wel verschillen naar 
voren in het denken over lichamelijke klachten tussen de twee patiëntgroepen, waarbij 
oudere patiënten met SOLK bijvoorbeeld vaker angstige gedachten over ziek zijn hebben.  
Sociale kenmerken van SOLK op latere leeftijd
Om sociale kenmerken goed te kunnen onderzoeken, hebben we in hoofdstuk 9 eerst een 
vragenlijst gevalideerd die sociale steun kan meten in Nederlandse epidemiologische studies. 
In hoofdstuk 10 gebruikten we deze en andere meetinstrumenten om sociale kenmerken 
van SOLK op latere leeftijd in kaart te brengen. We vonden dat oudere patiënten met SOLK, in 
vergelijking met oudere patiënten met verklaarde lichamelijke klachten, zich wat eenzamer 
voelden en een iets minder goede relatie met hun huisarts hadden. Als we hierbij in onze 
analyses rekening hielden met de aanwezigheid van somatische ziektes, bleven deze (kleine) 
verschillen tussen de twee patiëntgroepen bestaan. Het verschil in eenzaamheid werd 
verklaard door de aanwezigheid van psychiatrische stoornissen, die vaker voorkwamen 
bij ouderen met SOLK. Daarentegen bleek de kwaliteit van de relatie met de huisarts niet 
verklaard te worden door de aanwezigheid van psychiatrische stoornissen. We vonden geen 
verschillen tussen de patiëntgroepen op het gebied van sociale steun
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Ouderen met SOLK hadden vaker onvervulde zorgbehoeften op het gebied van hun 
lichamelijke gezondheid dan ouderen met verklaarde lichamelijke klachten (hoofdstuk 
10). Ook rapporteerden zij een grotere behoefte aan informatie over hun aandoening en 
behandeling. Er kwamen daarnaast aanwijzingen naar voren dat oudere patiënten met SOLK 
meer behoefte hadden aan ondersteuning bij psychische klachten dan oudere patiënten met 
verklaarde lichamelijke klachten. Dat is opvallend, omdat vaak gedacht wordt dat oudere 
patiënten met SOLK niet open zouden staan voor psychologische behandeling. 
Conclusies
De bevindingen van dit proefschrift laten zien dat SOLK op latere leeftijd een sterke en 
negatieve uitwerking hebben op de kwaliteit van leven, zelfs sterker dan verklaarde 
lichamelijke klachten. In de loop van de tijd neemt de aan gezondheid gerelateerde 
kwaliteit van leven bovendien af voor beide patiëntgroepen. Hoewel er in dit proefschrift 
niet onderzocht is welke interventies voor SOLK de kwaliteit van leven op latere leeftijd 
zouden kunnen verbeteren, geven de resultaten van ons onderzoek wel ideeën over waar al 
bestaande en nieuw te ontwikkelen interventies zich op zouden kunnen richten.
 
Aangezien eenzaamheid afname van kwaliteit van leven bij oudere patiënten met SOLK 
voorspelt, zouden interventies zich kunnen richten op het verminderen hiervan. Ook kan 
het behandelen van angstige cognities mogelijk het functioneren van oudere patiënten 
met SOLK verbeteren. In algemene zin laten onze diepte interviews zien dat deze oudere 
patiëntgroep gebaat lijkt te zijn bij het vertellen van het eigen verhaal en de eigen verklaring 
voor de lichamelijke klachten. Dit vraagt om een persoonlijke, creatieve benadering van 
behandelaars, die juist vaak geneigd zijn om vanuit vaste kaders, zoals het biomedische 
of cognitief gedragstherapeutische kader, te werken. Door aan te sluiten bij het verhaal 
en de behoeften van de patiënt, voelt de patiënt zich beter gehoord. Hierdoor staat de 
patiënt mogelijk eerder open voor passende behandelingen, ook als deze psychologisch 
georiënteerd zijn. 
In overeenstemming met wetenschappelijk onderzoek uitgevoerd bij jongere volwassenen, 
komen in dit proefschrift aanwijzingen naar voren voor een complex samenspel van 
lichamelijke, psychologische en sociale factoren bij SOLK op latere leeftijd. We dagen 
huisartsen, medisch specialisten en psychologen dan ook uit om voor elke individuele oudere 
patiënt met SOLK afzonderlijk te bekijken welke lichamelijke, psychologische en sociale en 
leeftijdsgerelateerde factoren een rol spelen bij de in stand houding van de lichamelijke 
klachten, om zo passende begeleiding en behandeling te kunnen bieden. 
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combinatie van onderzoekswerk en klinisch werk het allermooist is. Je stimuleerde me dan 
ook om de GZ-opleiding te volgen, ook al wisten we allebei dat dit niet bevorderlijk zou zijn 
voor de afronding van dit proefschrift. Inmiddels werken we na al die jaren dan toch eindelijk 
in hetzelfde gebouw en in dezelfde stad: ook dáárvoor wil ik je bedanken. 
Co-promotoren- Dr. Lucassen, Beste Peter: Als alle huisartsen zo deskundig zouden zijn als 
jij, zou SOLK zonder twijfel een veel minder groot probleem zijn in de huisartsenpraktijk. Je 
toegankelijkheid, je kennis over SOLK en het doen van kwalitatief onderzoek, en je oprechte 
interesse in anderen hebben mij in veel opzichten geholpen bij het werken aan dit proefschrift. 
Tel daar de gezelligheid van jullie kamer -in het bijzonder je interactie met Tim- bij op, en ik 
kan niet anders dan zeggen dat ik het erg getroffen heb met jou als copromotor. Ik hoop dat 
we elkaar nog vaak gaan tegenkomen in de toekomst. 
Dr. Naarding, Beste Paul: Van de drie begeleiders ben jij zonder twijfel de meeste nuchtere. Je 
hebt mij en de andere projectgroepleden gerust gesteld bij tegenvallende inclusie-aantallen 
(‘opstartproblemen’), hebt me geleerd dat er méér is dan alleen werken en hebt telkens weer 
het belang van verbinden van onderzoeksresultaten met de klinische praktijk genoemd. Veel 
dank daarvoor!  
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De leden van de manuscriptcommissie- Prof. dr. Speckens, prof. dr. Verhaak en prof. dr. 
Olde Rikkert, hartelijk dank voor het kritisch lezen en beoordelen van mijn proefschrift. 
De OPUS projectgroep- Carolien, Dorine, Margaret, Mirjam, Paul, Peter, Peter, Richard, Tim 
en Yolande, wat fijn dat jullie me het vertrouwen hebben gegeven om aan de slag te gaan 
met ‘jullie’ project. Jullie ideeën, feedback, enthousiasme, betrokkenheid en coaching in de 
afgelopen jaren hebben me telkens opnieuw gestimuleerd om iets moois te maken van de 
OPUS studie. Tim, ook al ben ik (mede dankzij jou) vertrokken uit de gezelligste wijk van 
Nijmegen, ik hoop dat we elkaar nog vaak gaan tegenkomen. Dorine, ik kijk nu al uit naar 
jouw proefschrift! 
Onderzoeksassistenten- Hanneke, dankjewel voor je hulp bij het opstarten van de 
OPUS studie. Een goed begin was echt het halve werk! Nikki, wat was het een klus om alle 
deelnemers thuis te bezoeken… Gelukkig hadden we de muziek van Tom Jones en elkaar! 
Je bent een hele lieve vriendin en ik hoop dat dit nog lang zo mag blijven. Mandy, je was 
een top stagiaire en ik was dan ook heel blij dat je ons na het afronden van je opleiding 
wilde versterken als onderzoeksassistente. Wat zullen ze blij zijn bij eerstelijnsgeneeskunde 
met jou! Lea Peters, ook al was je niet direct bij de OPUS studie betrokken, je hebt me erg 
geholpen door je kennis over o.a. het werven van SOLK patiënten te delen. Hartelijk dank 
daarvoor. Ook veel dank aan alle geneeskunde en (toegepaste) psychologie studenten die 
de afgelopen jaren stage gelopen hebben binnen de OPUS studie.  
De co-auteurs- Ik wil alle co-auteurs hartelijk bedanken voor hun feedback en de prettige 
samenwerking. In het bijzonder wil ik Inge bedanken, niet alleen omdat het hoofdstuk over 
de CPQ er zonder jou niet was geweest, maar ook omdat je me -al vanaf de tijd dat ik als 
student-assistent en later als docent voor je werkte- met je enthousiasme en nuchtere kijk op 
de academische wereld geholpen hebt om daar een weg in te vinden. 
Collega-onderzoekers op de afdeling psychiatrie- Boudewijn, Danique, Desirée, Felix, 
Geert, Jan, Janna, Janneke, Karlijn, Marloes, Melanie, Marten, Martine, Niels, Nikki, Rose, 
de dames van Karakter en alle andere onderzoekers uit de -1 gang: dankjulliewel voor de 
gezelligheid tijdens werktijd en de sociale venten na werktijd. In het bijzonder wil ik mijn 
fantastische kamergenoten bedanken: Desirée –voor je betrokkenheid, de gezelligheid en 
de mooie ervaring als paranimf-, Niels -voor je steun en je kritische blik op de wereld om je 
heen- en Rose –voor de belangrijke levensles dat een proefschrift schrijven stressvol kan zijn, 
maar een trouwjurk uitzoeken minstens zo stressvol is-. 
 
Collega’s van de poli psychiatrie- Wat fijn dat de afdeling Psychiatrie van het Radboudumc 
psychologen met onderzoekservaring de gelegenheid geeft om de opleiding tot GZ-
psycholoog te volgen. Dank aan alle collega’s van de poliklinieken, maar in het bijzonder 
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de psychologen en psychologisch medewerkers: Bart, Eline, Els, Evelien, Iris, Jeanneke, 
Katelijne, Lorraine, Pauline, Sophie, Thom en Zita, omdat jullie me –ieder op geheel eigen 
manier- hebben laten zien hoe mooi ons vak is. Evelien en Zita, jullie waren mijn steun en 
toeverlaat tijdens de GZ-jaren. Dank voor de colaatjes zero als ik het echt nodig had! 
 
Collega’s in het UMCG- Dankjulliewel voor de warme ontvangst in Groningen! Judith: 
Hoewel de overgang van ouderen naar innovatieve, gepersonaliseerde e-health zeker even 
wennen is, ben ik erg blij dat ik je onderzoeksgroep mag versterken. Veel dank daarvoor! 
 
Paranimfen- Janna en Rose: Mensen zouden kunnen denken dat ik jullie als paranimf heb 
gekozen, omdat jullie zo’n leuke (buur)kamergenoten waren, of omdat het goed staat om 
zulke talentvolle onderzoekers naast je te hebben staan op je promotiedag, of omdat ik 
zeker weet dat jullie alles tot in de puntjes precies zullen regelen voor de promotiedag, of 
omdat jullie de functie van paranimf kunnen combineren met die van stylist voor de dag, of 
omdat we in het zelfde tempo van onderwerp wisselen in een gesprek, of omdat jullie het zo 
leuk doen op de foto’s. Maar de echte reden is natuurlijk dat jullie in razendsnel tempo hele 
lieve en goede vriendinnen zijn geworden. Ik hoop dat een kilometertje of 208 daar geen 
verandering in gaat brengen. 
 
Vrienden- Mijn lieve vrienden en de vrienden van Luuk hebben me er in de afgelopen jaren 
aan herinnerd dat er ook andere leuke dingen in het leven zijn. Naast de mensen die ik 
hierboven al genoemd heb, wil ik in het bijzonder Eva, Gwen, Lotte, Louise, Rachelle, Vera 
en Vivian bedanken: wat fijn dat we het na ruim een half leven nog steeds zo leuk hebben 
samen! Lotte, we wisten het eigenlijk al op de middelbare school toen we wiskunde C 
‘uitvonden’: wat zijn we toch een goed duo, in goede en in stressvolle tijden! Als je ooit iets 
wil schrijven over binge eating bij ouderen, houd ik me aanbevolen. Etienne, Kim, Lizanne, 
Noortje en Rachelle: jullie zijn na al die jaren nog steeds onverminderd leuk! Lizanne, wat een 
geluk dat we nu eindelijk weer in dezelfde stad komen te wonen! Als jij ooit een paper over 
het effect van methylfenidaat op het brein van ouderen met ADHD wil schrijven, houd ik me 
óók aanbevolen. 
Familie- Pim, Amelie, Luthien en Casper; Koen, Renilde, Eyra en Euan; Bas, Femke, Roos en 
Quinn: wat ben ik blij met jullie als extra broers, zussen, neefjes en nichtjes! Een bijzonder 
woord van dank voor mijn schoonouders Ben en Margreet, omdat jullie met veel liefde, 
aandacht en geduld op onze mini gepast hebben als wij aan het werk waren. Erik, Debby, 
Danee en Chelsey; Silvia en Jack; pap en mam: Al joare mot geer wiet rieje um langs te 
kòmme en ut wurt allein mèr erreger. Danke dat geer mich ummer miene gank höb loate 
goan, auch es geer gein idee houwt wat ich noe precies aan ut doon woar en worum. Geer 
höb mich misjiens waal ut allermeiste geholpe mèt alle kwatsj en sjtiekeme brwedjes met 
pasta es ich weer ins op bezeuk woar. Dankedaag.  
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De mannen- Lieve Luuk: Ik ben op mijn gelukkigst sinds het moment dat ik je leerde kennen, 
slechts een paar maanden voordat ik solliciteerde op deze promotieplek. Ik vind je nog 
steeds zo ontzettend leuk dat het me zelfs niets uitmaakt dat je maar af en toe om mijn 
grappen kunt lachen. Bij niemand voel ik me zo fijn als bij jou. Lieve Lars: Wat ben je mooi, 
lief, eigenwijs en wat heb je -nu al- mooie verhalen. Ik hou mega van jullie. 
 
